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Zusammenfassung
In der Strahlentherapie mit Protonen und schwereren Ionen ist durch die erreichbaren steilen Do-
sisgradienten eine hochkonforme Anpassung der applizierten Strahlendosis an beliebig geformte
Zielvolumina möglich. Diese geht allerdings mit einer erhöhten Empfindlichkeit gegenüber poten-
ziellen Unsicherheiten, etwa durch Veränderungen in der Patientenanatomie, einher. Zusätzliche
Herausforderungen entstehen durch Atembewegungen, welche nicht nur zu schnellen anatomischen
Veränderungen, sondern, im Falle gescannter Ionenstrahlen, auch zur Ausprägung von Dosis-
inhomogenitäten führen können. Daher ist es unbedingt wünschenswert, die Applikation der
Bestrahlung genau zu verifizieren und mögliche Abweichungen von der geplanten Bestrahlung
zu detektieren. Das einzige derzeit klinisch eingesetzte Verfahren, welches die zeitnahe Ver-
ifizierung einzelner Bestrahlungsfraktionen erlaubt, basiert auf der Messung der während der
Bestrahlung gebildeten β+-Emitter mittels Positronen-Emissions-Tomographie (PET). Am Hei-
delberger Ionenstrahl-Therapiezentrum (HIT) wurde speziell hierzu ein kommerzieller PET/CT
(Computer-Tomographie)-Scanner direkt neben den Bestrahlungsräumen installiert. Bis heute
ist die Anwendung dieses Verfahrens jedoch klinisch auf statische Zielvolumina beschränkt.
Ziel dieser Dissertation war es, die Möglichkeiten der Anwendung PET-basierter Bestrahlungsver-
ifikation unter Berücksichtigung von Organbewegungen zu untersuchen. In einer experimentellen
Bestrahlungsstudie mit bewegten Phantomen konnte nicht nur erstmals die Machbarkeit einer
PET-basierten Bestrahlungsüberwachung bewegter Objekte mittels eines kommerziellen PET/CT-
Scanners gezeigt werden, sondern auch das hohe Potenzial dieser Methode, Abweichungen von der
geplanten Bestrahlung durch Bewegungen im Sub-Millimeter Bereich zu detektieren. Auch die
erste Anwendung unter erheblich schwierigeren, klinischen Bedingungen auf vier exemplarische
Leberzellkarzinom-Patienten zeigte mögliche Verbesserungen durch Berücksichtigung der Tumor-
bewegung, speziell für Patienten mit einer Bewegungsamplitude von über 1 cm, bei denen eine hin-
reichende Zahl von Koinzidenzen während des PET-Scans gemessen wurde. Trotz Anwendung der
in einer detaillierten Phantom-Bildgebungsstudie im Rahmen dieser Arbeit ermittelten optimalen
PET Rekonstruktions-Parameter, erwies sich jedoch eine zu niedrige Anzahl gemessener Koinzi-
denzen und das daraus resultierende Bildrauschen als ein entscheidender limitierender Faktor für
den Nachweis von Dosisinhomogenitäten im Patienten. Auch die Modellierung der biologischen
Auswaschung der induzierten Radio-Isotope erwies sich als nicht hinreichend genau und erschwert
bislang eine quantitative Analyse der gemessenen und simulierten Daten unter Berücksichtigung
der Organbewegung. Zukünftig sind Verbesserungen durch rauschärmere, zeitaufgelöste Rekon-
strucktionsalgorithmen, eine verbesserte Bewegungsüberwachung, z.B. mittels Ultraschallbildge-
bung, welche im Rahmen dieser Arbeit erstmals in die zeitaufgelöste PET-Bildgebung integriert
wurde, sowie einer patienten-spezifischen Modellierung der Aktivitäts-Auswaschung zu erwarten.

Abstract
Due to the accessible sharp dose gradients, external beam radiotherapy with protons and heavier
ions enables a highly conformal adaptation of the delivered dose to arbitrarily shaped tumour
volumes. However, this high conformity is accompanied by an increased sensitivity to potential
uncertainties, e.g., due to changes in the patient anatomy. Additional challenges are imposed by
respiratory motion which does not only lead to rapid changes of the patient anatomy, but, in the
cased of actively scanned ions beams, also to the formation of dose inhomogeneities. Therefore,
it is highly desirable to verify the actual application of the treatment and to detect possible
deviations with respect to the planned irradiation. At present, the only clinically implemented
approach for a close-in-time verification of single treatment fractions is based on detecting the dis-
tribution of β+-emitter formed in nuclear fragmentation reactions during the irradiation by means
of positron emission tomography (PET). For this purpose, a commercial PET/CT (computed to-
mography) scanner has been installed directly next to the treatment rooms at the Heidelberg
Ion-Beam Therapy Center (HIT). Up to present, the application of this treatment verification
technique is, however, still limited to static target volumes.
This thesis aimed at investigating the feasibility and performance of PET-based treatment ver-
ification under consideration of organ motion. In experimental irradiation studies with moving
phantoms, not only the practicability of PET-based treatment monitoring for moving targets, us-
ing a commercial PET/CT device, could be shown for the first time, but also the potential of this
technique to detect motion-related deviations from the planned treatment with sub-millimetre
accuracy. The first application to four exemplary hepato-cellular carcinoma patient cases under
substantially more challenging clinical conditions indicated potential for improvement by taking
organ motion into consideration, particularly for patients exhibiting motion amplitudes of above
1 cm and a sufficiently large number of detected true coincidences during their post-irradiation
PET scan. Despite the application of an optimised PET image reconstruction scheme, as re-
trieved from a dedicated phantom imaging study in the scope of this work, the small number of
counts and the resulting high level of image noise were identified as a major limiting factor for the
detection of motion-induced dose inhomogeneities within the patient. Moreover, the biological
washout modelling of the irradiation-induced isotopes proved to be not sufficiently accurate and
thereby impede a quantitative analysis of measured and simulated data under consideration of
target motion. In future, improvements are particularly foreseen through dedicated noise-robust
time-resolved (4D) image reconstruction algorithms, an improved tracking of the organ motion,
e.g., by ultrasound (US) imaging, as implemented for the first time in 4D PET imaging in the
scope of this work, as well as by patient-specific washout models.

Chapter 1
Introduction
According to the Eurostat database, cancer is the second leading cause of death in Germany and
the European Union. In 2010, there have been 480, 000 new cancer cases and 220, 000 cancer-
related deaths in Germany [Kaatsch et al., 2013]. Due to the ageing population, cancer incidences
are expected to increase further over the next years. Surgery, chemotherapy, radiotherapy and
combinations of these constitute the main treatment options for cancer patients. Radiotherapy
is a particularly suitable option for patients with a cancer diagnosis at the stage of a localised
primary tumour. In total, about 50% of all cancer patients undergo radiotherapy during their
course of treatment.
The goal of radiotherapy is the inactivation of cancer cells by irradiation-induced ionisation
processes. As similar mechanisms occur in non-tumour cells as well, the radiation burden to
adjacent healthy structures has to be kept as low as reasonably possible. Consequently, radio-
therapy aims at delivering a highly conformal lethal dose to the defined target volume, while not
exceeding the toxic dose in the surrounding normal tissue. As a promising alternative to the
conventional radiotherapy with photons, which has been used for tumour treatment since the
end of the 19 th century, ion beam therapy with protons and heavier ions, such as 12C, has been
investigated by several research facilities since the 1950s and integrated into clinical environments
since the 1990s. Recent studies have shown that the superior dose conformity, which is feasible
due to the favourable physical properties of ion beams with respect to photon beams, can result
in an improved tumour control rate for particular cancer indications [Schulz-Ertner et al., 2007;
Tsujii et al., 2007; Durante and Löffler, 2010].
At the same time, however, the accessible sharp dose gradients make ion beam therapy prone
to uncertainties, introduced e.g., by changes in the patient anatomy or deviations in the pa-
tient positioning. In order to fully exploit the potential of ion beam therapy, it is therefore
highly desirable to verify the correct application of the planned treatment. Up to date, the only
clinically implemented approach for in-vivo monitoring of single treatment fractions during or
shortly after ion beam irradiation is based on positron emission tomography (PET) imaging of
the irradiation-induced β+-emitter within the patient, which are produced as a by-product in
nuclear fragmentation reactions during the treatment. This method is, e.g., applied at the Hei-
delberg Ion-Beam Therapy Center (HIT), where the patient activation is measured directly after
the irradiation with a commercial full-ring PET/CT (computed tomography) scanner installed
next to the treatment rooms (offline).
Considerable challenges are additionally imposed to ion beam therapy if the target volume
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is affected by organ motion, e.g., due to respiration. Motion does not only result in a changing
anatomy of the target region during the actual beam application, but can also lead to dose
inhomogeneities in the target volume due to an interplay of the organ motion and the dynamic
beam delivery in the case of scanned ion beams. Despite the additionally introduced uncertainties,
the treatment of moving tumours is of high clinical interest: for hepato-cellular carcinoma (HCC)
patients, e.g., for which the 5-year survival rate in Germany was found to be below 10% in 2010
[Kaatsch et al., 2013], studies at the National Institute of Radiological Sciences (NIRS) in Chiba
(Japan) showed a clearly improved outcome by hypo-fractionated irradiation with carbon ions
[Kato et al., 2004; Tsujii et al., 2007]. The increased level of uncertainty in the treatment of
moving targets, however, strongly demands for a thorough monitoring of the actually applied
treatment.
Aim of this thesis is to expand the already clinically integrated offline PET-based treatment
verification at HIT from stationary to moving target volumes by considering the organ motion
during the irradiation, as well as during the subsequent PET/CT acquisition. Up to present, the
applicability of PET-based treatment monitoring to moving targets has only been investigated in
few irradiation studies with mobile phantoms, using dedicated dual-head in-beam PET cameras
[Parodi et al., 2009; Stützer et al., 2013]. In the scope of this work, the first moving phantom study
on the feasibility and potential of time-resolved (4D) offline PET-based treatment verification
with a commercial PET/CT scanner will be presented, as well as the first application of this
monitoring technique to clinical cases.
The thesis is organised as follows: chapter 2 introduces the physical and biological fundamen-
tals of ion beam therapy, together with its technical and clinical implementation, and reviews
the role of uncertainties and organ motion in particle therapy. In chapter 3 the approach of
PET-based treatment verification is explained in detail, with a special focus on the offline im-
plementation at HIT. The following chapter 4 presents a first detailed study on the feasibility
and potential of 4D offline PET monitoring after 12C ion irradiation with a commercial full-ring
PET/CT scanner in a high statistics moving phantom scenario. Moreover, a first integration
of ultrasound (US) based motion tracking into 4D PET imaging, which is foreseen as a future
option to enhance the accuracy of 4D patient PET imaging, will be covered. Chapter 5 deals
with a detailed analysis of the performance of the used PET/CT scanner under extremely low
counting statistics, which are generally considered as a main challenge in PET-based treatment
verification, but particularly impede 4D PET imaging at typically even reduced count numbers.
This chapter also aims at identifying the optimal reconstruction scheme to be applied under
the particular statistical conditions in post-irradiation PET imaging and discusses the impact of
the high radiation background emerging from the radioactive Lutetium-based PET detectors on
the acquired images. Eventually, chapter 6 introduces the first clinical application of 4D PET-
based treatment verification to four exemplary HCC patients treated with scanned 12C ion beams
at HIT and evaluates the potential, as well as the current limitations of post-irradiation PET
imaging for monitoring the treatment of moving tumours. Chapter 7 concludes this thesis and
discusses future perspectives and possible improvements of 4D PET-based treatment monitoring
in ion beam therapy.
Chapter 2
Fundamentals of ion beam therapy
2.1 A brief introduction to ion beam therapy
In general, radiotherapy aims at sterilising cancer cells by irradiation-induced ionisation processes.
The most sensitive target of the cell is represented by the Deoxyribonucleic acid (DNA). Single,
double and, even more effectively, complex clustered strand breaks of the DNA molecule can lead
to the inactivation of single cells and result in a local control or even shrinkage of the tumour
[Goodhead, 1994]. Similar processes, however, also occur in the surrounding healthy tissue and
close-by organs at risk, leading to side-effects during the irradiation or even inducing secondary
cancer on a time-scale of months to years. Consequently, a highly conformal dose delivery to the
tumour and best-possible sparing of the adjacent healthy structures has to be the aim of radiation
therapy.
Although the conformity of conventional external beam radiotherapy with photons could
be further increased over the last years by modern beam application techniques like intensity-
modulated radiation therapy (IMRT) [Webb, 2003] or volumetric intensity-modulated arc therapy
(VMAT) [Rao et al., 2010], it is still intrinsically limited by the physical properties of high-
energy (MeV) photon beams: the shallow maximum of the energy and herewith dose deposition
of a photon beam can be found few centimetres away from the patient surface and is followed
by an exponential decay with increasing depth. As an alternative to photon irradiation, the
application of proton or heavier ion beams had already been envisioned by Robert R. Wilson in
1946 [Wilson, 1946]: these beams show an “inverse” depth dose profile, exhibiting a sharp dose
maximum, known as the Bragg-peak (BP) [Bragg and Kleeman, 1905], close to the end of the
primary ions range, while the dose deposited in the entrance channel is comparably small (see
figure 2.1). The position of this BP is directly correlated with the energy of the incident ion beam
and can thus be adjusted with millimetre accuracy to the given target structure. Even extended
deep-seated tumours can be covered by the superposition of ion beams of different energies to a
so-called spread-out Bragg-peak (SOBP) at a still comparably low entrance dose, as also shown
in figure 2.1. Moreover, ions heavier than protons show a reduced lateral scattering, as well as an
enhanced biological effectiveness in comparison to photons, making them particularly interesting
for the treatment of hypoxic and radio-resistant tumours with poor response to conventional
radiotherapy. A detailed description of the underlying processes will be given in the following
sections. Making optimal use of these properties, the integral dose given to the patient can
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Figure 2.1: Comparison of photon and ion beam depth dose distributions. While photons exhibit
a shallow dose maximum close to the entrance region, ion beams show a distinct dose maximum,
known as the Bragg-peak, close to the end of the particles range (left). In order to cover a deep-seated
extended tumour volume with a homogeneous dose, ion beams of different energies are super-imposed
to a spread-out Bragg-peak (right). Figure from [Durante and Löffler, 2010].
be significantly reduced and a higher conformity to arbitrarily shaped target volumes can be
achieved, as shown for the case of a head tumour in figure 2.2.
Following the investigations of R. Wilson, first patients have been treated with protons in
1954 at the Lawrence Berkeley Laboratory (LBL) in Berkeley, USA [Tobias et al., 1958]. First
irradiations with Helium ions started in 1957, followed by first treatments with heavier ions
like Carbon and Neon at the same institution in 1975 [Castro et al., 1980]. Still, it took until
1990 before the first dedicated ion beam therapy facility, embedding proton therapy in a clinical
environment, opened at the Loma Linda University Medical Center (LLUMC). Up to date, more
than 100, 000 patients have been treated with protons and heavy ions world-wide. More than
40 ion beam therapy facilities are currently in operation and more than 30 centres are in the
planning or construction phase [PTCOG, 2013].
In Germany, first patients have been treated with carbon ions at the GSI Helmholtzzentrum
für Schwerionenforschung at Darmstadt in 1997 [Debus et al., 2000]. Until the shut-down in
2008, over 400 patients, mostly suffering from tumours in the brain and the skull-base, have
been treated. The promising clinical results achieved in the GSI pilot project [Schulz-Ertner
et al., 2004, 2007] motivated the building of a dedicated, hospital-based proton and carbon ion
treatment facility, the Heidelberg Ion-Beam Therapy Center [Haberer et al., 2004]. Starting
patient treatment in 2009, nearly 2000 patients have been treated at HIT until the end of 2013.
2.2 Physical properties of ion beams
The above-mentioned favourable physical properties of proton and heavy ion beams, namely the
inverse depth dose profile and the reduced lateral scattering in the case of heavier ions, are directly
related to the underlying physical interactions of ions in matter, which will be reviewed in this
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Figure 2.2: Comparison of the 2D dose distributions (color wash) achieved with 9 intensity-modulated
photon fields (left) and 2 opposing carbon ion fields (right). As can be seen, a higher dose conformity
and a lower integral dose outside the target volume can be achieved by the heavy ion beams. Coutesy
of O. Jäkel, Heidelberg University Hospital.
section.
The central physical quantity in external beam radiotherapy with photons and ion beams is
the dose deposited in a medium. According to [ICRU, 1993b] it is defined as the mean energy dε
deposited by the directly- or indirectly-ionising radiation in a mass element dm and is measured
in Gray (Gy):
D =
dε
dm
[1Gy = 1J/kg] . (2.1)
For a mono-energetic parallel beam, the dose absorbed in a thin layer of an absorber material
with mass density ρ is given by:
D[Gy] = 1.6× 10−9 × dE
dx
[
keV
µm
]
× Φ
[
cm−2
]
× 1
ρ
[
cm3
g
]
, (2.2)
where Φ is fluence of the incident particle beam, i.e. , the number of particles per area, and dE/dx
is the particles energy-loss per unit path-length, the so-called electronic stopping power S.
2.2.1 Energy-loss of ions in matter
Three different mechanisms contribute to the energy-loss of ion beams in matter. The inelastic
scattering of the ions on the target electrons, leading to the electronic stopping power, the elastic
scattering of the ions on the target nuclei, known as nuclear stopping power, and the energy-loss
by radiative processes.
In ion beam therapy, the initial beam energies are adapted to the requirement that deep
seated tumours in a water-equivalent depth of up to 30 cm within the patient can be reached
by the Bragg-peak. Therefore energies of up to 220 MeV for protons and up to 430 MeV/u for
12C ions are of need, corresponding to velocities of up to 0.7 · c, where c is the speed of light.
In this medium-relativistic energy regime, energy-loss is dominated by the electronic stopping
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Figure 2.3: Stopping power of protons and 12C ions in water. The residual ranges of 12C ions
corresponding to the specific energies (energy per atomic mass unit u) on the x-axis are shown at the
top. Figure from [Schardt et al., 2010].
power [Schardt et al., 2010], which can be well described by the Bethe-Bloch formula [Bethe,
1930; Bloch, 1933; Fano, 1963] down to energies of about 1 MeV/u:
−dE
dx
= 2πr2emec
2Ne
Z2p
β2
[
ln
(
2mec
2β2γ2Tmax
〈I〉2
)
− 2β2 − 2 C
Zt
− δ
]
. (2.3)
Here, Tmax is the largest possible energy transfer in a single collision with a free electron, re
the classical electron radius, me the electron rest mass, β the projectile velocity in units of c,
γ = 1/
√
1− β2 and Zp the projectile electric charge. 2C/Zt and δ describe the shell and density
effect correction, respectively. The absorber medium itself is characterised by its electron density
Ne and its mean ionisation potential 〈I〉. For water, e.g., an ionisation potential of 75 eV was
recommended by the ICRU [ICRU, 1994] in the case of protons, but proposals for higher values
(for protons as well as heavy ions), ranging from 75 to 80 eV, have been made in the literature
[Bichsel et al., 2000; Kumazaki et al., 2007; Schardt et al., 2008; Parodi et al., 2012; Kurz et al.,
2012].
The electronic stopping power of protons and 12C ions in water are shown in figure 2.3 as as
a function of the particle energy and the residual particle range. For incident ions at therapeutic
energies in the order of 102 MeV/u, the stopping power, and herewith the local dose deposition
will increase with decreasing energy due to the dominant 1/β2 dependence in equation 2.3. The
maximum energy-loss will occur shortly before the particles stop and their energy falls below
1 MeV/u, giving rise to the above-mentioned Bragg-peak. At even lower energies, the stopping
power finally decreases due to recombination processes in the media, which reduce the effective
charge of the projectiles. This can be incorporated in the Bethe-Bloch formula by replacing the
projectile charge Zp by the effective charge Zeff , given by empirical formula [Barkas, 1963]:
Zeff = Zp
[
1− exp(−125βZ−2/3p )
]
. (2.4)
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Figure 2.4: Illustration of different range definitions (left, courtesy of O. Jäkel) and mean ranges of
different ion species as a function of their initial energy in water (right) [Schardt et al., 2010].
At energies below about 10 keV/u, the contribution of the nuclear stopping power starts to in-
crease (see figure 2.3), but the contribution to the deposited dose is very small and generally
neglected in radiotherapy applications [Elsässer et al., 2009], just as contributions from the ra-
diative energy-loss processes at therapeutic energies.
The finite path-length RCSDA of a particle in an absorber until it comes to rest is given by:
RCSDA(E) =
E∫
0
(
dE′
dx
)−1
dE′. (2.5)
in the so-called continuous slowing down approximation (CSDA). For heavy charged particles,
which experience little lateral scattering, the average depth of penetration in the absorber, called
mean or projected particle range R, is very similar to the CSDA range RCSDA. An illustration
of the different range definitions, as well as the mean range in water of different therapeutically
used ion species as a function of their initial energy is given in figure 2.4. Taking into account
the main Z2p and 1/β
2 dependencies of the stopping power in the Bethe-Bloch formula, one can
find that the range for the same velocity β approximately scales with A/Z2p .
The Bethe-Bloch equation, however, only describes the mean energy-loss per unit path-length,
as the energy-loss in matter is affected by statistical fluctuations. These fluctuations, known as
energy-loss straggling, lead to a broadening of the energy spectrum of an incident ion beam,
consisting of a large number of particles, with increasing depth. In the limit of a large absorber
or many collisions, the broadened energy distribution can be approximated by a Gaussian of
width σE [Bohr, 1940; Ahlen, 1980]. The energy straggling directly translates into a straggling
of the residual range with width σR and leads to a broadening of the Bragg-peak, as well as to a
decrease of the peak-to-plateau dose ratio. The straggling width σR can by approximated by:
σR =
R√
M
f
(
E
Mc2
)
med
, (2.6)
where f is a nearly constant function depending on the absorber material [Schardt et al., 2010].
Consequently, range straggling, and herewith Bragg-peak width and entrance-to-peak dose ratio,
will increase with increasing particle range and decrease with increasing particle mass M .
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Figure 2.5: Mean lateral deflection of protons and different heavy ion species as a function of their
penetration depth in water. At the same depth, scattering of protons is clearly enhanced [Parodi,
2004].
2.2.2 Lateral scattering
Besides the discussed inverse depth dose profile, ions heavier than protons offer the advantage of
a reduced lateral scattering in comparison to MeV photon beams. The lateral scattering of ion
beams in a medium can mainly be attributed to the elastic Coulomb scattering of incident ions
on the target nuclei, deflecting them by an angle Θ from their original path. In order to obtain
the distribution of the scattering angle Θ, a Boltzmann transport equation [Arkeryd, 1972] has
to be solved. The analytical solution has been presented by Molière [Molière, 1948] and can be
approximated for small scattering angles by a Gaussian distribution with a standard deviation
given by the Highland formula [Highland, 1975]:
σΘ[rad] =
14.1MeV
βpc
Zp
√
d
Lrad
[
1 +
1
9
log10
(
d
Lrad
)]
, (2.7)
In this equation, the absorber material is characterised by its thickness d and its radiation length
Lrad (for water, e.g.,Lrad = 36 cm). Due to the 1/βpc factor, lateral scattering will increase for
low energies and will be reduced for heavier ions in comparison to protons at the same penetration
depth, as shown in figure 2.5.
2.2.3 Nuclear interactions
Besides the electromagnetic interactions discussed in the two previous sections, heavy ions can
interact with the target nuclei via the strong nuclear force. These interactions lead to an expo-
nential attenuation of the primary heavy ion fluence Φ in depth according to:
Φ(z) = Φ0 exp (−NσReacz) , (2.8)
where Φ0 is the initial ion beam fluence, σReac the total reaction cross-section and N the density
of target nuclei.
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Figure 2.6: Illustration of the abrasion-ablation model to describe peripheral nucleus-nucleus colli-
sions at therapeutic energies. After few nucleons are abraded in a small overlapping zone (“fireball”),
the generated projectile and target fragment, as well as the fireball de-excite in the so-called ablation
process. Taken from [Gunzert-Marx et al., 2008].
For geometrical reason, peripheral collisions of heavy ions in which only few nucleons of the
projectile and the target nuclei participate are much more common than central collision, which
could result in a complete disintegration of both particles. These peripheral nucleus-nucleus col-
lisions are described as a two step process in the so-called abrasion-ablation model [Serber, 1947],
which is schematically shown in figure 2.6. In a first step, nucleons are abraded in a small over-
lapping zone (“fireball”), while the remaining outer nucleons, having a Fermi-energy comparably
low to the projectile energy, are only slightly affected. In a second step, the newly build projectile
and target fragment, as well as the fireball de-excite in the so-called ablation process, emitting
prompt-γ radiation, protons, neutrons or nucleon clusters. According to the collision kinematics,
the target fragment almost stays at rest, while the projectile fragment proceeds at nearly the
same velocity as the incident nuclei. Further details on nuclear fragmentation reactions can, e.g.,
be found in [Goldhaber and Heckman, 1978; Hüfner, 1985].
The reduced fluence of incident particles (according to equation 2.8) directly translates into a
reduced peak-to-entrance dose ratio since the Bragg-peak is produced by only a reduced number
of primary heavy ions. Moreover, the on-going nuclear interactions lead to the build up of a
secondary particle spectrum. While the energy deposited by the target fragments, nearly at rest,
can be neglected, the dose deposited by the further penetrating projectile fragments has to be
considered in the dose calculation. Due to the A/Z2p dependence of the ion range, fragments with
charge Z < Zp, travelling at about the same velocity as the incident heavy ions, have typically
larger ranges in the media with respect to the primary ions and deposit dose behind the actual
Bragg-peak, where the primary particles are stopped. The contributions of various projectile
fragments produced by a 12C ion beam in water to the integrated depth dose distribution are
shown in figure 2.7. Although the reaction cross-section σReac is nearly constant down to energies
of about 100 MeV/u, ion beams of higher energies show a more pronounced dose tail and an
enhanced decrease of the dose in the plateau region due to the longer path-length travelled by
the primary particles.
The secondary particles produced in the nuclear fragmentation reactions not only affect the
depth dose distribution of heavy ion beams in matter, but also the lateral dose profiles. Although
the produced secondary particles are clearly forward peaked, their lateral distribution is broader
if compared to that of the primary ions, also due to the enhanced scattering of lighter particles
(cf. equation 2.7). Consequently, the lateral dose profile has to be described not only by one
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Figure 2.7: Simulation of the dose contributions of projectile fragments to the total depth dose
distribution of a 200 MeV/u 12C ion beam in water (right). While the generated carbon fragments
(mainly 11C) are stopped shortly before the Bragg-peak, projectile fragments with lower Z have
typically increased ranges and give rise to the exit dose behind the peak (left). Figure from [Gunzert-
Marx et al., 2008].
Gaussian (related to the multiple scattering of the primary beam according to section 2.2.2),
but a linear combination of at least two [Schwaab et al., 2011; Parodi et al., 2013] or even three
[Inaniwa et al., 2009].
Although nuclear processes have been described for the case of heavy ions up to this point,
protons will undergo nuclear interactions with the target nuclei, as well, resulting in a decrease
of the primary proton fluence according to equation 2.8 with increasing depth. These nuclear
reactions lead to the formation of target fragments, nearly staying at rest in the much more likely
peripheral collisions, and to the production of secondary protons, as well as other light secondary
particles evaporated from the excited target nuclei (e.g., deuterons, tritons and Helium isotopes)
[Paganetti, 2002]. In contrast to the previously discussed nucleus-nucleus interactions, however,
dose contributions by secondary particles are orders of magnitude lower. Moreover, no projectile
fragments and no fireball at the abrasion stage are generated in the case of incident proton beams.
Despite the fact that nuclear fragmentation reactions affect the spatial dose deposition pattern
in an unfavourable manner by reducing the number of primary ions reaching the Bragg-peak,
giving rise to an exit dose distal to the dose maximum (only in the case of heavy ions) and
enhancing the lateral spread of the dose distribution, they can be of clinical benefit: nuclear
interactions lead to the formation of neutron-deficient β+-emitting fragments, which can be used
for non-invasive, in-vivo ion beam treatment verification by PET imaging, as will be explained
in detail in chapter 3. At a pre-clinical stage, also the imaging of prompt gammas and secondary
ions emerging from the nuclear interactions is currently being investigated in the context of ion
beam therapy monitoring [Min et al., 2006; Gwosch et al., 2013; Knopf and Lomax, 2013].
2.3 Biological aspects of heavy ion beams
Besides the physical advantages covered in the previous section, ions heavier than protons might
also yield an enhanced biological selectivity with respect to photons. The quantity relating the
efficiency of ions to those of photons is the relative biological effectiveness (RBE), defined as the
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Figure 2.8: Illustration of the RBE definition for heavy ions from experimental cell-survival curves.
It can be seen that the RBE depends on the regarded iso-effect, here the 10% and 1% survival,
respectively. From[Schardt et al., 2010].
ratio of the physical dose by a reference radiation, typically 60Co γ-radiation, and the physical
dose by the ion radiation, both resulting in the same biological effect [Scholz, 2003] (see figure
2.8).
RBE =
Dref
Dion
∣∣∣∣
iso−effect
. (2.9)
By weighting the physical ion dose with the RBE, the so-called biological dose of the ion radiation
can be obtained and directly compared to an equivalent photon dose. By this, the experience
gained in photon therapy, e.g., the dose required for local tumour control, can directly be trans-
lated into the field of ion therapy.
The RBE itself is a complex quantity depending on a variety of parameter like the regarded
iso-effect in equation 2.9 (typically the 10% or 1% cell-survival, see figure 2.8), the cell-type under
investigation, the charge Z of the heavy ion species and the linear energy transfer (LET) of the
incident radiation [Weyrather et al., 1999]. The latter quantity is defined as:
LET∆ =
dE∆
dx
, (2.10)
where dE∆ is the energy locally transferred to charged secondary particles of the stopping
medium, not accounting for secondary particles with an energy above a given threshold ∆, as
these are not absorbed locally. Setting ∆ to infinity, one obtains the “unrestricted stopping
power”, which is equal to the electronic stopping power given by equation 2.3.
The dependence of the RBE on the LET is displayed in figure 2.9. As can be seen, heavy ions
provide an increasing RBE towards higher LET and smaller residual ranges. Consequently, when
approaching the Bragg-peak, positioned within the tumour, the LET and herewith the RBE of
the heavy ion beam will increase. At the same time, the RBE will be comparably low in the
beam entrance region, despite the lower dose level at which a higher RBE could be expected (cf. ,
figure 2.8). In the end, this differential effect between entrance and Bragg-peak region leads to
a superior biological selectivity of heavy ions with respect to photons. In the case of protons
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Figure 2.9: The RBE of 12C ions as a function of the LET (left) and the residual range (right) for
CHO-K1 chinese hamster cells and their repair deficient mutant xrs-5. Figure from [Weyrather et al.,
1999].
on the other hand, the increase of LET and herewith RBE towards the Bragg-peak is much less
pronounced due to the Z2p dependence of the LET, and it was shown to be sufficient to apply a
constant RBE of 1.1 in the whole treatment field [Paganetti et al., 2002]. An enhanced biological
selectivity with respect to conventional photon therapy is thus not given in proton therapy, as
there is no differential effect between the entrance and the target region.
For a deeper understanding of the LET dependence of the RBE, the local dose deposition
pattern and track-structure of heavy ions has to be considered. In general, heavy ions with high
LET show an increasingly inhomogeneous local dose deposition, leading to more complex DNA
damages and herewith an increased biological efficiency [Krämer et al., 2003].
2.4 Clinical implementation of ion beam therapy
2.4.1 Ion beam delivery
Up to present, most of the operating ion beam therapy facilities use a so-called passive beam
delivery : a narrow, almost mono-energetic ion beam is widened up in the lateral direction by
several scattering systems and in depth by a range modulator or binary range shifters, yielding
a homogeneous 3D dose-cube. This cube is then adapted to the patient-specific target anatomy
by a collimator (lateral shaping) and a patient-specific bolus (distal edge shaping) [Chu et al.,
1993]. Besides the need for patient-individual hardware, this method has limitations in adapting
the dose to the proximal edge of the tumour and shows a comparably high yield of fragments and
secondary particles like neutrons due to interactions in the passively beam shaping elements.
In order to overcome these drawbacks, most of the planned or recently built centres use a
3D active scanning beam delivery system [Haberer et al., 1993; Pedroni et al., 1995]. The idea is
as follows (cf. figure 2.10): the tumour is sub-divided into slices corresponding to the same ion
beam energy in beam’s eye view (BEV). In each of these slices, the tumour volume is covered
with a grid of so-called raster-spots which are subsequently irradiated with a prescribed number
of particles by deflecting the ion beam with a set of two dipole magnets in the horizontal and
vertical direction. If all spots of one energy layer are irradiated to the given particle number, the
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Figure 2.10: Illustration of the 3-D Raster Scanning technique at HIT. The presently irradiated
iso-energy layer is selected by tuning the ion beam energy directly at the synchrotron. A double
magnet system accomplishes the lateral beam deflection to the individual raster-spots within each
layer. Moreover, the beam application monitoring system (BAMS) in front of the patient is depicted.
(Source: Siemens Healthcare, Particle Therapy).
energy of the beam is changed to the next adjacent energy slice.
These active beam delivery systems enable sub-millimetre accuracy and, as the intensity is
varied from spot to spot in order to achieve a homogeneous dose within the tumour, inherently
offer intensity-modulation and best-possible dose conformity to the target volume, including the
proximal edge. Moreover, if the energy variation from slice to slice is applied directly at the
accelerator level, passively shaping elements can be avoided completely. On the other hand,
active scanning techniques are technically much more challenging: the position and intensity
of the beam needs to be verified in real-time for each single raster-spot, as small deviations can
already lead to remarkable changes in the dose distribution because of the sharp dose gradients of
the single pencil beams. Hence, beam application monitoring systems need to be installed. They
typically consist of a redundant set of ionisation chambers (IC) and position sensitive detectors
(e.g., multi-wire proportional chambers (MWPC) or strip chambers) for fluence and position
verification, respectively. Feedback-loops then have to enable the regulation of deviations or, in
critical cases, the abortion of the beam application within µs.
2.4.2 The Heidelberg Ion-Beam Therapy Center
At HIT, 3D intensity-modulated raster-scanning is applied, using active energy variation at the
synchrotron accelerator level. In order to optimise patient care, the accelerator system offers a
comprehensive library of possible beam settings, which can be used in the treatment planning
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Figure 2.11: The main components of HIT: ions are produced at the ion sources and accelerated
stepwise in the linear accelerator (LINAC) and the synchroton. The high energy beam transfer line
(HEBT) guides the ions to the two horizontal treatment places, the gantry and the experimental area.
[Winkelmann et al., 2010].
process (see next subsection): 255 energy steps, corresponding to particle ranges between 2 and
30 cm in water, can be combined with 4 different foci (lateral beam widths) and ten different
intensity levels [Haberer et al., 2004; Parodi et al., 2012].
A sketch of the Heidelberg ion beam facility is shown in figure 2.11. Patients are irradiated in
three different treatment rooms: two with a fixed horizontal beam line and one with the world-
wide first 360◦-rotating heavy ion gantry. Up to date, patients have only been treated using
protons and 12C ions, but the synchrotron is also able to deliver 4He, as well as 16O ion beams
[Kurz et al., 2012], which might become a future treatment alternative.
2.4.3 Treatment planning
Besides the complex technical implementation, the approach of an actively scanned ion beam
delivery poses great demands on the treatment planning system (TPS). The TPS has the complex
task of overlapping between about 20, 000 and 50, 000 pencil beams, each corresponding to a single
raster-spot in the given target volume, to the optimal dose pattern within the patient. For this, an
objective function taking into account, among others, the dose coverage of the target volume, the
dose homogeneity in the target volume and the dose given to the surrounding normal tissue and
organs at risk, has to be minimised. The settings for a single pencil beam can be retrieved from
the above-mentioned library of available beam parameter settings (energy, spot-size, intensity).
As a result of the optimisation process, the TPS yields a number of particles to be applied to each
of the raster-spots, which is later controlled by the beam monitoring system during the actual
patient irradiation.
At HIT, a TPS similar to the dedicated planning software TRiP (TReatment plannIng for
Particles) [Krämer et al., 2000], developed for the GSI pilot project in Darmstadt, is used. Dose
calculation within the software (Siemens Syngo PT Planning System) is accomplished by a so-
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called pencil beam algorithm, in which the total dose is composed as the sum of the individual
pencil beams dose per primary ion, weighted by their specific particle number NPB:
Dtot(~x) =
∑
PB
DPB(~x)×NPB , (2.11)
with
DPB(Ebeam, ~x) = d(Ebeam, z)× L(r, z), . (2.12)
Here, d(Ebeam, z) is the laterally integrated depth dose profile, and L(r, z) the normalized (to one)
lateral dose distribution of a pencil beam of energy Ebeam in depth z. L(r, z) is described by a
combination of two Gaussian distributions (cf. section 2.2.2) with depth dependent widths σi(z)
and weights w(z) and 1 − w(z) [Parodi et al., 2013]. The widths σi(z) and the weight w(z) of
the pencil beam lateral dose profiles at each available beam foci, as well as the integrated depth
dose distributions for all available pencil beam energies are generated by dedicated Monte-Carlo
(MC) simulations. These are tuned such that dosimetric measurements of lateral and depth dose
distributions at a limited number of beam settings can be reproduced precisely, as described in
detail in [Parodi et al., 2012, 2013]. All MC-generated profiles are stored in a database and can
directly be accessed by the TPS for dose calculation.
The steps for dose calculation described up to this points, as well as the MC generation of the
basic TPS input data, are performed in water as a reference medium. When calculating the dose
to a patient, however, the depth dose profiles need to be scaled in depth in order to account for the
patient-specific anatomy and herewith tissue composition. For this, the depth in a given tissue is
translated into the corresponding equivalent depth in water. The conversion factor is called water
equivalent path-length (WEPL) and can be derived from the patient CT Hounsfield number by
using a so-called Hounsfield look-up table (HLUT), as shown in figure 2.12 [Jäkel et al., 2001a;
Rietzel et al., 2007]. This table is usually based on a piecewise-linear interpolation of a set of
measurements with tissue-equivalent media, in which their WEPL as well as their Hounsfield unit
(HU) in a CT scan are determined (see data points in figure 2.12). The TPS then translates the
patient anatomy into a water equivalent frame, on which the dose can be calculated as previously
described.
In the case of radiation therapy with heavy ions, their biological effectiveness has to be in-
cluded in the optimisation process as well: after having found a clinically acceptable physical dose
distribution, the biological dose within the patient has to be optimised in a non-trivial final step.
As the RBE is a complex quantity depending on a wide range of parameters (cf. section 2.3), a
bio-physical model within the TPS is of need. At HIT, the so called local effect model (LEM)
is used [Scholz and Kraft, 1994, 1996; Scholz and Elsässer, 2007]: it considers the highly inho-
mogeneous local dose deposition pattern of heavy ions and establishes the relationship between
the response of the cells to this distribution and the corresponding response to a homogeneous
photon dose, as measured in previous cell experiments or retrieved from clinical photon experi-
ence. It assumes that locally, there is no fundamental difference in the response of cells to heavy
ions and photons and that differences in the biological efficiency solely arise from the different
characteristics of the local dose distribution.
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Figure 2.12: For translation of the patient CT into a water equivalent frame, CT numbers are con-
verted into WEPL using a piecewise-linear interpolation of a set of WEPL and CT HU measurements
of tissue equivalent materials. The TPS will calculate the optimal dose on a water equivalent system,
right side. (Adapted from [Krämer et al., 2000]).
2.5 Uncertainties in ion beam therapy
By making optimal use of the physical, as well as biological properties of proton and heavy ion
beams and by applying modern 3D active beam scanning techniques, treatment planning systems
can achieve highly conformal dose distributions. The accessible sharp dose gradients allow for an
increase of the tumour dose with respect to conventional photon therapy, while not increasing or
even reducing the radiation burden to adjacent healthy structures and organs at risk.
On the other hand, the high degree of conformity makes ion beam therapy prone to uncer-
tainties in the radio-therapeutic treatment chain. Small changes in the patient anatomy on the
day of the actual irradiation with respect to the treatment planning CT can immediately result
in a dose pattern which considerably deviates from the planned one. This is illustrated in figure
2.13 for a hypothetical patient case, where a 1 cm wide air gap is filled up with water during the
actual treatment. While there is only a slight impact on the shallow photon dose profile, a serious
degradation of the of the 12C ion SOBP dose pattern can be observed: the distal tumour part
receives a significantly lower dose, whereas the normal tissue proximal to the tumour is exposed
to a remarkably higher dose. In a similar way, deviations in the patient set-up and immobilisation
can diminish the anticipated superiority of ion beam dose distributions.
In order to minimise the impact of anatomical changes and patient miss-alignments, modern
radiotherapy implements image guidance in the treatment course. Typically, 2D orthogonal X-
ray imaging in treatment position for the matching of bony landmarks or implanted markers is
performed right before the actual beam application and minimises set-up uncertainties to about
1.5 mm [Jäkel et al., 2001b]. These systems, however, only provide 2D projections and poor soft-
tissue contrast. For this reason, the use of 3D X-ray CTs (conventional or cone-beam CT) for
image guidance is more and more spreading, particularly in modern photon therapy, although it
is accompanied by an additional radiation burden on the patient.
Still, image guidance cannot account for uncertainties in the imaging process itself, where
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Figure 2.13: Impact of anatomical changes on the depth dose distributions of a 6 MeV photon beam
(top) and a 12C SOBP (bottom), assuming the filling of a 1 cm wide air gap with water during the
actual treatment. While the impact on the photon dose profile is rather small, the induced shift of
the SOPB leads to a significant under-dosage of the distal tumour part and a critical over-dosage in
the normal tissue proximal to the tumour. (Adapted from [Enghardt, 2005]).
errors can e.g., be introduced by partial volume effects, metal implants, beam hardening effects,
image noise or the CT number dependence on the object size. Due to these intrinsic CT inac-
curacies and errors in the WEPL measurements, the HLUT which connects the CT numbers to
corresponding WEPLs is affected by uncertainties, as well. They directly translate into uncer-
tainties of the beam range within the patient, as calculated by the TPS [Rietzel et al., 2007].
Further errors can be introduced, if materials of different stopping power cannot be distinguished
by their Hounsfield number. A deep investigation of numerous sources of range uncertainties in
proton therapy can be found in [Paganetti, 2012]. Here, the total range accuracy for the proton
beams has been determined to be in the order of 2− 5% + 1.2 mm, depending on the complexity
of tissue inhomogeneities. A similar estimate of 1− 3% for carbon ion beam ranges can be found
in [Jäkel et al., 2001b]. For a deep-seated tumour at about 20 cm depth in water, this corresponds
to an uncertainty of approximately 4− 10 mm.
The simplest way to account for the underlying uncertainties in ion beam therapy is to extend
the identified tumour volume by a safety margin at the stage of treatment planning on the basis
of the treatment planning patient CT [ICRU, 1993a, 1999]. This enlargement of the irradiated
volume might, however, lead to conflicts with close-by organs at risk, generally increases the
dose given to adjacent healthy tissue and thereby degrades the conformity of ion beam therapy.
Moreover, when selecting the incident beam directions during the treatment planning stage, it
is typically avoided to place the distal dose fall-off in front of critical structures. Instead, the
less sharp but more reliable lateral dose gradients are used, sacrificing the best possible dose
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distribution for the sake of safety. In future, progress in treatment planning is foreseen by
dedicated robust planning techniques, which inherently consider possible uncertainties at the
stage of plan optimisation, but are not yet established in clinical routine [Unkelbach et al., 2009;
Chen et al., 2012].
2.6 Organ motion in ion beam therapy
Besides the uncertainties covered in the previous section, severe errors can be introduced by organ
motion for specific treatment sites, like the prostate, the lung or the liver.
2.6.1 Introduction to organ motion
Depending on the time-scale on which changes of the patient anatomy occur, organ motion is
typically divided into inter-fractional motion (i.e. , changes from fraction to fraction on a time-
scale of days) and intra-fractional motion (i.e. , changes during the treatment application on a
time-scale of seconds to minutes).
The sources of inter-fractional motion are diverse. Tumour shrinkage, e.g., can occur for a
wide range of tumours and particularly affects the treatment at locations where large density
gradients between target volume and surrounding tissue can be found, like in the lung [Mori
et al., 2009b]. Lung tumours are moreover sensitive to base-line drifts of the patients respiratory
motion [Sonke et al., 2008] from fraction to fraction. Other tumour localisations, like the prostate
and the pancreas are strongly effected by inter-fractional motion due to variations in bladder and
gut filling [van Herk et al., 1995; Whitfield et al., 2012].
Intra-fractional motion 1 on the other hand can be mainly attributed to heart beat and
respiration. Respiratory motion does not only affect tumours in the lung, but also in many
other organs, like the pancreas [Mori et al., 2009a], the liver or even the prostate [Malone et al.,
2000]. For tumours in the lung, a large variation of the motion trajectory from patient to patient
is typically found. Even for an individual patient, trajectories might change from fraction to
fraction [Seppenwoolde et al., 2002]. In general, it was found that motion amplitudes depend,
among others, on the location of the lesion within the lung, and that amplitudes are on average
larger in the superior-inferior (SI) direction than in the anterior-posterior (AP) and left-right
(LR) directions [Shirato et al., 2004]. About 40% of the lung tumour patients investigated in
[Liu et al., 2007] showed a SI motion amplitude of above 5 mm, while the motion amplitude did
not exceed 13.4 mm in 95% of the patients. For tumours in the liver, which are of main interest
in the scope of this work, a pronounced motion in the SI direction was found, as well. In [Case
et al., 2010] a mean motion of 8 mm in this direction was found, ranging from about 0 to 19 mm.
Changes of the motion amplitude within the individual treatment fractions and from fraction to
fraction were found to be small (below 2 mm). Similar results have been reported in [Kitamura
et al., 2003], where beyond that a dependence of the motion amplitude on the location of the
lesion within the liver was observed.
1In the context of this work, the term organ motion will from now on be used synonymously for
intra-fractional motion.
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Figure 2.14: In the presence of respiratory motion, significant differences in the WEPL, corresponding
to the depicted iso-range lines, can appear between different motion states (here inhale (left) and exhale
(right)). In this case, the changes can be mainly attributed to the movement of the gross tumour volume
(GTV) with respect to the treatment field. Figure from [Bert and Durante, 2011].
2.6.2 Implications of organ motion for ion beam therapy
In the presence of organ motion, the patient anatomy can undergo changes within seconds. As
discussed in section 2.5, these anatomical changes can have a significant impact on the actually
applied dose to the patient due to changes in the WEPL traversed by the beam particles, as
shown for the case of a lung tumour in figure 2.14. In this case, the relatively large density
gradients between the lung tissue and the tumour result in a significant shift of the iso-range
lines. If density gradients are smaller, e.g., for central lesions in the liver, changes of the iso-range
lines are generally smaller, but the amount of dose deposited outside the actual target volume
can still be significant.
Besides compromising the dose distribution by anatomical changes, organ motion can lead to
so-called interplay effects in the case of an active scanning beam delivery. Here, irradiation times
are typically in the order of minutes, i.e. , much larger than the typical respiratory period, and the
spot-wise beam delivery sequence interferes with the organ motion [Phillips et al., 1992]. This can
lead to areas of severe under- and over-dosage within the target volume, as well as to unwanted
exposure of healthy structures, as shown in figure 2.15 for the case of three liver tumour patients.
The magnitude of interplay effects depends, among others, on the tumour motion amplitude and
the direction of the motion with respect to the scanning direction and the incident beam direction
[Lambert et al., 2005; Grözinger et al., 2006; Bert et al., 2008].
2.6.3 Organ motion management in ion beam therapy
In order to minimise the negative impact of organ motion on the treatment outcome, a wide
range of techniques have been developed over the last years. Considering inter-fractional motion,
the approach of image guided radiotherapy, as mentioned in section 2.5, is very promising: the
current location of the target volume on the treatment day is retrieved and can directly be used
for a correction of the patient position or an adaptation of the planned treatment. Determination
of the target volume position can e.g., be based on 3D cone-beam CT imaging, 2D Xray imaging
of implanted fiducial markers or ultrasound imaging [Kupelian et al., 2008]. Up to present,
image guidance techniques are, however, predominantly applied to modern photon therapy. The
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Figure 2.15: Study of interplay effects in three different liver tumour patients treated with scanned
proton beam therapy (bottom row). In all cases, the dose conformity and uniformity within the target
volume is clearly diminished, while the dose to particular areas of the normal tissue is significantly
enhanced with respect to the static reference study (top row). Adapted from [Zhang et al., 2012].
most frequently applied approach in ion beam therapy still is to include potential inter-fractional
changes in the treatment planning process by an increase of the applied safety margins. Yet,
this generally leads to a degradation of the dose conformity and possibly to an increase of the
radiation exposure to close-by organs at risk, like the rectum in the case of prostate radiotherapy.
The approach of increased margins can also be applied to account for respiration-related inter-
fractional motion [Nihei et al., 2006; Bush et al., 2004]. Although range changes due to respiratory
motion of the target volume can be included in the definition of the so-called internal target volume
(ITV) [Graeff et al., 2012], consisting of the gross tumour volume and a set of margins accounting
for all expected uncertainties, the increase of margins still leads to an increased radiation burden
on healthy tissues and cannot reduce interplay effects in the case of a scanned beam delivery.
Consequently, a variety of motion mitigation techniques have been developed to foster ion beam
therapy of moving tumours.
One straightforward approach is the reduction of the amplitude of organ motion. This can
be accomplished, e.g., by breath-hold techniques [Remouchamps et al., 2003], apnoea [RPTC,
2012], the so-called jet-ventilation [Hof et al., 2003] or abdominal compression systems [Negoro
et al., 2001; Wunderink et al., 2008]. The latter have shown to reduce the SI motion amplitude
of liver tumours on average by more than 50%. Besides these motion suppression techniques,
special beam application techniques for motion mitigation have been developed: beam gating,
rescanning and beam tracking.
In beam gating, the target volume is only irradiated in a predefined part of the breathing
cycle, the gating window (GW) [Minohara et al., 2000]. This is schematically shown in figure 2.16:
the tumour motion is detected by a motion monitoring system (see section 2.6.4), which creates
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Figure 2.16: Illustration of the beam gating technique for a synchrotron accelerator. The target
volume motion is detected by a motion monitoring system, which creates a logical gate signal according
to the predefined GW. If the tumour motion coincides with the GW and beam is available from the
synchrotron, the beam is extracted and delivered to the target. Figure from [Richter, 2013].
a logical gate signal based on the pre-defined gating window, typically arranged symmetrically
around the comparably stable end-exhale position. If the gate is open, i.e. , the tumour is in
the desired position, and beam is available from the accelerator, beam extraction starts. If the
tumour moves out of the gating window, beam application is aborted immediately. Beam gating
has already been implemented for patient treatment at several facilities, like NIRS [Miyamoto
et al., 2007], the Proton Medical Research Center at Tsukuba University, Japan [Hashimoto
et al., 2006] or the Heidelberg ion beam facility [Richter, 2013]. The effectiveness of beam gating,
however, strongly depends on the size of the gating window, which defines the residual motion of
the tumour during the gated beam delivery. Particularly in the case of an active beam delivery,
residual motion can still cause a notable interplay pattern in the target region. Increasing the
lateral width of the single raster-spots was found to reduce the impact of residual motion on
the dose homogeneity, but only at the expense of a decreased dose conformity [Bert et al., 2009;
Richter, 2013]. In addition, beam gating relies on a accurate tracking of the target motion by the
monitoring system.
This is not the case for the approach of rescanning, which is based on a statistical averaging
effect by repeated irradiation of the target volume with a certain fraction of the total dose in each
scan [Phillips et al., 1992]. Rescanning can be applied in different ways: in volumetric rescanning,
the whole target volume is rescanned, while in slice-by-slice rescanning the single iso-energy slices
are rescanned to the total dose one after the other. Rescanning can efficiently diminish interplay
patterns by the averaging effect (provided that there are no synchronisation effects between the
respiratory motion and the beam delivery [Furukawa et al., 2010]), but still requires safety margins
covering the whole range of the target motion, thus decreasing dose conformity and increasing
dose to normal tissue [Bert and Durante, 2011]. A promising approach, which is planned to be
implemented in the near future at several centres using actively scanned ion beams, is therefore
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the combination of gating and rescanning: gating restricts the tumour motion amplitude and
herewith the applied margins to the residual target motion within the GW, rescanning mitigates
residual interplay effects by repeated scanning [Furukawa et al., 2007; Zenklusen et al., 2010].
A completely different approach is pursued with the technique of beam tracking in scanned
particle therapy: here, the applied ion beam follows the tumour movement, as detected by a
motion monitoring system. Lateral tracking is accomplished by the scanning magnets, while
possible range changes are accounted for by fast energy modulation of the beam, e.g., by a
mechanical passive energy degrader. The parameters for correction of the beam position and
energy in each motion state are pre-calculated on the basis of the time-resolved 4D planning CT,
stored in a look-up table and applied online according to the presently detected motion phase
[Bert et al., 2007; Saito et al., 2009; Bert et al., 2010]. Theoretically, an increase of safety margins
is not necessary in beam tracking, but as neither the target motion is reduced, nor the applied
dose smoothed by repeated scans, this technique is highly sensitive to errors in the tracking of
the tumour motion, and to changes in the respiratory motion of the patient with respect to the
treatment planning 4D CT. As a consequence, beam tracking in ion beam therapy is still at a
pre-clinical stage.
2.6.4 Motion monitoring
As already stressed in the previous section 2.6.3, motion monitoring systems play an important
role in the field of 4D radiotherapy with ion beams. Accurate and precise determination of
the target position in real-time is, however, not only important in the context of the beam
delivery (gating, tracking), but also in the context of patient imaging during the treatment
planning process, e.g., in order to adapt safety margins to the target motion. The latter is
usually determined on the basis of a 4D CT image, for which projection data are acquired in
such a way that for each image slice, data in each respiratory state are available. These data are
then split into the single motion phases (either before or after reconstruction) according to the
simultaneously recorded respiratory motion signal [Vedam et al., 2003a; Pan et al., 2004].
Inaccuracies in the detection of the target motion can result in severe imaging artefacts [Wood
and Henkelman, 1984; Vedam et al., 2003a; Liu et al., 2009], leading to an incorrect delineation
of the tumour volume during treatment planning and consequently to significant deviations of
the applied treatment from the intended one, particularly in the case of gating or tracking.
Up to date, most clinically available motion monitoring systems infer the actual target position
from an external motion surrogate, which is supposed to be well-correlated to the actual internal
organ motion [Vedam et al., 2003b]. This external motion signal can be deduced in various
ways, e.g., by optical tracking of surface markers (Varian RPM system, Varian Medical Systems,
Palo Alto, USA) or by measuring the expansion of the patient chest-wall either with a laser
distance sensor or with a pressure sensor attached around the patient with a dedicated belt
(ANZAI AZ-733V, ANZAI Medical, Tokyo, Japan). The assumption of a reliable and stable
correlation between internal and external motion has, however, been found to be questionable
in particular cases, especially if the target motion is undergoing phase-shifts or base-line drifts
[Chen et al., 2001; Zhang et al., 2003; Ionascu et al., 2003; Koch et al., 2004; Hoisak et al., 2004].
Consequently, it is highly desirable to detect the actual internal target movement directly, e.g.,
by magnetic tracking of implanted radio-frequency marker [Seiler et al., 2000] or by fluoroscopic
imaging of implanted high density fiducials [Shirato et al., 2000]. These techniques are however
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invasive [Bhagat et al., 2010] and, in the case of fluoroscopic tracking, put additional dose burden
on the patient [Shirato et al., 2004]. A promising approach to avoid these side-effects could be
motion tracking by real-time ultrasound imaging. A first implementation of this technique for
4D PET imaging will be presented later in this work.
2.6.5 Treatment of moving targets at HIT
At HIT, the treatment of moving tumours is up to date limited to HCC patients with respiration-
affected target volumes in the liver. Until the end of 2013, in total 16 HCC patients have been
irradiated. In order to reduce the tumour motion amplitude and diminish possible interplay effects
by the scanned beam delivery, 15 of those patients were treated with an abdominal compression
system. Typically, SI motion amplitudes could be reduced to below 1 cm. In two critical cases,
as well as in the single case without compression, a gated beam delivery has been applied. In
addition, the lateral beam width has been increased from the standard size of 6 mm to 10 mm
full-width-at-half-maximum (FWHM), using a 2 mm lateral raster grid spacing [Richter et al.,
2014].
Treatment planning for these patients has been performed with the Siemens Syngo PT TPS,
either on a free-breathing 3D CT for patients irradiated with the abdominal compression system,
or on a breath-hold 3D CT in the end-exhale position for the pure gating patient. Motion has,
nevertheless, been considered in the treatment planning step as well, namely by an increased
ITV margin around the clinical target volume (CTV, region of visible malignant growth and
surrounding subclinical microscopic malignant disease [ICRU, 1993a, 1999]), covering the entire
tumour motion trajectory, as retrieved from a contrast enhanced 4D CT scan. On top, safety
margins of 5 mm in the lateral and 7 mm in the longitudinal direction were added to form the
planning target volume (PTV). All patients have been treated by a single right-lateral carbon
ion field to a total biologically effective PTV dose of 32.4 Gy(RBE) in four treatment fractions,
following the fractionation scheme of [Tsujii et al., 2007]. During the 4D CT imaging, as well as
during the actual beam application, the patient respiratory motion has been monitored by the
pressure sensor of the ANZAI AZ-733V respiratory gating system [Combs et al., 2011; Habermehl
et al., 2013].
In order to minimise set-up uncertainties and to avoid unfavourable consequences by inter-
fractional motion (particularly due to variations in gut filling), all patients underwent a 3D posi-
tion verification CT in treatment position right before the actual irradiation. Moreover, treatment
verification by means of post-irradiation PET imaging has been carried out (see chapters 3 and
6 for details).
2.7 Summary
In this chapter, the most important physical and biological rationale of ion beam therapy have
been introduced. The favourable physical and, in the case of heavy ions, biological properties of
ion beams in combination with modern beam application techniques allow for an increased dose
conformity to the target volume and a reduced dose burden on healthy tissues with respect to
conventional photon therapy.
This chapter, however, also pointed out that the accessible sharp dose gradients make ion
beam therapy prone to uncertainties. The sources of uncertainty are manifold. Usually, they are
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taken into account by a cautious increase of the applied safety margins around the actual target
volume and careful selection of the incident beam directions at the expense of a less conformal
dose distribution within the patient. In order to fully exploit the promised potential of ion beam
therapy, it is therefore indispensable to control uncertainties in the treatment chain and to verify
the actually applied treatment in-situ and in 3D. The only clinically implemented approach for an
independent verification of the entire treatment chain shortly after single irradiation fractions is
based on 3D PET imaging of the radiation induced β+-emitter within the patient, as introduced
in detail in the following chapter.
Additional challenges and uncertainties arise in the presence of organ motion. A variety of
different motion mitigation techniques have been developed. Approaches like beam gating or
tracking can theoretically achieve results close to static reference cases, but they heavily rely on
the validity of the underlying patient 4D CT data and an accurate detection of the target motion
during beam delivery. Variations in the shape or the baseline of the respiratory trajectory of the
target volume, or the practically unavoidable residual motion in the case of gating can still lead to
severe deviations of the applied treatment with respect to the planned one. Due to the increased
level of uncertainty in the treatment of moving targets, especially in the case of a scanned beam
delivery, a time-resolved (4D) verification of the actually applied treatment is highly desirable. In
the scope of this work, the extension of the PET-based treatment verification approach, presently
being restricted to clinical applications with static target volumes, to moving tumour entities will
be investigated under clinical conditions for the first time.
Chapter 3
PET-based treatment verification in
ion beam therapy
This chapter will review in detail the concept of PET-based treatment verification in ion beam
therapy. First, the physical rationale behind PET-based treatment monitoring and the basics of
PET imaging will be introduced. Then, the clinical implementation, with a focus on the approach
pursued at HIT, will be discussed.
3.1 Production of β+-emitter
As has been mentioned in section 2.2.3, nuclear fragmentation reactions of incident projectile
nuclei in the penetrated tissue can lead to the formation of neutron-deficient positron emitters,
which can be detected by PET imaging systems [Enghardt et al., 1999, 2004a; Parodi et al.,
2008a].
While in the case of carbon ions, projectile and target nuclei can fragment, incident proton
beams can only form target fragments, as the protons themselves cannot fragment (cf. figure
3.1). An overview of the irradiation-induced β+-emitter which contribute most significantly to
the detectable activity signal in the target volume is given in table 3.1 [Parodi et al., 2008b].
Thereof, the most important isotopes are 11C and 15O, with half-life times of about 20 and 2 min,
respectively.
The cross-sections of the main production channels of these two β+ emitter are depicted in
figure 3.2, once for the case of protons and once for the case of carbon ions. For protons and carbon
ions, the reaction cross-sections are almost constant down to about 100 MeV and 10 MeV/u,
respectively. Below this energy, the β+-emitter production cross-sections will increase, until
Table 3.1: Overview of the most important β+-emitter in PET-based ion beam therapy monitoring
and their corresponding half-lives.
Isotope 11C 15O 13N 30P 34Cl 38K
Half-life [min] 20.38 2.04 9.97 2.50 32.00 7.63
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Figure 3.1: Illustration of the formation of positron emitter in proton (left) and carbon ion (right)
therapy. While in the case of protons only positron emitting target fragments can be generated,
β+-active projectile fragments can additionally be produced in the case of carbon ions.
Figure 3.2: Cross-sections of the main reaction channels for the formation of 11C and 15O β+-emitter
by protons (left, measured data) and carbon ions (right, calculated data). Taken from [Parodi, 2004].
the projectile energy falls below the threshold of the regarded nuclear reaction. These energies
typically correspond to just a few millimetre residual range of the incident particles in soft tissue.
In the case of protons, where only target fragments nearly staying at rest are produced in the
nuclear interactions (cf. section 2.2.3), this results in a rather flat or slightly increasing activity
profile as a function of depth. Right in front of the Bragg-peak, the projectile energy falls below
the reaction threshold and the activity profile shows a substantial fall-off which follows the shape
of the decrease of the underlying dominant cross-sections. This is exemplarily shown in figure 3.3
for a proton beam in a Polymethyl-methacrylate (PMMA) target.
In the case of carbon ions, this flat distribution of target fragments is superimposed by the
activity distribution originating from the produced projectile fragments, mostly 11C. The latter
are produced at nearly the same velocity as the incident projectile (cf. section 2.2.3) and, due
to the A/Z2 dependence of the ion stopping power, have a comparable range. This gives rise to
a characteristic maximum in the activity distribution shortly before the Bragg-peak, where the
primary ions are stopped (see figure 3.3). One should also notice that target fragments can still
be produced distal to the Bragg-peak by long-penetrating secondary particles, like protons.
3.2 Positron emission tomography imaging
The irradiation-induced activity pattern within the target volume can be assessed in 3D by PET
imaging techniques. These rely on the coincidence detection of two 511 keV photons [Phelps et al.,
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Figure 3.3: Measured activity depth profiles (solid line) and calculated depth dose distributions
(dashed line) of 140 MeV protons (left) and 259.5 MeV/u 12C ions in Polymethyl-methacrylate
(PMMA), normalised to the maximum. While the activity profile is rather shallow in the case of
protons, a distinct peak, formed by the projectile 11C fragments, can be noticed in the case of carbon
ions. Figure from [Parodi, 2004].
1975; Ter-Pogossian et al., 1975], which originate from the annihilation of the positron generated
in the radio-active decay of a β+-emitter A(Z,N), with mass number A, atomic number Z, and
neutron number N according to:
A(Z,N) −→ A(Z − 1, N + 1) + e+ + νe . (3.1)
The positron is emitted with a continuous energy spectra and slows down over a few millimetres in
the surrounding tissue. Here, it can suffer from direct annihilation under the emission of two anti-
parallel gammas or it can form the unstable e+e− bound state positronium with an electron of
the tissue before annihilating into either two or three gammas. As described in detail in [Harpen,
2004], the decay into two gammas is, however, much more likely. Due to momentum conservation,
the two gammas are emitted in anti-parallel directions (if neglecting the small residual motion
of the positron) with an energy of the e+ and e− rest mass of 511 keV, each. The anti-parallel
gammas are detected in coincidence by an opposed detector pair, and attributed to a decay along
the line connecting the two detectors, the so-called line of response (LOR), as schematically
shown in figure 3.4.
Besides coincidences ascribed to the two primary gammas emitted by a single β+-decay (“true
coincidence”), coincidences of two gammas from independent decays might be detected by chance
(“random coincidence”). Moreover, one, or even both, of the emitted gammas might undergo
scattering before reaching the detector, leading to an incorrectly projected LOR, not containing
the actual location of the annihilation (“scattered coincidence”). This is illustrated in figure 3.5.
In PET imaging, only true coincidences contain valuable information for the recovery of
the underlying β+-activity distribution. Hence, scattered and random coincidences need to be
corrected for, when processing the acquired coincidence data, as described e.g., in [Ollinger,
1996; Watson et al., 1996; Brasse et al., 2005]. Moreover, the attenuation of gammas along each
LOR needs to be considered in the case of quantitative imaging [deKemp and Nahmias, 1994;
Kinahan et al., 1998], as well as the efficiency of the single detectors and the geometrical detection
probability for each emission position.
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Figure 3.4: Illustration of PET imaging: the β+-active nucleus emits a positron which is stopped
in the close-by medium and annihilates with an electron into two anti-parallel gammas of 511 keV,
each. These are detected in coincidence by a detector pair and attributed to a decay along the line of
response, connecting the two opposed detectors. Figure from [Verel et al., 2005].
Figure 3.5: Sketch of the different coincidence types in PET imaging. In a true coincidence, the
original gammas are detected and the LOR (dashed line) contains the spot of annihilation. In scat-
tered coincidences, at least one of the emitted gammas is scattered before detection and in random
coincidences, two independent gammas are accidentally attributed to the same event, leading to an
incorrectly projected LOR in both cases. Taken from [Parodi, 2004].
The corrected true coincidence data represents a projection of the underlying activity dis-
tribution, which can thus be recovered by tomographic reconstruction algorithms like a filtered
back-projection (FBP) [Brooks and Di Chiro, 1975; Ollinger and Fessler, 1997], or by so-called
iterative reconstruction algorithms. The latter are based on the statistical nature of radio-active
decay (Poisson statistics) and solve the problem of finding the most likely activity distribution
that would yield the measured projection data [Qi and Leahy, 2006]. The most widely used iter-
ative algorithms are the so-called maximum likelihood expectation maximisation (MLEM) [Shepp
and Vardi, 1982] and the ordered subset expectation maximisation (OSEM) [Hudson and Larkin,
1994], which differs from the MLEM in the fact that the projection data is subdivided into a
user-defined number of subsets during the reconstruction process for faster convergence.
Iterative reconstruction algorithms are particularly suitable in low counting statistics scenarios
and are thus of particular interest in PET-based treatment verification, where the amount of
irradiation-induced activity in the subject of investigation is significantly lower than in diagnostic
PET imaging with injected radio-tracers: in diagnostic PET imaging, activity densities in the
order of 10 − 100 kBq/ml are typically found, while PET-based treatment verification has to
struggle with activities in the order of 0.05−10 kBq/ml, depending on the specific implementation
[Enghardt et al., 2004a; Parodi et al., 2007a; Bauer et al., 2013b] (as briefly reviewed in the
subsequent section).
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Figure 3.6: Illustration of the different time regimes in PET-based treatment verification. In-beam
acquisition starts during the treatment and can be prolonged shorty after. In-room and offline ap-
plications can start with a delay of 1 − 3 and 5 − 10 min, respectively. Consequently, the number
of detectable counts, is highest for in-beam and lowest for offline PET monitoring, thus calling for a
prolonged measurement time. Taken from [Shakirin et al., 2011].
The achievable intrinsic spatial resolution in whole-body PET imaging is about 3 − 5 mm
FWHM. It is mainly limited by the non-perfect co-linearity of the two coincidentally detected
gammas, the residual range of the emitted positron (approximately 1 − 3 mm FWHM) and the
detector granularity [Moses, 2011]. This limited resolution leads to an overall blurring of the
reconstructed images, but does not prevent millimetre accuracy in the detection of activity gra-
dients, as desired in PET-based treatment verification and demonstrated in dedicated phantom
experiments [Parodi et al., 2005b].
3.3 Clinical implementation of PET-based treatment
verification
PET-based monitoring of ion beam therapy has already been implemented at several facilities
worldwide. The different approaches which are being pursued can be classified into three cate-
gories: in-beam, in-room and offline (cf. figure 3.6). In in-beam treatment verification, PET data
is acquired during the actual irradiation (typically during the synchrotron spill pauses to avoid
high random rates by irradiation-induced prompt gammas [Parodi et al., 2005a]) and might be
prolonged up to few minutes after the treatment [Enghardt et al., 2004b; Parodi et al., 2008a;
Nishio et al., 2010]. This technique yields a comparably high number of counts (depending on
the length of the spill pauses used for data acquisition) and is less sensitive to washout processes
of the induced activity, e.g., due to blood perfusion [Shakirin et al., 2011; Helmbrecht et al.,
2013]. On the other hand, this approach is up to present limited to the application of dedicated
PET-detectors in dual-head or partial-ring geometries with high integration costs in order to
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not obstruct the movement of the patient couch. These geometries provide a reduced detection
efficiency and suffer from limited-angle artefacts in the reconstructed images [Crespo et al., 2006].
Improvements are, however, foreseen by further evolved PET detectors with high time-of-flight
(TOF) resolution [Crespo et al., 2007] or by dedicated open-ring PET geometries [Yamaya et al.,
2008; Tashima et al., 2012], which are presently being investigated at a pre-clinical stage.
The latter limitations are overcome in in-room and offline PET-based treatment verification
by the usage of commercial full-ring PET or PET/CT scanner. The two approaches only differ in
the localisation of the used PET imaging device, being installed either directly in the treatment
room [Zhu et al., 2011; Min et al., 2013] or at a separate site [Parodi et al., 2007c; Bauer et al.,
2013b]. In both cases, however, data is acquired with some delay after the actual irradiation.
Consequently, part of the detectable amount of irradiation-induced activity has already decayed
at the time of data acquisition, and the number of detected true coincidences might be reduced
with respect to in-beam PET, hence calling for an increased data recording time [Shakirin et al.,
2011]. In the offline approach, where delay times between irradiation and imaging are typically in
the order of 5− 15 min, the residual signal by the fast-decaying 15O isotopes is almost negligible
and the residual activity can predominantly be ascribed to 11C [Parodi et al., 2008b]. The in-
room approach offers remarkably shorter delay times, even allowing for the imaging of 15O [Zhu
et al., 2011], but is much less practicable in terms of clinical workflow and cost-effectiveness, as
the treatment room cannot be used during the time of data acquisition and as the PET scanner
might not be used for clinical applications besides treatment monitoring [Shakirin et al., 2011].
Both approaches, the in-room and the offline verification, are also remarkably affected by washout
effects in the irradiated tissue [Parodi et al., 2007c]. These processes lead to a further decrease of
the detectable activity, as well as to a distortion of the induced activity pattern and were found
to be described only with limited accuracy by the currently applied washout models [Zhu et al.,
2011; Bauer et al., 2013b].
Regardless of the time regime of PET data acquisition, the approach of in-vivo PET-based
treatment verification requires modelling of the expected irradiation-induced activity distribution,
possibly including washout effects, since a direct comparison of PET measurement and planned
dose is not feasible: activity and dose distributions are correlated but not equal, as can be seen in
figure 3.3. The quality of the actually applied treatment, consequently, has to be deduced from a
comparison of the expected activity distribution within the patient, calculated on the basis of the
treatment plan and the time course of irradiation and imaging, to the actual PET measurement.
This will be described in detail for the implementation chosen at HIT in the next section. Without
an adequate modelling of the induced activity to be expected, only an inter-fractional treatment
comparison by means of measured PET images would be feasible, as implemented by [Nishio
et al., 2010].
Despite the above-mentioned challenges, an accuracy in the order of 1.5−5 mm, depending on
the actual treatment site, has been reported to be achievable in PET-based treatment verification
[Parodi et al., 2007c; Knopf et al., 2011].
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Figure 3.7: Depiction of the offline PET-based treatment verification workflow at HIT. Patient treat-
ment planning (TP) data is used as input for a Monte-Carlo simulation of the β+-emitter distribution
in the patient. This raw distribution is corrected for the time structure of the irradiation and the
data acquisition of the given fraction, as well as for the biological washout. The resulting reference
activity pattern within the patient is then aligned (CT-CT registration of TP-CT and PET-CT) and
compared to the actually measured PET data of the fraction in order to verify the treatment.
3.4 Implementation of offline PET-based treatment
verification at HIT
At the Heidelberg ion beam facility, a commercial PET/CT scanner (Siemens Biograph mCT,
Siemens Molecular Imaging, Knoxville TN, USA [Jakoby et al., 2011]) for treatment verification
is installed next to the patient treatment rooms (offline). The workflow is depicted in figure
3.7: starting from the treatment planning (TP) data, i.e., the irradiation plan (RTplan) and the
TP-CT, β+-emitter distributions for all relevant isotopes are calculated within the patient. The
obtained β+-emitter pattern is converted to an activity distribution by accounting for the fraction-
specific time course of the irradiation, transportation and imaging, as well as for the biological
washout. The calculated activity is then registered to the actual PET/CT measurement on the
basis of a manual rigid registration of the PET-CT (acquired for attenuation correction of the
measured coincidence data at the PET/CT scanner) and the TP-CT. As a result, the activity to
be expected within the patient under assumption of a correct dose application is retrieved and
can be compared directly to the actual PET measurement of the given fraction in order to verify
the correct application of the irradiation. The single steps are explained in detail in the following
sections.
Up to present, the treatment of more than 120 patients has been monitored by means of
post-irradiation PET imaging at HIT. About 2/3 of these patients have been irradiated with
carbon ions, 1/3 with protons. The most frequent tumour location is the head and neck region,
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contributing about 50% of all patients, followed by the prostate (≈ 20%) and the liver (≈ 10%).
3.4.1 MC simulation of the β+-emitter distribution
The expected β+-emitter distribution within the patient is calculated using the FLUKA MC
code [Battistoni et al., 2007; Ferrari et al., 2005]. FLUKA is a general purpose MC code for
the modelling of particle transport and interaction in matter. It explicitly simulates the electro-
magnetic and nuclear interactions of the incident ion beams within the patient. The properties
of the incident beam, i.e., energy, focus, lateral position and number of particles for each raster-
spot of the scanned beam delivery, are retrieved from the treatment plan and converted to the
required beam properties within the simulation by a dedicated source routine. The patient
anatomy is described by the underlying TP-CT data, which is segmented into 33 materials of
different elemental composition and nominal physical properties (density, ionisation potential) on
the basis of the retrieved Hounsfield units according to the approach of [Schneider et al., 2000;
Parodi et al., 2007c]. For a continuous scaling of the physical properties (nuclear and electro-
magnetic) as a function of the HU, additional correction factors are applied within each of the 33
segmented HU intervals. This scaling is chosen such that it further ensures FLUKA to follow the
same the HU-WEPL calibration curve as used in the TPS (cf. section 2.4.3) in order to enable a
consistent beam range verification [Parodi et al., 2007a, c; Bauer et al., 2013b].
As a result of the FLUKA simulation, the yield of the most important β+-emitter, as listed
in table 3.1, and the 3D physical and biological dose deposition pattern within the patient per
incident primary particle is obtained. Typically about 107− 108 primary particles are simulated,
corresponding to about 1% of the total amount of particles in the treatment plan and requiring
about 6−8 h of CPU time when using 40−60 parallel executions on a high performance computer
cluster.
3.4.2 Calculation of the irradiation-induced activity
Starting from the results of the FLUKA simulation, i.e., the spatial distribution of the irradiation-
induced β+-emitter, the activity which is expected to be measured within the patient during the
post-irradiation PET scan needs to be determined.
In this post-processing step, the decay of the activity during the actual irradiation time tirr,
the delay between the end of the irradiation and the start of the PET measurement ∆t and during
the PET data acquisition time tframe has to be determined. In addition to the physical decay, the
amount of irradiation-induced radio-isotopes is reduced by biological washout effects. According
to [Mizuno et al., 2003], a fast (half-life T1/2f = 2 − 10 s), a medium (T1/2m = 100 − 200 s)
and a slow (T1/2s = 3000 − 10000 s) component of biological decay exist. In the pursued offline
PET monitoring approach, ∆t is typically in the order of 6 − 12 min at HIT, so that the fast
and medium component have already decayed and only the slow biological decay component
is typically considered. On the basis of the CT Hounsfield numbers, the irradiated tissue is
segmented into regions of low, intermediate and normal perfusion. Each of these regions is
characterised by its specific relative fraction of the slow decay component Ms and its biological
decay constant λsbio (λ
s
bio = ln(2)/T1/2s). The intervals of the HU segmentation, as well as the
applied values for Ms and λ
s
bio are reported in [Parodi et al., 2007c]. Finally, the expected average
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activity within the patient 〈A(r)〉 can be calculated as:
〈A(r)〉 = G(r) ∗
{∑
i
ni ·
∑
j
[
Ms(r)Nij(r) ·
[1− exp(−λjtirr,i)]
tirr,i
·
exp(−λtot,j(r)∆ti) ·
[1− exp(−λtot,j(r)tframe)]
λtot,j(r)tframe
]}
(3.2)
where Nij is the amount of isotopes j formed by irradiation field i as calculated by the FLUKA
simulation, ni the total number of particles of each individual field and λj and λtot,j the physical
and total (λtot,j(r) = λj + λ
s
bio(r)) decay constants. In order to enable a direct comparison of
the simulated expectation to the measured PET data, the limited resolution of the PET scanner
is modelled by a 3D convolution of the post-processed simulation data with a Gaussian kernel
G(r).
3.4.3 Data acquisition and the Biograph mCT scanner
For acquiring the post-irradiation PET data to be compared to the simulation on the basis
of the treatment planning data, patients are either walked over or transported by a dedicated
shuttle system (PatLog by ONCOlog, Medical QA AB, Uppsala, Sweden) to the PET/CT room
immediately after their irradiation. Before starting the PET/CT scan, they are re-immobilised
using the same equipment, e.g., thermo-plastic masks in the case of head patients, that have
been used for fixation during the beam application. In the case of liver patients, which will
be investigated in depth in the scope of this work (cf. chapter 6), however, immobilisation is
much more complex, including a vacuum mattress, head and arm holder and in most cases an
abdominal compression system. Hence, a re-immobilisation would be too cumbersome and time-
consuming. Instead, these patients are immobilised only once at the PET/CT room before the
actual treatment and transported to the treatment site with the shuttle system. This also enables
the acquisition of a 3D position verification CT at the PET/CT scanner before the patients are
irradiated. After having completed the beam application, the shuttle transfers the patients back
to the PET/CT room for acquiring the verification PET data.
In all cases, data is acquired in list-mode (LM) format by the Biograph mCT scanner at one
single bed-position within the scanner field of view (FOV), which has a size of 21.8 cm (axial)×
60.5 cm (transaxial). The PET scanner consists of four detector rings, each containing 48 detector
blocks with 13×13 crystals having a dimension of 4×4×20 mm3 each. At the coincidence processor
level, a time window of 4.1 ns and an energy window of 435− 650 keV are applied.
Moreover, the use of lutetium oxyorthosilicate (LSO) detector crystals with high scintillation
light yield and fast scintillation light decay [Melcher and Schweitzer, 1992] enables the application
of time-of-flight PET techniques: the time difference td between the two detected events of a
single coincidence can be used to attribute the origin of the underlying annihilation to a distinct
distance x = ctd/2 from the central axis of the scanner. The achievable TOF resolution ∆t
directly translated into a resolution ∆x in space for the origin of the positron annihilation.
The probability density for the origin of a detected coincidence is no longer constant over the
corresponding LOR within the imaged object, but has a Gaussian shape with a maximum at
position x and FWHM ∆x, as depicted in figure 3.8. The utilisation of TOF information in the
image reconstruction algorithm mainly leads to a faster convergences to the final image and an
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Figure 3.8: Scheme of TOF PET. While in conventional PET the probability of the localisation of
the positron annihilation is equally distributed among all image elements nconv along the LOR within
the object of size D (left), it follows a Gaussian shape (TOF filter) covering a reduced number of image
elements nTOF if TOF information is available (right). Taken from [Conti et al., 2005].
improvement of the signal to noise ratio (SNR) with respect to conventional (conv) PET imaging,
which can be approximated by [Surti et al., 2002]:
SNRTOF =
√
D
∆x
· SNRconv, (3.3)
where D is the diameter of the imaged object. The Biograph mCT scanner allows for a TOF
resolution ∆t of about 530 ps [Jakoby et al., 2011], resulting in more than two times higher SNRs
for an average transaxial patient size of 40 cm.
A certain drawback is, however, given by the intrinsic radioactivity of the LSO crystals, since
natural lutetium consists to about 2.6% of the radioactive isotope 176Lu. The latter emits β−
particles with a mean energy of 420 keV, as well as three gammas with energies of 307, 202 and
88 keV [Goertzen et al., 2007], which leads to a significant increase of the single and herewith of
the random count rates [Yamamoto et al., 2005]. In [Parodi et al., 2007b], a random background
of about 1000 counts per second (cps) was determined for a comparable scanner as used at HIT.
At the same time, the background of true events from LSO was reported to be negligible. A
detailed analysis of the LSO-induced random background and its impact on the reconstructed
images for the Biograph mCT scanner has been carried out in the scope of this work and will be
presented in chapter 5.
The acquired post-irradiation LM data of a patient scan are reconstructed iteratively by a fully
3D ordinary-Poisson-OSEM (OP-OSEM) algorithm [Comtat et al., 2004], taking into account not
only the available TOF information, but also the space dependent resolution within the FOV by
means of a point-spread function (PSF) [Casey, 2007, 2008]. During reconstruction, the acquired
coincidence data are corrected for attenuation on the basis of an attenuation correction CT with
extended FOV and for scatter coincidences on the basis of a single scatter simulation [Watson,
2000], which is additionally scaled to the measured emission sinogram data in order to account
for scatter contributions from outside the axial PET FOV [Watson et al., 2004]. By selecting
22Na with a half-life of 2.6 years as imaged radio-tracer, the mandatory decay correction can be
avoided and the mean activity during the scan can be retrieved if the branching ratio of 0.9 for
the β+-decay of 22Na is considered in the data analysis [Bauer et al., 2013b].
The Biograph mCT scanner also allows for 4D PET and CT imaging in the presence of organ
motion, e.g., in the case of liver patients which will be investigated in depth in the course of this
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Figure 3.9: Illustration of phase-sorting in 4D gated PET imaging. The continuously acquired LM
data is subdivided between each two inhale peaks (here marked as gates ’G’) into a user-defined number
of equally sized bins in time which correspond to the single motion phases (in the depicted case P1 to
P4). The data within each respiratory phase is then reconstructed separately.
work. Motion is monitored by the ANZAI pressure sensor and recorded in parallel to the CT or
PET scan. In the case of 4D CT imaging, the continuously (helical mode) acquired CT data, which
needs to cover each image position along the scanner axis in each respiratory phase [Keall et al.,
2004], is sorted into a set of user-defined phases on the basis of the relative breathing amplitude
(relative amplitude-sorting): each respiratory cycle is split into an inspiration and expiration
part, which is then scaled to 0 − 100%. The data within each of the user-defined respiratory
states, corresponding to a certain relative amplitude of the inspiration or the expiration part, is
then reconstructed separately in order to retrieve a time-resolved CT image. In the case of 4D
PET imaging, the data is split into a user-defined number of equally sized time bins between
every two inspiration peaks (phase-sorting, see figure 3.9). These inspiration peaks are the only
information which is written into the acquired LM data stream by the motion monitoring system
as so-called gate-tags. For reconstructing the 4D PET image, the data within each of the defined
time bins is reconstructed separately (4D gated PET [Nehmeh et al., 2002]). This leads to a
significantly reduced residual motion within each motion state, but also to a reduced number of
counts and herewith a reduced SNR, which is approximately proportional to the square root of
the number of true coincidences.
3.4.4 The SimInterface
For the analysis and comparison of planned, simulated and measured data, a dedicated soft-
ware framework, called SimInterface, has been developed at HIT on the basis of the MeVisLab
(Fraunhofer MeVis, Bremen, Germany) development environment [Unholtz et al., 2011]. The
SimInterface also serves as a management system of patient data (TP, PET/CT, MC simula-
tion) and accomplishes several tasks within the workflow of PET-based treatment verification.
These tasks include the preparation of patient data for input to the FLUKA MC simulation (see
section 3.4.1), the running and monitoring of the automated MC calculations on the connected
computer cluster, the post-processing of the calculated β+-emitter pattern (cf. section 3.4.2) and
36 3. PET-based treatment verification in ion beam therapy
the visualisation of multi-modal image data (CT, PET, TPS dose, RT structure sets etc) and
corresponding simulation output data. Moreover, the SimInterface provides an environment for
manual rigid registration of CT data-sets, as required, e.g., for the comparison of expected and
measured activity distributions, based on the TP-CT and the PET-CT, respectively.
Making use of the above-mentioned capabilities of the SimInterface, a patient-specific simu-
lation of the irradiation-induced activity can be prepared, run and post-processed within a few
steps, and can directly be compared to the measured post-irradiation PET/CT data to asses the
quality of the applied treatment. The SimInterface is, however, not restricted to the analysis and
comparison of PET or activity data. It can also be used for comparing, e.g., TPS dose (physical
and biological) to MC calculated dose, or MC calculated dose distributions on the TP-CT and
the fraction-specific PET-CT.
Besides the ability to compare planned, simulated and measured data-sets by a 2D-synchronised
visualisation of multi-modal images and 1D profiles, the SimInterface contains a module for
preparing the required input data to a dedicated range verification tool. Verification of the beam
range is of particular interest in ion beam therapy monitoring, because uncertainties in the beam
range are typically larger than those in the lateral direction, which are e.g., not affected by errors
in the HU-WEPL calibration curve. In this context, the SimInterface is used to align the refer-
ence data-set, as well as the data-set being investigated for range deviations, to the incident beam
direction. The aligned data, usually consisting of two PET data-sets and the corresponding CTs,
are then analysed within an additional range verification module: it determines the most-likely
shift between two given 1D profiles (typically simulated and measured activity) along the beam
axis at each lateral position within the irradiation field. This yields a 2D map of range deviations
in beam’s eye view. The corresponding CT data are also analysed in terms of inhomogeneities
(variance) and WEPL along each profile, as well as in terms of the CT contour position, which
might hint on a patient mis-positioning. Details on the implementation of the range verification
for PET-based treatment verification can be found in [Frey et al., 2014]. Basically, the imple-
mented algorithm normalises both of the compared activity profiles to their maximum, then
determines the shift δminz at which the absolute difference between both profiles in a properly
chosen interval Ik along the beam axis is minimal. δ
min
z is referred to as most-likely shift.
The SimInterface is used as standard tool in clinical applications of 3D PET-based treatment
verification at HIT for stationary target volumes. In the scope of this work, the extension of the
established PET monitoring workflow to moving tumour entities has been investigated and the
SimInterface capabilities had to be extended in order to enable the handling of 4D TP data (4D
TP-CT and a set of state RTplans) and to yield an expectation of the irradiation-induced activity
within the patient under consideration of the respiratory motion during the beam application.
The necessary extensions of the SimInterface performed in this thesis will be described in detail in
chapter 6 in the context of the first application of 4D offline PET-based treatment verification to
clinical cases, after a thorough report on the feasibility and potential of this approach, as assessed
in dedicated experimental campaigns with phantoms, in the following chapters.
Chapter 4
On the feasibility of 4D PET-based
treatment verification: moving
phantom studies
This chapter deals with comprehensive moving phantom studies on (1) post-irradiation 4D of-
fline PET-based treatment verification and (2) the implementation of a novel motion monitoring
system, based on ultrasound imaging, for time-resolved PET imaging. In the first part, a moving
phantom irradiation campaign will be discussed and analysed with the aim to infer the feasibil-
ity and potential of 4D treatment monitoring by means of time-resolved post-irradiation PET
imaging with a commercial PET/CT scanner. The presented experiments serve as a controlled
simplified scenario with high counting statistics, paving the way towards a first application to
clinical cases, as discussed in chapter 6. The second part will cover a first implementation of ultra-
sound motion tracking in 4D PET imaging and compare this novel approach to the performance
of the standard ANZAI motion monitoring system. Ultrasound tracking promises accurate, dose-
free and real-time tracking of internal structures and might result in an improved sorting of the
acquired data into the single motion phases and herewith in an improved 4D image quality.
4.1 Moving phantom irradiation studies on 4D offline
PET-based treatment verification
4.1.1 Material and methods
4.1.1.1 Phantom irradiation
In order to investigate the feasibility of 4D offline PET-based treatment verification, PMMA
phantoms have been set up in three different geometries, referred to as Square, Line Mono and
Line Mult, and irradiated once under static (reference) and once under moving conditions by a
scanned 12C ion beam. The experimental set-up for the Line Mult study is shown in figure 4.1:
the beam passes through a PMMA fence with a thickness of 1.5, 2.25, 2.75 or 3.25 cm, depending
on the lateral beam position, and is stopped in a PMMA block phantom with a dimension of
9 × 9 × 30 cm3. The phantom itself has been positioned on the QUASAR respiratory motion
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Figure 4.1: Experimental set-up of the Line Mult moving phantom irradiation study: the 12C ion
beam was entering from the left (along the depicted red arrow) and reached the PMMA phantom
through a PMMA fence of laterally varying thickness. The PMMA phantom was positioned on the
QUASAR motion platform, which performed a cos4-shaped motion perpendicular to the beam axis.
Motion was monitored during the irradiation and the subsequent PET/CT acquisition by the pressure
sensor of the ANZAI respiratory gating system, which had been attached directly to the QUASAR
platform.
platform (Modus Medical, London, Canada), while the fence was put stationary on the patient
table. In the Line Mono case, the geometry was modified in so far that the PMMA fence was
positioned directly next to the PMMA block on the QUASAR motion platform. For the Square
study, the fence has been removed, and the PMMA phantom rotated by 90◦ on the platform in
order to align the long axis of the phantom to the incident beam direction.
Except for the static reference measurements, the QUASAR motion platform moved the
phantom (and the PMMA fence in the Line Mono study) perpendicular to the incident beam
with a cos4-shaped motion of A = 2 cm amplitude and T = 3 s period, imitating a regular
patient-like breathing pattern [Lujan et al., 1999]. The displacement of the phantom during the
actual beam application, as well as during the subsequent PET/CT scan, has been monitored
by the pressure sensor of the ANZAI respiratory gating system. In order to account for the
phantom motion during the irradiation, a gated beam delivery in combination with rescanning
has been applied. The gating window covered the shallow minimum of the cos4-shaped motion,
corresponding to the stable end-exhale position of a patient, plus another 20% or 50% of the
respiratory cycle amplitude around this position, limiting the residual motion amplitude to 4 or
10 mm, respectively. Rescanning has been applied in addition in order to deliver a high total
number of particles, while keeping the number of particles irradiated within one rescan to each
of the raster-spots in a patient-like range.
An overview of the chosen irradiation parameters for each of the three investigated geometries
is given in table 4.1. In the Line Mult case, four different energies have been applied in order
to correct for the different thicknesses of the PMMA fence and to gain a constant residual range
within the PMMA block downstream the fence. In the Line Mono case, on the other hand, the
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fence was used to induce a range modulation of the beam, stopping within the phantom, in order
to investigate the accuracy of the PET-based treatment monitoring approach under stationary
and moving conditions.
4.1.1.2 Post-irradiation PET imaging
Right after the irradiation, the activated PMMA phantoms were transported to the adjacent
PET/CT room. An overview of the irradiation times tirr, the number of applied beam spills
Nspill, the average spill times tspill, the average beam extraction times textr = tirr/Nspill and the
delay times between irradiation and PET acquisition ∆t are given in table 4.2. The phantoms
were kept in exactly the same position on the motion platform and the same cos4-shaped motion
(A = 2 cm, T = 3 s) was applied during the PET LM data acquisition (not for the static reference
measurements). The PET scan time was set to 30 min, in order to collect a reasonable number of
true coincidences, which is also given in table 4.2. In comparison, a typical 4D patient examination
will provide between 400, 000 and 900, 000 true coincidences at a comparable number of randoms.
The acquired LM data have been reconstructed in 3D by an OP-OSEM algorithm using 3
iterations with 24 subsets (3i24s) and a 5 mm (FWHM) post-reconstruction Gaussian filter (gf5)
on a voxel grid of 2×2×3 mm3, corresponding to the standard settings for phantom data analysis
Table 4.1: Irradiation parameters for the different phantom set-ups Square, Line Mono and Line
Mult. The depicted gating windows (GW) only apply to the moving phantom cases.
Study Lateral field size [cm] Beam energy Total number GWs Number of
(horizontal × vertical) [MeV/u] of particles [%] rescans
Square 4.8× 4.8 200.28 7.45620 · 109 20&50 60
Line Mono 14.1× 1.5 200.28 7.51680 · 109 50 60
Line Mult 14.1× 1.5 200.28, 212.12 2.00448 · 109 20&50 16
219.79, 227.29
Table 4.2: Overview of the time course of the beam delivery and subsequent PET acquisition as well
as the number of detected true and random coincidences for the eight investigated phantom irradiation.
Gated irradiation are labeled by G20 or G50 for an applied gating window of 20 or 50%, respectively.
Study tirr [s] Nspill tspill [s] textr [s] ∆t [s] Ntrue Nrand
Square 400 60 2.50 6.66 330 3,623,600 1,913,121
Square G50 546 60 4.33 9.10 422 3,262,937 1,872,870
Square G20 541 60 3.93 9.02 412 3,163,861 2,112,582
Line Mono 410 60 2.55 6.83 274 3,478,959 1,858,254
Line Mono G50 483 60 3.76 8.05 371 3,128,771 1,993,110
Line Mult 356 64 1.30 5.56 284 935,421 2,034,819
Line Mult G50 453 65 1.90 6.97 357 846,933 2,108,005
Line Mult G20 514 64 1.80 8.03 340 848,264 2,189,409
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at HIT [Bauer et al., 2013a]. In the case of moving phantoms, the ANZAI system, used for
monitoring of the phantom motion, enabled an additional 4D gated PET image reconstruction
with phase-sorting, as described in section 3.4.3. In all considered cases, eight motion phases
have been reconstructed with the above-mentioned settings (OP-OSEM, 3i24s, gf5). All image
reconstructions included scatter coincidence correction as well as attenuation correction on the
basis of a free-breathing 3D CT. The use of an averaged 4D CT or a phase-specific 3D CT of each
individually reconstructed PET phase is, up to present, not implemented on the Biograph mCT
scanner.
In order to obtain one single motion-compensated 4D PET image for further analysis, the
images of the single motion phases were registered to a common reference phase, here chosen as the
first phase after the inhale peak, by a manual rigid transformation, summed up and divided by the
number of phases. The accuracy of the manual registration was retrieved as 0.1±0.1 mm from the
ability to recover an artificially introduced 3D shift of various regarded single-phase PET images.
Moreover, the precision of the registration procedure was determined by multiple registrations
of various image pairs and found to be in the order of 0.5 mm. Thus, when performing eight
registrations to retrieve the motion-compensated 4D PET image, the combined registration error
decreases to 0.5/
√
8 mm ≈ 0.2 mm, which was ensured to not significantly affect the outcome of
the image data analysis discussed later in this section.
4.1.1.3 Calculation of the irradiation-induced activity pattern
The corresponding MC calculations of the expected irradiation-induced activity patterns within
the phantoms were performed on the basis of the analytical phantom geometry and the applied
treatment plans, using FLUKA 2011.2b. The not precisely known material stopping properties
of PMMA (density and ionisation potential) were tuned such that the simulation reproduces the
measured position of the activity peak within the phantom for the static Square irradiation (see
figure 4.3 in section 4.1.2.1).
In the case of moving phantoms, the motion-cycle has been divided into 20 equally-sized
phases on the basis of the relative motion amplitude (cf. section 3.4.3). This means the in- and
exhale motion were subdivided into 10% steps with a residual motion of 2 mm. For each of these
motion states, the average displacement of the phantom has been calculated under consideration
of the cos4-shaped motion and a phase-specific FLUKA simulation has been set-up. This phase-
specific simulation also requires a set of so-called state raster files. These files are equivalent
to treatment plan files for each considered motion state: they contain the number of particles
that have been irradiated to each raster-spot in each of the regarded motion states. The state
raster files used for the simulation of the moving phantom irradiation in this work have been
retrieved by the TRiP4D software, developed at GSI, Darmstadt and extensively validated in
dedicated experiments [Richter et al., 2013]. The procedure of generating the required set of
state raster files for the 20 chosen motion states on the basis of relative amplitude-sorting is
described in detail in [Richter, 2013]. In principle, the ANZAI motion signal acquired during the
phantom irradiation is synchronised to the corresponding machine beam record, which contains
time stamps after the irradiation of each single raster-spot has been finished, the so-called next-
point signal (NXP). Then, by using the latter information and the time-correlated motion signal,
the number of particles that have been applied to a single spot in a particular motion state can
be retrieved. The number of simulated primaries was set to about 0.5% of the irradiated particles
in each motion state in order to assure a similar level of statistics in the single simulations.
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As a result of these calculations, the yield of 11C, 15O and 13N in the PMMA phantoms
per incident 12C primary ion has been obtained. According to [Parodi et al., 2008b], the mean
activity to be expected in the acquired post-irradiation PET scan has then been calculated as:
〈A(r)〉 = G(r) ∗
{∑
i
ni ·
∑
j
[
Nji(r−∆i) ·
[1− exp(−λjtspill)]
tspill ·Nspill
· exp(−λj∆t)·
[1− exp(−λjtframe)]
λjtframe
·
Nspill∑
k=0
exp(−kλjtextr)
]}
. (4.1)
Here, ni is the number of irradiated particles according to the (motion state i specific) treatment
plan, Nji the output of the FLUKA simulation in motion state i for isotope j, ∆i the calculated
phantom displacement in state i and λj the physical decay constant of isotope j. Compared
to equation 3.2, the spill structure of the synchrotron beam delivery has been explicitly taken
into account and the isotope washout omitted. Following equation 4.1, the time-resolved or 4D
activity pattern within the phantom has been retrieved by summing up the mean activities of each
single motion state i, shifted according to the determined average displacement ∆i. The width σ
of the applied Gaussian filter G(r) was optimised by comparing the shape of the activity at the
entrance of the PMMA phantom in the simulated and the measured data and set to 3.5 mm.
For a direct comparison to the measured data, the post-processed simulation data was reg-
istered by a manual rigid registration to the static reference measurement of the regarded geo-
metrical set-up. Along the beam axis, the data-sets were matched on the activity increase at the
phantom entrance in order to enable a thorough range analysis and comparison.
4.1.2 Irradiation specific data analysis and results
4.1.2.1 Square irradiation
Data analysis The collected data, consisting of the 3D and 4D (motion-compensated) re-
constructed images of the three Square irradiation studies (static, G50 and G20 ) and the post-
processed MC data for each of the three investigated cases, have been analysed by dedicated
python (version 2.6.5) routines. The properties of main interest in the analysis were the PET-
based ion beam range, the lateral width and the lateral penumbra of the irradiation-induced
square-shaped activity distribution.
The PET-based range RPET of a regarded activity depth profile (ADP) has been defined as
the distance between the position of the maximum activity of the 1D profile, interpolated by
a cubic spline, and a fixed proximal reference position A5 (cf. figure 4.2). Here, A5 has been
defined as the proximal position at which 5% of the maximum activity is reached in the laterally
integrated (i.e., summed up over both directions perpendicular to the beam axis) ADP of the
static Square reference measurement. For a thorough range evaluation, all 1D profiles along the
beam direction which exhibit a maximum activity of at least 50% of the overall maximum activity
value in the investigated 3D activity distribution have been included in the analysis.
The width of the induced activity pattern has been determined for both lateral directions
as the FWHM on the basis of the profile specific averaged maximum activity 〈A95〉, defined as
the mean of all activity values above 95% of the activity maximum of the regarded profile. All
1D lateral profiles along the given axis exhibiting a maximum activity of at least 50% of the
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Figure 4.2: Illustration of the PET profile data analysis. The PET range RPET has been determined
as the distance between the maximum of the interpolated ADP and A5 (left). The upper and lower
penumbra have been defined as the distances of the positions of the 20 and 80% activity thresholds
with respect to 〈A95〉, on which also the FWHM has been based (right).
global maximum activity have been taken into account in the analysis. Moreover, the lower and
upper penumbra Plow/up of the lateral profiles have been retrieved as the distance between the
20% and 80% activity increase or decrease, respectively, as shown in figure 4.2. All data have
been analysed in the PET coordinate system: the beam enters parallel to the positive x-axis, the
y-axis corresponds to the vertical lateral direction and the z-axis, being parallel to the scanner
axis, coincides with the horizontal lateral direction and the direction of the phantom motion
(left-right in BEV). Consequently, profiles along the x- and y-axis exhibit a 2 mm pixel spacing,
while profiles along the z-axis have a 3 mm spacing.
In order to measure the similarity of the 2D activity distributions of different data-sets, a 2D
γ-index analysis (3%, 3 mm) has additionally been carried out [Low et al., 1998]. The γ-index
analysis has been performed in all planes perpendicular to the incident beam direction with an
integrated activity of at least 90% of the maximum activity of the laterally integrated ADP. The
lateral region for analysis was restricted to the area exhibiting activities of more than 20% of
the plane maximum activity, plus a 2 cm margin. In order to enable the comparison of data-sets
with different time structures, the compared 2D data-sets have been normalised to the integral
activity in the analysed part of the regarded lateral plane.
Results An overview of the results retrieved for the PET-based range and the lateral FWHM
and penumbra is given in table 4.3 for the static Square irradiation, the two moving phantom
studies G20 and G50 (reconstructed in 3D and 4D) and for the corresponding MC calculations.
For all depicted quantities, the mean value and standard deviation σ over of all analysed 1D
profiles are presented.
In terms of the PET-based range RPET, an agreement within 0.6 mm between all consid-
ered data-sets has been found. For most cases, this corresponds to an agreement within 1σ,
thus demonstrating the feasibility of sub-millimetre precision in offline PET-based range verifi-
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cation. In the comparison of simulated and measured ADPs, a generally good agreement has
been found in terms of the shape and quantification, with some remaining differences (below 5%
of the maximum activity) in the shallow plateau region proximal to the activity peak (see figure
4.3). These deviations can be attributed to inaccuracies in the MC modelling of the underlying
nuclear interactions, to the simplified modelling (by a Gaussian filter) of the PET imaging pro-
cess when calculating the expected activity (see equation 4.1) and to uncertainties in the activity
quantification in the reconstructed PET images (cf. chapter 5). As expected, the motion of the
homogeneous phantom perpendicular to the beam direction was found to have a negligible impact
on the determined beam range and ADP shape. With respect to these quantities, no significant
differences between 3D and 4D image reconstruction have been observed.
A similar finding has been made for the profile analysis in the vertical lateral direction,
perpendicular to the actual phantom movement. Neither the FWHMy, nor the Py have been
found to be affected significantly by the target motion and a generally good agreement (within
1σ) of the different measured data-sets, reconstructed in 3D or in 4D, and the simulated data
has been observed. Differences in the amount of induced activity between measurement and
simulation were confirmed to not exceed 5% of 〈A95〉 in the analysed y-profiles. The simulated
data, however, exhibits an enhanced symmetry of the lateral activity profiles along the y- and z-
axis, as shown for the integrated (summed up over the two respective perpendicular axis) lateral
profiles of the static Square irradiation study in figure 4.4. This can mainly be attributed to
differences in the PET scanner resolution along the two regarded axes, once being parallel to
the scanner axis and once perpendicular to the latter, as well as to a space dependent resolution
along each of the axes, which is neglected in the MC data post-processing. Still, with respect
to the application of dual-head PET detector systems, the achieved symmetry is considerably
improved.
In contrast to the previously discussed results for the two axis perpendicular to the actual
phantom movement, the investigated quantities along the z-axis are significantly affected by the
target motion (cf. bold entries in table 4.3). The main impact was found to be a 45±9 % enhanced
Table 4.3: Results of the Square irradiation study. PET-based range, FWHM and penumbra are
shown for the static reference measurement, the 3D and 4D reconstructions of the two gated irradiation
(G50 and G20 ) and the corresponding FLUKA simulations. The penumbra is given as the mean value
of Plow and Pup for the analysed lateral profiles along the y- and z-axis. Considerable deviations with
respect to the static reference are given in bold.
Study RPET[mm] FWHMy[mm] FWHMz[mm] Py[mm] Pz[mm]
Square, static 65.9± 0.3 50.7± 0.6 49.9± 0.4 10.0± 0.5 10.5± 0.4
Square G50, 3D 65.7± 0.2 50.9± 1.2 49.1± 0.6 10.6± 0.8 15.1± 0.8
Square G50, 4D 65.8± 0.2 50.7± 0.9 48.0± 0.4 10.6± 0.7 11.3± 0.5
Square G20, 3D 66.1± 0.2 51.1± 0.3 50.5± 1.0 10.1± 0.4 16.3± 0.8
Square G20, 4D 65.8± 0.2 51.1± 0.6 49.7± 0.5 10.0± 0.5 10.5± 0.6
FLUKA, static 65.7± 0.1 50.5± 0.1 50.5± 0.1 9.9± 0.1 10.0± 0.1
FLUKA G50, 4D 65.7± 0.1 50.0± 1.3 50.6± 0.2 10.5± 1.1 11.0± 0.3
FLUKA G20, 4D 65.5± 0.1 50.5± 0.4 50.8± 0.2 10.0± 0.3 10.2± 0.1
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Figure 4.3: Comparison of measured (blue) and simulated (red) ADP (left) and of the determined
range histograms containing all analysed 1D profiles along the x-axis (right) for the static Square study.
A high agreement has been observed in terms of shape and amount of irradiation-induced activity.
The mean PET-based ranges agree well within 1σ, as the unknown material stopping properties of
PMMA used in the simulation have been tuned to this measurement. Due to the underlying PET
image noise, the standard deviation is enhanced for the measured data.
penumbra Pz, if performing a stationary (3D) PET image reconstruction under phantom motion.
Similar results have been reported in [Parodi et al., 2009] and [Stützer et al., 2013] for moving
phantom activation studies with a dedicated in-beam dual-head PET camera at GSI, Darmstadt.
For the Square G20 study, this enhancement of the penumbra is illustrated for a central 1D
profile along the z-axis in figure 4.5 and for the entire population of analysed z-profiles in figure
4.6. If the target motion is, however, considered by a motion-compensated 4D gated PET image
reconstruction, the penumbra has been found to be substantially reduced and results similar to
the static reference study could be achieved (see figures 4.5 and 4.6). In the Square G50 study,
though, a slight enhancement of the penumbra with respect to the static reference measurement
has been observed in the 4D reconstruction of the measured data and could be confirmed by
the 4D MC simulation, where this enhancement even exceeds 1σ. The observed difference with
respect to the static reference can be attributed to the residual motion within the applied gating
window during the irradiation and indicates a high sensitivity of 4D offline PET-based treatment
verification, being able to detect these small alterations. If applying the smaller gating window,
no significant difference to the static reference can be found in the simulation as well as in the
4D reconstruction of the measured data due to the reduced residual motion.
Besides the enhanced penumbra, a significantly reduced lateral width in the direction of mo-
tion has been observed in the 4D gated PET image of the Square G50 study. This, however, could
not be reproduced by the performed 4D FLUKA simulation and has thus been attributed to the
inaccurate attenuation correction due to motion-induced artefacts in the underlying attenuation
correction CT (AC CT), in which the width of the phantom is reduced from 9 to 7.5 cm along the
direction of motion. A reconstruction on the basis of an averaged 4D CT would be beneficial, but
is not feasible on the used commercial PET/CT machine. Nevertheless, the observed deviation to
the static reference case and to the corresponding 4D MC simulation is still below the dimension
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Figure 4.4: Comparison of the integrated lateral profiles, normalised to the maximum activity, along
y- and z-axis (blue and green) for the static Square study. The measured data (left), shows an overall
reduced symmetry in the two lateral axis with respect to the simulated data (right).
of a single image pixel (3 mm).
In addition to the discussed range and lateral profile analysis, the obtained 2D activity dis-
tributions have been investigated by means of a 2D γ-index analysis, as previously mentioned.
All the regarded 2D activity patterns are shown in the lateral (y-z) plane of maximum activity in
figure 4.7. For the static (3D) reconstructions of the two considered gated irradiation studies, the
previously analysed blurring in the direction of motion (z-axis) is clearly visible. An additional
effect of the target motion, which has not been observed in the previous profile analysis, was found
to be a distortion of the square-shaped activity within the phantom along the z-axis, particularly
in the Square G50 study. This distortion, although corresponding to a lateral displacement of the
50% activity thresholds of the 1D lateral profiles along the direction of motion by only 3 mm, has
clearly been detected in the corresponding 4D PET image and could be reproduced by the corre-
sponding 4D MC calculation with an agreement of less than 1 mm (see figure 4.8). The observed
deformation of the activity pattern can be attributed to the residual motion of the phantom
within the gating window and the synchronisation of the irradiation with the periodic phantom
trajectory. Irradiation was performed by scanning line after line along the z-axis (horizontally),
such that, effectively, horizontal scanning was significantly faster than vertical scanning (along the
y-axis). Consequently, the phantom was moving continuously, with a residual motion amplitude
of approximately 1 cm, during the slow vertical beam scanning, leading to the observed distortion
of the induced activity. This effect could not be diminished by the 60 times rescanning, as the
irradiation of each spill started at almost the same respiratory phase. If, however, the gating
window is reduced (G20), the observed deformation is notably smaller. This has been confirmed
by the γ-index analysis: the γ-index of the Square G20 4D study is significantly smaller than the
one of the Square G50 4D study if compared to the static reference case, as shown in table 4.4.
Moreover, the analysis confirmed the enhanced agreement of the 4D reconstructions to the static
reference measurement compared to the blurred 3D PET images of the moving phantoms.
Concerning the agreement of measured and simulated data, it has been found that the 4D
simulations yield a comparable similarity (γ-index in the order of 90%) to the motion-compensated
reconstruction of the measured data, as has been observed in the static reference study. For the
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Figure 4.5: Comparison of central lateral profiles in the direction of motion for the Square G20 study.
The 3D reconstruction (blue) of the acquired PET data shows a significantly increased penumbra with
respect to the 4D reconstruction (red, left plot), which can achieve results similar to the static reference
measurement (green, right plot). The static reference has been normalised by a factor of 0.9 to account
for the different time structures of the two studies.
Square G20 study, it could also be confirmed that including the phantom motion in the MC
calculation leads to an enhanced agreement with the measured data, although differences between
stationary and moving phantom data are generally small. In the Square G50 study, the retrieved
γ-index was found to be slightly smaller than in the two other Square studies due to the reduced
lateral width of the 4D PET image, as previously discussed. This particularly limits the similarity
of the 4D simulation to the 4D image. Still, on the basis of the underlying experimental results,
a comparable performance of PET-based treatment verification under stationary and moving
conditions has been found if phantom motion is considered properly by a 4D simulation and a
Table 4.4: Results of the γ-index analysis of the Square irradiation study. Mean value and standard
deviation of the analysed y-z-planes are presented in each case.
Study 1 Study 2 γ-index
Square, static FLUKA, static 90.9%± 0.6%
Square, static Square G50, 3D 79.2%± 0.3%
Square, static Square G50, 4D 86.9%± 0.1%
Square, static Square G20, 3D 75.4%± 0.1%
Square, static Square G20, 4D 89.3%± 1.3%
Square G50, 4D FLUKA, static 87.4%± 0.2%
Square G50, 4D FLUKA G50, 4D 87.2%± 0.2%
Square G20, 4D FLUKA, static 90.5%± 0.5%
Square G20, 4D FLUKA G20, 4D 93.3%± 0.9%
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(a) Square static (b) Square G20, 3D recon. (c) Square G20, 4D recon.
Figure 4.6: Box-plots of the penumbra determined for the 1D profiles along the direction of target
motion in the Square G20 irradiation study. A significant enhancement in the 3D reconstruction
(middle), with respect to the static reference (left) has been observed. The 4D gated PET image
reconstruction (right) yields results similar to the static reference case.
motion-compensated image reconstruction.
4.1.2.2 Line Mono irradiation
Data analysis The 3D and 4D reconstructions of the acquired post-irradiation PET data
and the corresponding FLUKA MC calculations of the Line Mono static and G50 studies have
been analysed in terms of the PET-based range RPET by the same approach used in the Square
irradiation analysis. Due to the range modulation introduced by the PMMA fence placed in front
of the phantom, different ranges with respect to the fixed proximal position A5 could be found
in the PMMA block and have been compared to the known geometrical shape of the fence in
order to infer the accessible accuracy of PET-based range verification under static and under
moving conditions. Moreover, the lateral (perpendicular to the incident beam) profiles of the
activity distributions have been analysed by means of their FWHM and penumbra, following
the description in the previous section. To measure the similarity of the retrieved data-sets, a
2D γ-index analysis has been performed in all x-z-planes, which exceed an integral activity of
90% of the maximum activity of the integrated profile along the vertical y-axis. The choice of
transaxial planes, as was the case in the Square data analysis, has been avoided since the shape
of the activity distribution is expected to change significantly as a function of depth within the
phantom due to the given range modulation, while it is rather constant along the vertical y-axis.
In addition, the similarity of the detected range deviations, being the central issue of the Line
Mono irradiation study, can only be evaluated in planes parallel to the incident beam direction.
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(a) Square static, FLUKA (b) Square static
(c) Square G50, 4D FLUKA. (d) Square G50, 3D recon (e) Square G50, 4D recon
(f) Square G20, 4D FLUKA. (g) Square G20, 3D recon (h) Square G20, 4D recon
Figure 4.7: 2D activity distributions in the y-z-plane, i.e., perpendicular to the incident beam, for
the investigated square irradiation studies. The simulation data is shown in the left column, the 3D
reconstructed images in the middle column and the 4D reconstructions (only for the gated irradiation)
are depicted in the right column. The images of the moving phantom studies are significantly blurred
along the direction of motion, if not considering the movement in the reconstruction process. Due
to the residual motion in the G50 study, the square-shaped activity pattern is distorted along the
direction of motion, as can be seen in the simulated and the 4D reconstructed data. This effect is
notably reduced for the smaller gating window G20, in the simulation as well as in the measurement.
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Figure 4.8: Illustration of the motion-induced Square G50 activity distortion, corresponding to a
displacement of the 50% activity thresholds in the direction of motion. For the lower (left) and the
upper (right) 50% threshold, the displacement in measurement (blue) and simulation (red) agree within
about 1 mm. The threshold positions of the simulated data have been shifted in order to compensate
the different FWHMs (cf. table 4.3) in simulation and measurement for easier comparison.
Results An overview of the results obtained from the analysis of the different mono-energetic
line irradiation studies is given in table 4.5, addressing the lateral properties of the considered
activity distributions in the direction of motion, as well as the PET-based verification of the
induced particle beam range deviations. These have theoretical dimensions of DR1 = 7.5 mm,
DR2 = 12.5 mm and DR3 = 17.5 mm. The range differences have been determined on the basis of
the four different absolute PET-based ranges found within the PMMA phantom, as exemplarily
shown for the measured data in figure 4.9. The retrieved absolute PET-ranges are depicted in
appendix A.1 and have been found to agree within 0.9 mm for all investigated data-sets.
In terms of the determined range deviations DRi, the theoretical shape of the PMMA fence
could be reproduced with an accuracy better than 1 mm for all investigated data-sets, with the
exception of the 3D PET reconstruction of the gated irradiation. Here, especially the smallest
range difference DR1 could not be accurately recovered. The presented results prove the ability to
detect range deviations with sub-millimetre accuracy and precision (1σ) under static and moving
Table 4.5: Results of the Line Mono irradiation study. The FWHM and penumbra (mean of upper
and lower) in the direction of the phantom motion are presented, together with the determined range
differences induced by the PMMA fence. Notable deviations with respect to the static reference are
given in bold.
Study DR1[mm] DR2[mm] DR3[mm] FWHMz[mm] Pz[mm]
Line Mono, static 6.8± 0.9 12.5± 0.6 17.2± 0.5 143.9± 0.7 10.1± 0.3
Line Mono G50, 3D 5.9± 1.3 11.7± 1.1 17.2± 1.1 148.3± 1.2 13.9± 1.0
Line Mono G50, 4D 6.8± 0.7 12.1± 0.6 17.6± 0.5 143.2± 0.4 11.9± 0.5
FLUKA, static 6.8± 0.7 12.3± 0.4 17.3± 0.4 144.1± 0.2 9.9± 0.2
FLUKA G50, 4D 6.7± 1.0 12.2± 0.7 17.3± 0.6 144.3± 0.1 11.1± 0.1
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(a) Line Mono, static (b) Line Mono G50, 3D recon. (c) Line Mono G50, 4D recon.
Figure 4.9: Range histograms of the Line Mono static and Line Mono G50 measurements. In
the stationary image reconstruction of the moving target (middle), the range distribution shows an
increased spread, which results in a less precise and accurate range verification, particularly for the
smallest induced range difference. If performing a 4D motion-compensated reconstruction (right),
results similar to the static reference case (left) can be achieved.
conditions by offline PET-imaging of the irradiation-induced activity. But, they also show that
neglecting the target motion in the PET image reconstruction process can lead to a remarkable
degradation of the retrieved results in terms of accuracy and precision (see figure 4.9 and table
4.5). By applying a motion-compensated 4D gated PET image reconstruction, however, results
similar to the static reference measurement could be achieved, in agreement with the findings
of the Square study. With respect to the simulated data, a comparable accuracy and an only
slightly reduced precision has been observed in the analysis of the measured PET images of the
static and the moving case, thus indicating the high reliability of the acquired post-irradiation
PET data at the considered high statistics scenario.
The increased level of uncertainty in the quantification of the introduced range deviations
determined for the 3D reconstruction of the Line Mono G50 PET data is directly related to a
remarkable blurring of the induced activity pattern along the direction of motion. The blurring
is characterized by a significant increase of FWHMz and Pz with respect to the static reference
and can clearly be seen in the 2D activity distribution in the x-z-plane, as shown together with
the other investigated data-sets in figure 4.10, and in the exemplary 1D lateral profiles depicted
in figure 4.11. Both figures also show the notably reduced smearing and apparently improved
agreement to the static reference measurement for the motion-compensated image reconstruction
of the acquired 4D PET LM data. Still, with respect to the static reference, a significantly
enhanced penumbra has been detected in the 4D reconstruction, but could be confirmed by the
corresponding MC simulation and thus be attributed to the residual motion within the GW.
Moreover, it has been found that the residual motion of the phantom leads to a shift of the two
central activity maxima in the regarded lateral profiles by approximately 2 mm and to a slight
distortion of the peak on the right. Both observations could be reproduced with sub-millimetre
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(a) Line Mono static, FLUKA (b) Line Mono static
(c) Line Mono G50, 4D FLUKA. (d) Line Mono G50, 3D recon (e) Line Mono G50, 4D recon
Figure 4.10: 2D activity distributions in the x-z-plane of maximum activity for all investigated Line
Mono data-sets. The 3D PET reconstruction of the moving phantom study G50 shows a significant
blurring along the axis of motion compared to the static reference and the motion-compensated 4D
PET image. In general, a high agreement of simulation and measurement for the 3D and the 4D
(motion-compensated) study has been found.
agreement by the corresponding 3D and 4D FLUKA calculations, which are displayed in figure
4.11, as well.
Concerning the quantification of the irradiation-induced activity an agreement within about
5−10% of 〈A95〉 between measurement and simulation has been achieved. Compared to the Square
irradiation study, the agreement is slightly reduced, which can be attributed to the spatially more
inhomogeneous activity pattern and the more condensed activity spots (see figure 4.10) leading
to an overall increased level of uncertainty in simulation and measurement.
In the analysis of the lateral profiles along the vertical axis, i.e., perpendicular to the phantom
movement, a high agreement (within 1σ) in terms of FWHMy and Py of all the five considered
data-sets has been found and an impact of the target motion could not be identified, as expected.
Additionally, the similarity of the different data-sets quantified by the 2D γ-index is sum-
marised in table 4.6. Compared to the Square irradiation study, an overall reduced agreement
between different data pairs has been identified, which can be attributed to the overall higher
complexity of the induced activity pattern with respect to the simple, shallow square shape,
as well. Nevertheless, the γ-index analysis could indicate a significantly enhanced agreement
between the 4D image reconstruction of the gated irradiation and the static reference measure-
ment with respect to the 3D PET reconstruction of the gating case, proving the importance of
incorporating the target motion to the reconstruction process. In agreement with the Square
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(a) Measurement (b) Simulation
Figure 4.11: Comparison of the lateral profiles along the direction of motion for the measured
(left) and simulated (right) activity distributions. The 3D image reconstruction of the moving target
(green) shows a significant blurring and an enhanced penumbra. Besides, a 2 mm shift of the two
central activity maxima has been noticed in the 4D image (magenta) and the 4D simulation data
(cyan) with respect to the corresponding static reference (blue, red). The 3D data-sets have been
normalised to account for the different time structure of the two measurements.
irradiation study, a comparable similarity of the 4D FLUKA simulation to the corresponding 4D
motion-compensated reconstruction and of the static FLUKA simulation to the static reference
measurement has been found, which reflects the reliability of the performed 4D PET-based ir-
radiation verification. Even the small influence of the residual motion on the induced activity
pattern could be reproduced accurately, as also confirmed by the enhanced gamma index of 4D
simulation and 4D PET with respect to 3D simulation and 4D PET.
4.1.2.3 Line Mult irradiation
Data analysis The available data-sets, consisting of the post-irradiation PET measurements
of the static reference case and the irradiation with 20 and 50% GWs, together with the cor-
Table 4.6: Results of the γ-index analysis of the Line Mono irradiation study. In each case, mean
value and standard deviation of the analysed x-z-planes are given.
Study 1 Study 2 γ-index
Line Mono, static FLUKA, static 85.6%± 1.9%
Line Mono, static Line Mono G50, 3D 81.2%± 0.4%
Line Mono, static Line Mono G50, 4D 87.0%± 0.6%
Line Mono G50, 4D FLUKA, static 79.4%± 0.5%
Line Mono G50, 4D FLUKA G50, 4D 83.8%± 0.7%
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responding FLUKA MC calculations, have been analysed in a similar way as the previously
discussed Square study, using the same thresholds for the lateral profile and range analysis, but a
study-specific fixed value of A5, based on the static Line Mult reference measurement. Addition-
ally, a 2D γ-index analysis has been performed within a dedicated region of y-z-planes that have
been selected according to the same parameters used in the Square data analysis. The y-z-planes
were chosen as the alteration of the qualitative shape of the underlying activity pattern with
depth is small due to the range-compensated irradiation of the phantom through the PMMA
fence.
Results An overview of the results of the profile-based analysis of the Line Mult studies is given
in appendix A.2. The PET-based range of all investigated data-sets was found to agree within
0.7 mm. A deviation of less than 1σ has been identified between measured and simulated data
for all investigated cases. A comparable, sub-millimetre precision has also been observed for the
width and the penumbra of the analysed 1D profiles in the vertical lateral direction, perpendicular
to the phantom motion, which has been found not to affect the quantities discussed up to here, as
expected. In terms of absolute activity quantification, a similar agreement between measurement
and simulation as reported in the Line Mono data analysis has been determined (about 5− 10%
of 〈A95〉).
In contrast to the depth and vertical lateral profiles, the properties of the horizontal lateral
profiles along the direction of the phantom movement, were identified to be significantly affected
by the target motion, particularly in the case of the larger gating window. Here, especially the
lateral penumbra and its uncertainty were found to be considerably enhanced in the measurement
as well as in the simulation. This observation could be attributed to a notable distortion of the
induced horizontal lateral activity profiles with respect to the static reference measurement, as
can be seen from the 2D activity distributions depicted in figure 4.12: particularly the 50% GW
study is affected by significant interplay effects of the ion beam delivery and the residual phantom
motion. When applying a reduced GW of 20%, the shape of the static reference distribution
could be largely recovered and a FWHM and penumbra comparable to the static case have been
observed. For all moving irradiation, an enhanced blurring of the induced activity pattern has
been noticed in the stationary PET image reconstructions.
The 2D distributions shown in figure 4.12 have also been analysed by means of their 2D γ-
index, yielding the results presented in table 4.7. The enhanced similarity of the G20 study to the
static reference with respect to the G50 study could be confirmed and a significantly enhanced
agreement of the 4D simulations to the corresponding 4D image reconstructions compared to the
3D MC calculations has been found. As observed in the Square and Line Mono studies, the 4D
simulations and corresponding measurements were found to show a correlation comparable to
those of the static reference, hinting on the reliability but also on the necessity of a 4D simulation
under consideration of the phantom motion during the beam application.
Still, in the particular case of the Line Mult irradiation, which provides a remarkably more
complex interplay pattern with respect to the Square and Line Mono studies, remaining dif-
ferences between 4D measurements and 4D simulations concerning the particular shape of the
underlying activity distributions have been observed (cf. figure 4.12). One major source of un-
certainty within the 4D simulation workflow was identified in the temporal co-registration of the
logged ANZAI motion signal and the NXP signals of the corresponding machine beam records
(MBR). Slight changes of the temporal offset between motion and beam signal, corresponding to
54 4. Moving phantom studies
(a) Line Mult static, FLUKA (b) Line Mult static (c) Line Mult static
(d) Line Mult G50, 4D FLUKA (e) Line Mult G50, 3D recon (f) Line Mult G50, 4D recon
(g) Line Mult G20, 4D FLUKA (h) Line Mult G20, 3D recon (i) Line Mult G20, 4D recon
Figure 4.12: 2D activity distributions of the analysed Line Mult irradiation study data. By adapting
the beam energy to the shape of the PMMA fence, range deviations are largely avoided (see top-right).
Due to the finite beam size and the sharp edges of the PMMA fence, regions of over- and under-shoot
in the PMMA block have, however, been found and lead to a pattern of 7 single spots in the lateral
(y-z) image planes of maximum activity. The G50 study (middle row) is significantly affected by
interplay effects, while the G20 study (bottom row) yields results close to the static reference (top
row) if performing a gated 4D PET reconstruction (bottom-right).
a phase shift of the target motion, can immediately result in significant changes of the determined
state raster files and herewith of the irradiation-induced activity. All 4D FLUKA calculations
presented up to this point have been performed using a synchronisation of the end of the first
spill according to the ANZAI beam status (directly retrieved from the accelerator) and the last
NXP of the first spill within the MBR. Although the ANZAI system provides a sampling rate of
25 ms (the MBR provides 1µs) deviations between the ANZAI beam signal and the NXP signals
in the MBR of up to ±75 ms during the course of irradiation have been found. In addition, delays
in the logging and processing of the acquired motion data within the ANZAI system had been
observed in dedicated experiments at the Heidelberg facility, just as a non-constant offset between
the system times of the ANZAI and the accelerator system [Richter, 2014]. Consequently, phase
shifts between 0 (ph000, 4D FLUKA data presented up to here) and 300 ms (ph300) have been
introduced when generating the state-raster files in order to carefully investigate the impact of a
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(a) Line Mult G50, 4D recon (b) 4D FLUKA, ph000 (c) 4D FLUKA, ph050
(d) 4D FLUKA, ph100 (e) 4D FLUKA, ph200 (f) 4D FLUKA, ph300
Figure 4.13: Investigation of phase shifts between the ANZAI motion data and the beam delivery
sequence for the Line Mult G50 study. An enhanced agreement to the measurement was found for
phase shifts of 50 and 100 ms, while the similarity decreased for larger offsets.
possible temporal mismatch of the motion signal and the beam delivery sequence. The obtained
results are shown for the Line Mult G50 study in figure 4.13 and compared to the corresponding
motion-compensated PET image. It can be seen that an overall enhanced agreement to the mea-
surement has already been achieved by applying a phase shift of 50 ms: the determined γ-index
was found to increase significantly from 86.9% ± 0.2% to 89.2% ± 0.2%. For a phase shift of
100 ms, a slightly enhanced γ-index of 87.2%± 0.3% could still be found, while for larger, as well
as for negative shifts, a decreasing similarity has been observed.
For the Line Mult study with a 20% GW, a slight visual improvement by applying a 100 ms
phase shift has been achieved without, however, increasing the determined γ-index. As expected,
the G20 simulation is more robust against phase-shifts compared to the G50 study due to the
Table 4.7: Results of the γ-index analysis of the Line Mult irradiation study. Mean value and
standard deviation of all analysed lateral planes are given.
Study 1 Study 2 γ-index
Line Mult, static FLUKA, static 88.4%± 0.9%
Line Mult, static Line Mult G50, 4D 79.9%± 0.9%
Line Mult, static Line Mult G20, 4D 85.0%± 0.1%
Line Mult G50, 4D FLUKA, static 81.0%± 0.5%
Line Mult G50, 4D FLUKA G50, 4D 86.9%± 0.2%
Line Mult G20, 4D FLUKA, static 84.5%± 0.8%
Line Mult G20, 4D FLUKA G20, 4D 86.3%± 0.9%
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(a) G20, 4D recon (b) G20, 4D recon, phase 0 (c) G20, 4D recon, phase 5
Figure 4.14: Comparison of the motion-compensated 4D PET image (left) and two exemplary single
PET phases (middle and right). The single phases are clearly suffering from severe image noise, leading
to notable deviations in the amount and shape of the reconstructed activity. The motion-compensated
image is smoother due to the summation of all phases, registered to the reference phase 0.
reduced residual motion and interplay effects. Similar findings have been made when investigating
the impact of a possible phase shift on the Square and Line Mono gating studies: due to the lack
of a prominent interplay pattern, the impact of the initial motion phase on the calculated activity
pattern was found to be notably smaller than in the Line Mult G50 study. Nevertheless, the latter
study clearly demonstrated the potential of 4D PET-based treatment verification: it has been
demonstrated to be feasible to determine the initial motion phase of the moving phantom with a
precision of about 50 ms and to achieve an equivalent agreement of simulation and measurement
as found for the static reference case.
The high accuracy of the results retrieved within the moving Line Mult studies becomes even
more remarkable if considering the low counting statistics of the acquired PET data. According to
table 4.2, each of the eight reconstructed motion states contains only about 100, 000 true counts,
leading to a substantial noise in each of the reconstructed phases, as shown for two exemplary
phases in comparison to the 4D motion-compensated PET image in figure 4.14. The latter image
is considerably smoothed by the registration and subsequent summation of the eight single phases
in the chosen reference phase. With respect to the static reference measurement, the number of
counts within each phase is about a factor of nine lower, leading to a SNR reduced by a factor of
three. As a consequence, the results retrieved in the profile analysis of single-phase PET images
are significantly less precise and a sub-millimetre accuracy cannot be ensured, as shown for two
exemplary motion phases of the Line Mult G50 and G20 study in table A.3 in appendix A.2.
Moreover, remarkable differences between the PET images in different motion phases have been
observed: for the two phases 0 and 5 shown in figure 4.14, e.g., a γ-index of just 78.0%±0.5% has
been determined. Despite these findings, a comparable accuracy and precision with respect to
the static reference could still be achieved when analysing the smoothed motion-compensated 4D
gated PET image, although only providing a comparable number of true coincidences (≈ 850, 000
in total, i.e., ≈ 100, 000 in each of the eight gated PET phase) as in the clinical patient cases
discussed in chapter 6.
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4.1.3 Discussion and conclusion
The moving phantom irradiation studies presented in the first section of this chapter contribute a
first thorough experimental investigation on the applicability of offline PET-based treatment ver-
ification, using a commercial full-ring PET/CT scanner, to moving targets. Besides an in-depth
comparison of the results retrieved once in static reference measurements and once in measure-
ments with moving phantoms (applying a motion-compensated beam delivery by gating and
rescanning), the performance of corresponding 4D FLUKA MC simulations under consideration
of the target movement during the irradiation has been studied.
In general, it could be found that in the given comparably high statistics scenario (850, 000−
3, 600, 000 true coincidences) an accuracy and precision of below one millimetre can be achieved
in terms of the beam range as well as in terms of the lateral profile properties, namely the profile
width and its penumbra. Similar results in terms of the accessible precision and accuracy have
been reported in [Parodi et al., 2005b] for static and in [Parodi et al., 2009] and [Stützer et al.,
2013] for moving phantom irradiation studies, using a dedicated dual-head in-beam PET detector.
In contrast to these studies, however, the use of a commercial PET/CT system allowed for an
absolute quantification of the irradiation-induced activity. Here, differences between simulation
and measurement were typically found to be in the order of 5 − 10% and can be attributed to
uncertainties in the modelling of nuclear interactions within the FLUKA MC code, to inaccuracies
by the approximate modelling of the image acquisition and reconstruction process in the activity
calculation by only a post-simulation Gaussian filter, as well as to intrinsic uncertainties in the
activity quantification by the PET/CT scanner (cf. chapter 5) and the limited accuracy of the
applied attenuation correction on the basis of the free-breathing 3D CT during 4D gated PET
image reconstruction.
For all three investigated geometries, namely the Square, Line Mono and Line Mult study, the
importance of 4D motion-compensated PET imaging in the case of moving phantoms has clearly
been demonstrated. The applied 4D gated PET image reconstruction, currently being the only
available option for 4D PET imaging on the Biograph mCT scanner, clearly out-performed the
additionally performed 3D PET image reconstruction without taking the motion into account.
In the case of the Square irradiation study, target motion lead to a significantly enhanced lateral
profile penumbra in the 3D reconstructed images, similar to the observations presented in [Parodi
et al., 2009; Stützer et al., 2013]. The shape of the lateral profiles was, however, found be recovered
by the 4D image reconstruction, yielding results comparable to the static reference measurement.
Similar observations have been made for the Line Mono study, where motion also remarkably
impeded the precision and accuracy of determining the induced range deviations in the static
reconstruction under target motion. The 4D reconstruction, however, enabled an equivalent
performance, i.e., sub-millimetre accuracy in the detection of range differences, compared to the
static reference, in agreement with the observation in [Stützer et al., 2013]. In the case of the
Line Mult study, the considerable blurring along the direction of motion in the 3D reconstruction
of the moving phantom hindered the identification of the irradiation-induced interplay effects,
introduced by the residual motion of the phantom within the applied GW, thus further indicating
the need of a motion-compensated 4D PET image reconstruction in order to fully exploit the
potential of 4D PET-based treatment monitoring.
In the Square and Line Mono irradiation study, slight distortions of the detected activity
due to the residual phantom motion have been identified as well, although typically not exceed-
ing a scale of few millimetres. In the case of the Square irradiation, a slight distortion of the
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square-shaped activity in the vertical lateral direction has been observed due to the unavoidable
synchronisation of the synchrotron duty cycle and the phantom motion. In this particular case,
the enhanced symmetry of the used full-ring detector geometry with respect to the dual-head
set-up used in previous studies promises considerable advantages due the lack of limited angle
artefacts, which lead to a significant degradation of the resolution along the lateral direction
connecting the two detector heads [Crespo et al., 2006].
Concerning the corresponding 4D FLUKA calculations, an equivalent agreement of static
reference measurements with static FLUKA calculations and of 4D motion-compensated PET
images with 4D FLUKA simulations has been found for all studies, based on a 2D γ-index
analysis. The FLUKA simulations particularly confirmed the observed alterations due to the
residual phantom motion within the GW and herewith the high sensitivity of 4D offline PET-based
treatment verification. One critical issue in this context was spotted in the synchronisation of the
ANZAI-detected motion trajectory and the beam delivery sequence, having an uncertainty in the
order of about 100−200 ms. A dedicated simulation study for the Line Mult geometry, exhibiting
the most prominent interplay pattern, showed the sensitivity of the calculated expected activity
distribution in the phantom to the actual motion phase at the start of the beam application.
The study, however, also showed the high potential of 4D PET monitoring: by comparing the
simulated data to the motion-compensated 4D PET image, the time offset could be determined
with a precision of about 50 ms. Future studies will benefit from a dedicated EtherCAT system
which has been installed in the mean time and allows for a synchronous detection of ANZAI
and beam status signals, thus eliminating uncertainties in the synchronisation and enhancing the
achievable precision of the performed 4D MC calculations [Richter et al., 2014].
In conclusion, the conducted studies not only proved the feasibility of 4D offline PET-based
treatment verification by means of a commercial full-ring PET/CT scanner, but also indicated
the high potential of this approach. In the considered simplified experimental scenario (compara-
bly high counting statistics, no washout, regular phantom movement), motion-induced interplay
effects, leading to a distortion of the induced activity pattern with respect to the static refer-
ence, could be monitored with high (sub-millimetre) accuracy, yielding an equivalent similarity
of measurement and simulation as observed in the static reference cases. Interplay effects are
one main hazard in the treatment of moving tumours with scanned ion beams, and an accurate
identification is consequently highly desirable. 4D PET-based treatment verification has been
shown to have the potential of significantly contributing to control these risks and herewith to
contribute to an improved treatment of patients with mobile tumours.
A first application of 4D offline PET-based treatment monitoring to motion affected patient
irradiation will be presented in chapter 6, in order to investigate in detail the potential of this
method under clinical conditions. One main challenge is anticipated to be the further reduced
number of detected true coincidences, being in the order of 400, 000 − 900, 000. As reported in
[Parodi et al., 2009] and [Stützer et al., 2013], reduced counting statistics will lead to a degra-
dation of the retrieved results, typically hindering a sub-millimetre precision and accuracy. A
similar finding has been made in this work when analysing single phases of the gated 4D PET re-
construction of the Line Mult study, where each phase contained only about 100, 000 true counts.
Moreover, a thorough identification of the induced interplay pattern in these single phases was
found to be considerably more challenging due to the strongly enhanced image noise.
The issue of low counting statistics, and herewith high image noise, is one of the major
challenges in PET-based treatment monitoring in general, but is of particular interest for the 4D
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offline treatment verification approach pursued in this work due to the used gated 4D PET image
reconstruction, which further reduces the number of true coincidences within each single motion
state. Consequently, in the following chapter 5, an in-depth analysis of the noise properties and
geometrical fidelity of the Biograph mCT scanner over a wide range of counting statistics (also
covering the patient-relevant regime) will be carried out. Moreover, the accuracy of activity
quantification and the often-debated impact of the high random background due to the intrinsic
radio-activity of the LSO detectors will be addressed in detail.
4.2 A first implementation of ultrasound-based mo-
tion tracking in 4D PET imaging
In the previous section, the importance of the motion monitoring system in the context of 4D
PET-based treatment verification has been pointed out: an accurate tracking of the target motion
is necessary for the generation of the state-raster files, which are used in the 4D simulation of
the irradiation-induced activity, and it is also essential for motion mitigation during the post-
irradiation PET acquisition. The sensitivity of the induced activity pattern to the underlying
state-raster files has been shown particularly in the Line Mult G50 study (see section 4.1.2.3),
where slight phase shifts of the detected motion with respect to the beam delivery sequence were
found to have a remarkable impact on the calculated activity pattern. In a similar way, a mis-
identification of the actual motion state during the irradiation, e.g., due to a lack of correlation
between an external motion surrogate and the actual internal organ motion (cf. section 2.6.4), can
lead to significant differences between calculated and actually applied dose or induced activity.
Moreover, the previous moving phantom irradiation studies showed a remarkable degradation
of the quality of the retrieved PET images if motion is not accounted for in the PET image
reconstruction. Neglecting motion can lead to a significantly degraded accuracy and precision
of the determined ion beam range, as shown for the Line Mono study (see section 4.1.2.2), and
a substantial blurring along the direction of motion, hindering e.g., a thorough identification
of irradiation-induced interplay patterns. Similar to the generation of the state raster files,
accurate 4D imaging requires an accurate identification of the current patient motion state during
data acquisition. As a consequence an enhanced 4D imaging performance by advanced motion
tracking techniques is foreseen, particularly in the presence of breathing irregularities, as typically
encountered during the prolonged 4D post-irradiation patient PET acquisition.
Aim of the study discussed in this section is to investigate the feasibility of implementing an
advanced ultrasound-based tracking system in time-resolved PET and to compare its performance
to the reference monitoring system at HIT, namely the ANZAI respiratory gating system, within
a 4D PET imaging study with moving 22Na point sources.
4.2.1 Material and methods
4.2.1.1 US tracking device
For US-based motion monitoring, the prototype US tracking system Sonoplan II (mediri GmbH,
Heidelberg, Germany) was used. It is based on the Digital Phased Array System (DiPhAS,
Fraunhofer IBMT, St. Ingbert, Germany) in combination with an US T-probe which includes two
perpendicular 5.5 MHz, 64 element phased array transducers, allowing for simultaneous imaging
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Figure 4.15: Image of the experimental set-up for investigating the feasibility of US-based 4D PET
imaging. The US marker and the rigidly attached 22Na PET point source were moved parallel to the
scanner axis by the QUASAR motion platform. Movement was synchronously detected by the ANZAI
system and the US probe, which has been coupled to the water tank through a Mylar-foil window.
in two perpendicular planes. The captured US images are post-processed and evaluated by the US
tracking software which includes a probabilistic algorithm for real-time tracking of user-defined
structures in the acquired images [Zhang et al., 2010]. Target motion can be described by up to
five parameters (translation and scaling in x and y, plus a rotation) in each of the two considered
planes at a frame-rate of approximately 5 Hz with a precision of below 1 mm [Prall et al., 2014].
In comparison, the certified ANZAI respiratory gating system only provides a one dimensional
external signal, the patient chest-wall expansion, from which the actual internal motion has to
be inferred. Consequently, due to the questionable correlation of internal and external motion,
particularly in the case of irregular breathing patterns (cf. section 2.6.4), a superiority of real-time
internal motion tracking, as potentially provided by the US-system, is anticipated.
4.2.1.2 Experimental set-up
An image of the used experimental set-up for investigating the feasibility of US tracking based
4D PET imaging is shown in figure 4.15. The used 22Na point source has been moved along the
PET/CT scanner axis (z-axis) by the QUASAR respiratory motion platform and rigidly attached
to an US marker, represented by a rubber ball. In order to be able to monitor this marker, it has
been placed in a water-filled tank, to which the US transducer was coupled through a window
covered with a thin Mylar-foil. Motion was simultaneously detected by the ANZAI system,
directly connected to the motion platform as a standard reference (similar to the previously
discussed moving phantom irradiation study), and by the US system, tracking the contour of the
US marker. The whole set-up has then been placed in the bore of the Biograph mCT scanner.
Regular motion patterns (sinusoidal- and cos4-shaped) with different amplitudes A and periods
T have been investigated, as well as a real patient motion trajectory recorded during a 4D post-
irradiation patient PET scan.
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Figure 4.16: Image of the experimental set-up used to investigate the impact of the US probe on the
acquired PET images. The three 22Na point sources have been positioned in a diagonal line within
the Plexiglass frame, aligned to the PET/CT laser system. In the depicted case, the US probe has
been placed beside the source holder.
In addition, the impact of the US probe, placed in different positions within the FOV of
the PET detector ring, on the acquired PET images has been analysed in terms of activity
quantification and geometrical fidelity in order to exclude undesirable image artefacts due to the
application of US tracking. For this purpose, three 22Na point sources have been placed in a
diagonal line within a fixed Plexiglass source holder. The middle source was positioned at the
iso-centre of the scanner, while the two other sources were positioned with an offset of ±4 cm
along the scanner axis and ±6 cm in the radial direction. One reference scan and four scans with
the US probe fixated at different positions within the FOV have been acquired. The probe has
been positioned (1) beside the Plexiglass holder (see figure 4.16), (2) on the short edge of the
source holder, (3) under the source holder, about 6 cm below the middle source, and (4) right on
top of the central source on the source holder.
4.2.1.3 Data acquisition, processing and analysis
In all cases, PET data have been acquired in LM format with time tags every ms. In order to
enable a 4D image reconstruction in the moving phantom study, the positions in time of the inhale
peaks are provided by the ANZAI respiratory gating system within the acquired LM data stream
as gate-tags. For the 4D gated PET image reconstruction, the LM data has been subdivided
into eight motion phases, as typically done in 4D patient examinations, and reconstructed by a
filtered back-projection (FBP). The single respiratory phases have then been registered manually
to the maximum inhale phase, chosen as a reference.
In contrast to the standard ANZAI motion surrogate, the US tracking device cannot be
coupled directly to the PET/CT scanner. Instead, the US motion signal has been acquired in
parallel on a separate computer system and fed back to the acquired LM data retrospectively. For
this purpose, the inhale peaks in the the US tracking signal, considering only the displacement
parameter along the scanner axis, have been determined, corrected for the time offset between the
two computer systems and used to replace the ANZAI gate-tags within the acquired LM data.
The retrieved modified LM stream, now containing US-based gate-tags, has then been fed back
to the PET/CT scanner and reconstructed in the same way as the original LM data with ANZAI
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(a) Static reference (b) cos4, A = 3 cm, 3D recon. (c) cos4, A = 3 cm, 4D recon.
Figure 4.17: Comparison of static (left) and moving point source PET images. The activity of the
source is smeared over the whole motion amplitude (here 3 cm) if not corrected for (middle). Using
the standard ANZAI-based 4D gated image reconstruction, the Gaussian shape of the point source
can be recovered (right).
gate-tags. This enabled a direct comparison of 4D gated PET based once on the new US tracking
device and once on the reference ANZAI system. The quantity of interest in this comparison
was the width of the point source in the direction of motion (along the scanner z-axis) in the
reconstructed images, as determined by a Gaussian fit at the x-y position of maximum activity.
To quantify the impact of the US probe on the statically reconstructed PET images of the
second experiment, the integral activity within a generous volume-of-interest (VOI) around each
of the three imaged sources has been determined, as well as the position of the three sources in x, y
and z. The latter have been retrieved from 1D Gaussian fits along the three scanner axis through
the maximum activity of each single point source. As a measure for possible image distortions,
the relative positions of the individual sources with respect to the reference measurement without
US transducer in the FOV have been analysed.
4.2.2 Results
4.2.2.1 4D PET image reconstruction and comparison of tracking data
As shown in figure 4.17 for a cos4-shaped breathing pattern, motion of the point source leads
to a remarkable smearing and distortion of the point-like activity in the direction of motion, as
observed in the previously discussed moving phantom irradiation study, and to a notably larger
integral activity if not performing a motion-compensated image reconstruction. By applying a
4D gated PET image reconstruction (here based on the reference ANZAI gate-tags), however,
the original Gaussian shape of the point source, as well as the correct integral activity, can be
recovered. Still, with respect to the static reference measurement, the FWHM along the direction
of motion was found to increase from 5.2 mm to 9.6 mm in the depicted case due to the residual
motion within the eight considered motion states.
Following the aim of this study, namely to investigate the feasibility and performance of an
ultrasound-based motion-mitigated image reconstruction, the acquired tracking data of the US
system and the ANZAI reference surrogate, on which the gate-tags written into the PET LM
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(a) cos4, A = 3 cm, T = 4 s (b) Patient, Amax = 3 cm
Figure 4.18: Comparison of synchronised US (red) and ANZAI (blue) tracking data for a regular
cos4-shaped motion (left) and an original patient trajectory (right). As the US system provides a
considerably lower frame rate, the acquired data have been interpolated. In general, a good agreement
between the two data-sets has been found. Particularly the positions in time of the inhale peaks agree
quite well, typically within less than 100 ms.
data are based, have been compared. Out of the ten available tracking parameters delivered by
the US device, only the displacement in the direction of motion, used in the retrospective LM
data manipulation, has been considered. All further US tracking parameters were found to be
constant in time for the selected one-dimensional motion aligned to the perpendicular US planes
and could thus be neglected. As shown in figure 4.18 for the cos4-shaped motion, with T = 4 s
and A = 3 cm, and for a real patient breathing pattern with a maximum peak-to-peak amplitude
of 3 cm, a good agreement between the two tracking systems has been found. Minor deviations
have typically been identified in the exhale part of the trajectory. In the performed 4D gated PET
image reconstruction, however, only the positions of the inhale peaks are of importance: here,
a standard deviation in time of less than 100 ms has been found for all investigated breathing
patterns (cf. table 4.8), hinting on a comparable performance of both tracking systems in terms
of motion-mitigated 4D PET imaging. It should be noticed that the mean time difference of
the inhale peak positions has been set to zero by the prior synchronisation of the two tracking
data-streams.
4.2.2.2 Performance of US-based 4D PET
An overview of the FWHMs obtained by the 1D Gaussian fit along the direction of motion (z-
axis) in the 4D-reconstructed motion-mitigated PET images, based once on the ANZAI and once
on the US tracking signal, is presented in table 4.8, together with the standard deviation of the
above-mentioned time differences between ANZAI- and US-detected inhale peaks (corresponding
to the LM data gate-tags), ∆tANZAIUS . The depicted FWHM values have an uncertainty of 0.2 mm
originating from the manual registration of the reconstructed phases to the chosen reference phase
and the uncertainty of the performed fit. An error of 0.2 mm in the manual registration process
was estimated by multiple registrations of the same data-set and comparison of the determined
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(a) cos4, A = 3 cm, T = 4 s (b) Patient, Amax = 3 cm
Figure 4.19: Comparison of profiles along the direction of movement for the cos4-shaped motion
with A = 3 cm and T = 4 s (left) and the real patient trajectory (right). The ANZAI-based (blue,
cyan) and the US-based (red, magenta) 4D gated PET images agree within less then 0.8 mm in terms
of the point source position and show an equal FWHM in the direction of motion.
FWHMs. The error in the 1D Gaussian fitting was typically found to be below 0.1 mm.
Taking these uncertainties into account, an equivalent performance of the clinically used
ANZAI gating system and the prototype US tracking device has been identified in terms of motion
mitigation in 4D PET imaging under the given experimental conditions. The profiles along the
direction of motion, as retrieved with the two investigated tracking devices, are compared for the
cos4-shaped motion with A = 3 cm and T = 4 s, as well as for the investigated patient motion
trajectory in figure 4.19. In both cases, the FWHM agrees within 0.2 mm and the position of
the point source, corresponding to the mean value of the fitted Gaussian, agrees within 0.8 mm.
In general, for all investigated motion patterns of table 4.8, the position of the point source has
been observed to agree within less than 5% of the case-specific motion amplitude in the ANZAI-
Table 4.8: Overview of the determined point source FWHMs along the scanner axis and the standard
deviations of the inhale peak time differences. The combined error of the manual registration and the
Gaussian fit in the FWHMs has been determined as 0.2 mm in all cases.
Motion Sinusoidal Cos4 Cos4 Cos4 Patient
Shape T = 4 s T = 4 s T = 4 s T = 2.5 s
A = 4 cm A = 3 cm A = 2 cm A = 3 cm Amax = 3 cm
FWHMz[mm] 9.6 8.2 7.2 8.3 7.3
ANZAI
FWHMz[mm] 9.6 8.3 7.4 8.3 7.5
US
STD(∆tANZAIUS ) 50.0 32.3 41.4 33.6 81.1
[ms]
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and US-based 4D motion-compensated images.
The retrieved results (cf. table 4.8) moreover confirmed that a higher motion amplitude results
in a larger FWHM due to an enhanced residual motion in the single PET phases. Concerning
the patient-like data-set, it must be considered that the average breathing amplitude was about
2 cm, i.e., smaller than the maximum peak-to-peak amplitude of 3 cm. The breathing period, on
the other hand, was found to not affect the results because of the used phase-based sorting of the
LM data.
In general, the method of retrospectively replacing the ANZAI gate-tags in the acquired LM
PET data by the determined US gate-tags has proven to work reliably during the data preparation
process. However, a prior synchronisation of each independent data-set has been found to be
necessary, in order to correct for an observed, non-constant time offset between the two different
operating systems on which the tracking routines were run, and which consequently had to be
determined at the beginning of each single PET acquisition. This problem can likely be solved by
running the US tracking software directly on the ANZAI computer, which was not feasible in the
context of this study as the ANZAI computer is in clinical use and additional software installation
not allowed. Further efforts on an improved synchronisation of both devices are, however, not of
need if pursuing the approach of retrospective introduction of the US gate-tags into the acquired
LM data, but would be required for future prospective gated PET acquisitions on the basis of
US motion tracking.
In the presented results, the anticipated superiority of the US tracking system could not be
shown due to the chosen set-up with a regular 1D motion and the only available gated 4D PET
image reconstruction, which solely relies on the position of the inhale peaks and not on the actual
source position. In order to demonstrate the promised advantages of US tracking, a more detailed
investigation with a more complex, uncorrelated 3D point source motion and a more sophisticated
way of sorting the acquired LM data into the different motion phases, making use of all the ten
US tracking parameters, would be of need. A realisation within the restricted environment of a
clinically used PET/CT device is, however, expected to be too elaborated and beyond the scope
of this work, which focused on a first proof-of-principle study on the feasibility of US-based 4D
PET.
4.2.2.3 Artefact effects by the US probe
The results of the investigations on possible imaging artefacts induced by the ultrasound probe
being positioned within the PET FOV are presented in tables 4.9 and 4.10. Table 4.9 presents
the impact of the US transducer on the quantification of the point source activity. Repeated
measurements of a single point source showed a quantification uncertainty of about 1%. The
alterations caused by the US probe are typically in the same order of magnitude, not exceeding a
value of 3.5% with respect to the reference measurement without US probe. The only exception
has been found for the probe positioned directly next to the central source S2. Here, artefacts in
the underlying AC CT lead to an over-correction of the point source activity by about 20%, thus
surpassing a clinically acceptable limit. This extreme situation will, however, rarely appear in
clinical cases where the activity of main interest is usually not positioned directly at the patients
skin. Particularly in the context of PET-based verification of the applied ion beam range, the
distal activity fall-off, which is of main interest in the data analysis, is typically located several
centimetres below the patient skin.
Concerning the spatial distortion introduced by the US probe, similar conclusions could be
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drawn: the impact of the transducer on the determined positions of the three imaged point sources
has been found to be smaller than one single image pixel, having a size of 2 mm perpendicular and
3 mm parallel to the scanner axis (see table 4.10). Considering the point source resolution of the
scanner, which has been determined as 4.4 mm in [Jakoby et al., 2011], the retrieved alterations
are not expected to significantly impact the quality of clinical PET data-sets. In this context, it
should also be mentioned that the chosen experimental set-up represents an extreme case, being
highly sensitive to imaging artefacts. In a patient scenario, the contribution of the ultrasound
probe to the attenuation of the emitted gamma rays will be significantly smaller and the more
shallow activity pattern with respect to the investigated sub-millimetre point sources will be
notably less prone to image distortions.
Consequently, clinical US-based 4D PET imaging will not be significantly impeded by artefacts
introduced by the used US transducer if keeping a distance of a few centimetres between the US
probe and the investigated activity distribution within the patient.
4.2.3 Discussion and conclusion
In the second part of this chapter, a first implementation of US-based motion tracking in 4D
PET imaging has been performed and compared in terms of motion mitigation to the presently
used standard motion monitoring device at HIT, namely the certified ANZAI pressure sensor,
in dedicated phantom imaging studies. US-tacking is a promising technique which enables non-
invasive, dose-free and real-time tracking of the internal target movement, thus not relying on
the questionable correlation of external and internal motion in contrast to the ANZAI system.
This capability is important for an advanced sorting of the acquired image data to the single
motion phases for an improved, artefact-free 4D imaging, as well as for an improved sorting
of the irradiated beam spots to the single motion phases when retrieving the 4D state-raster
files. Both applications have been shown to be of utmost importance for 4D offline PET-based
treatment verification in the discussed moving phantom irradiation studies (cf. section 4.1.3).
The conducted 4D PET imaging study showed that 4D gated PET imaging based on US
motion tracking is feasible and that results equivalent (differences on the sub-millimetre scale) to
the clinically used ANZAI respiratory gating system can be achieved. The standard deviations
of time differences between the required gate-tags in the acquired LM data were found to be
Table 4.9: Impact of the US probe on the point source quantification. The determined integral VOI
activities A are given for each of the three imaged point sources Si, together with the deviation to the
reference measurement without US probe (in brackets). All determined activities have an uncertainty
of 1.0%.
AS1 [10
8Bq/ml] AS2 [10
7Bq/ml] AS3 [10
8Bq/ml]
Reference 2.95 8.25 2.93
Beside source holder 2.89(−2.0%) 8.23(−0.2%) 2.91(−0.7%)
Edge of source holder 3.01(+2.0%) 8.17(−1.0%) 2.83(−3.4%)
Below source holder 2.99(+1.4%) 8.23(−0.2%) 2.88(−1.7%)
Top of source holder 3.01(+2.0%) 9.96(+20.7%) 2.93(+0.0%)
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below 100 ms and the investigated FWHMs along the direction of motion were observed to agree
within 0.2 mm for all investigated cases when comparing the 4D data-sets retrieved with the
two monitoring systems. Moreover, the positions of the moving point-source in the 4D motion-
compensated images were found to agree within less than 5% of the respective motion amplitude.
In line with these findings, a sub-millimetre agreement between the US tracking device and a
high-precision laser distance sensor has also been reported by [Prall et al., 2014].
Moreover, a study with a fixed point-source set-up proved that quantification and geometrical
fidelity of the scanner are not significantly degraded when positioning the US-transducer in the
PET FOV, as long as a minimum distance of few centimetres between the imaged activity pattern
and the US probe is kept. This will be the case in most clinical scenarios, where the relevant
activity is very rarely to be found close to the patient skin. Another challenge that might be
encountered in clinical scenarios is the motion of the US probe, attached to the patient surface,
during respiratory motion. This problem, however, can be solved by additional optical tracking
of the US probe motion, which enables US tracking in absolute coordinates within the PET/CT
coordinate system, as shown in [Schwaab et al., 2014].
Further studies with more complex motion patterns, particularly with uncorrelated motions
in more than one dimension, and with an advanced way of sorting the acquired LM data into
the different reconstructed motion states should aim at showing the anticipated benefits from
US motion tracking in 4D PET imaging under conditions closer to clinical scenarios. Moreover,
these investigations should clarify the issue of timing synchronisation between the two tracking
systems, also considering possible delays in the US tracking system which have been described
in [Schwaab et al., 2014; Prall et al., 2014]. Although these delays are not of concern for the
presented retrospectively gated US-based PET imaging with prior synchronisation of the motion
data-streams, they become a crucial issue for prospective gating in 4D PET imaging and real-time
motion monitoring during irradiation, as being of need for generating the state-raster files for 4D
dose and activity calculations. As has been shown for regular target movement in [Prall et al.,
2014], motion prediction by an artificial neural network, might be one possible solution to this
complication.
Table 4.10: Image distortions induced by the US transducer. The depicted values show the spatial
deviations determined along all three axes for each of the three point sources with respect to the
reference image without US transducer in the PET FOV. The error in the fitted positions and in the
retrieved deviations is below 0.1 mm.
(∆xS1, ∆yS1, ∆zS1) (∆xS2, ∆yS2, ∆zS2) (∆xS3, ∆yS3, ∆zS3)
[mm] [mm] [mm]
Beside source holder (−0.3,−0.1,+0.9) (−0.2,−0.1,+1.7) (−0.2,−0.1,+0.7)
Edge of source holder (+0.0,−1.5,+1.0) (−0.0,−0.0,+1.8) (+0.1,+1.0,+1.5)
Below source holder (−0.3,−0.1,+0.7) (−0.3,−0.1,+0.8) (−0.2,−0.1,+0.2)
Top of source holder (−0.3,−0.1,+1.1) (−0.2,+0.0,+1.9) (−0.2,−0.1,+1.6)

Chapter 5
Investigations on the performance of
the Biograph mCT PET/CT scanner
at very low true count rates
In the post-irradiation PET/CT studies of moving phantoms discussed in the previous chapter,
analysis of the retrieved PET images has been found to be challenged by a decreasing number
of true coincidences. In particular, when analysing the single motion state PET images obtained
from the 4D gated image reconstruction in the Line Mult study, sub-millimetre precision in
the depth and lateral profile analysis could no longer be provided, and a proper identification
of the residual motion-related interplay pattern was found to be considerably undermined (cf.
section 4.1.2.3). Similar observations have been made for comparable moving phantom studies at
low counting statistics with a dedicated BGO(Bismuth germanate)-crystal based in-beam PET
camera in [Parodi et al., 2009; Stützer et al., 2013].
In the same way, the small amount of irradiation-induced activity and the directly related
high level of noise in the reconstructed PET images has been reported to be one of the major chal-
lenges of in-vivo PET-based treatment verification under clinical conditions [Parodi et al., 2008a;
Shakirin et al., 2011; Bauer et al., 2013b]. The numbers of detected coincidences for carbon-ion
post-irradiation PET acquisitions at HIT are presented in table 5.1 for several exemplary pa-
tient cases with various tumour indications. The given random fraction (RF) is calculated as the
number of random coincidences divided by the number of prompt (sum of random and true) coin-
cidences. As can be seen, the acquired clinical data provides between about 80, 000 and 1, 200, 000
true coincidences for image reconstruction, which is about 1− 3 orders of magnitude less than in
standard nuclear medicine imaging with injected radio-tracers like 18F-Fludeoxyglucose (FDG)
[Nagaki et al., 2011]. The number of random coincidences has been found to be almost constant,
as predominantly attributed to the intrinsic LSO-related random background (cf. section 3.4.3).
The latter has been determined as 1032 ± 27 cps by a fit of the measured random rates in 18
different patient scans by an exponential decay plus a constant background term according to
equation (3) in [Parodi et al., 2007b]. Due to this constant background, RFs range from about
60 to 96% in the taken data-sets. In the case of 4D gated PET image reconstruction, which is of
particular interest in the scope of this work and where the acquired data are reconstructed sepa-
rately within each motion phase, the number of available true coincidences is even further reduced
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(at constant RF) by the number of considered motion states. For the depicted liver patients in
table 5.1, e.g., which will be studied in depth in chapter 6 with respect to the applicability of 4D
offline PET-based treatment monitoring, the number of true counts per phase will be decreased
to 100, 000 or less if reconstructing a set of eight individual motion states, as done in the previous
moving phantom irradiation study (cf. chapter 4).
The investigations presented in this chapter address in detail the reliability and accuracy of
the activity quantification, as well as the geometrical fidelity of the Biograph mCT scanner, under
these particular statistical conditions of small numbers of true counts and high RFs for different
image reconstruction methods and settings, with the aim of identifying the best-performing algo-
rithm and its optimal configurations for PET-based treatment verification. Moreover, the impact
of the exceptionally high random background on the reconstructed PET images is thoroughly
investigated.
5.1 Material and methods
5.1.1 Phantom imaging and simulation study
In order to investigate the performance of the Biograph mCT scanner over a wide range of count-
ing statistics, a dedicated imaging study with a cylindrical water phantom has been performed
(see figure 5.1). A cylindrical insert with a diameter of 46 mm within the phantom, emulating a
patient-like activity distribution for verification of the geometrical fidelity and range-like assess-
ment power, has been filled to an activity of 2007± 22 Bq/ml with FDG and aligned parallel to
the PET/CT scanner axis. 30 subsequent PET scans with a duration of 30 min each have been
acquired, collecting between 8, 000, 000 and 40, 000 true coincidences at RFs between 21 and 98%,
thus covering the whole patient-like counting regime in terms of true counts and RFs, as depicted
in figure 5.1. The retrieved data have been reconstructed by 4 different reconstruction algorithms:
the standard 3D OP-OSEM (in the following referred to as OSEM), 3D OP-OSEM with imple-
mentation of TOF information (OSEMTOF), 3D OP-OSEM with PSF modelling (PSF) and 3D
Table 5.1: Counting statistics of exemplary post-irradiation PET scans acquired after 12C irradiation
at HIT for various tumour locations. The presented liver tumour cases will be analysed in depth with
respect to the applicability of 4D offline PET-based treatment verification in chapter 6.
Location True counts Random counts Random fraction
Head 75, 346 1, 981, 590 96.3%
Head/Neck 121, 712 1, 881, 088 93.9%
Sacrum 1, 190, 642 1, 822, 141 60.5%
Prostate 588, 401 1, 774, 623 75.1%
Liver (L1) 891, 871 1, 850, 903 67.5%
Liver (L2) 693, 686 1, 922, 683 73.5%
Liver (L3) 379, 308 1, 873, 157 83.2%
Liver (L4) 703, 576 1, 941, 071 73.4%
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Figure 5.1: Image of the used cylindrical phantom including the FDG insert (left) and the number of
counts acquired in the 30 subsequent PET frames (right). The patient-like counting regime is indicated
by the grey shaded area and completely covered by the performed measurements.
OP-OSEM with TOF and PSF information (PSFTOF). For each algorithm, a variety of recon-
struction parameters (number of iterations, number of subsets, post-reconstruction filter size)
has been investigated in order to identify the optimal reconstruction approach for PET-based
treatment verification. The voxel-size was kept constant at the available maximum value of
4×4×2 mm3 in order to optimise the number of counts per voxel under the given poor statistical
conditions. In all cases, attenuation correction, on the basis of an AC CT, and scatter correction,
on the basis of a single scatter simulation [Watson, 2000], scaled to the measured emission sino-
gram data in a region outside of the phantom (in order to account for scatter contributions from
outside the axial PET FOV [Watson et al., 2004]), have been applied. All reconstructions have
been performed at the Siemens Molecular Imaging headquarters in Knoxville, USA, using directly
the basic reconstruction routines of the Biograph mCT scanner, which cannot be accessed by the
standard end-user of the device, who is restricted to steer them via the Syngo user-interface. For
the presented study, the direct usage of the underlying basic routines enabled the investigation of
a wider range of reconstruction parameters than provided by the Syngo interface, concerning not
only the number of iterations and subsets, but also the underlying scatter correction algorithms.
The precision and accuracy of the activity quantification, as well as the image noise, have
been analysed for each reconstruction of each acquired PET frame in 16 equally spaced planes
along the scanner axis in a circular region-of-interest (ROI) with a diameter of 32 mm, placed
within the cylindrical FDG insert (see figure 5.2). The geometrical performance of the different
reconstruction settings has moreover been inferred from the determination of the FWHM and
penumbra (80%−20% fall-off) of the 1D activity profiles along the transaxial scanner coordinates
through the centre of the 16 evaluated ROIs, as also shown in figure 5.2. The correct recovery of
the two edges in each of the profiles resembles the detection of the distal fall-off of the irradiation-
induced activity within a patient, as requested for analysing the particle beam range.
The impact of the high LSO-related random background on the reconstructed images has
been addressed by truncating the acquired LM data of the different PET frames to fixed numbers
of true coincidences and herewith yielding LM data-sets containing a constant number of true
coincidences at different random fractions. This also enabled to separate the impact of low true
count rates and of the high random fractions on PET imaging.
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Figure 5.2: Sketch of the data analysis for the phantom experiment. Activity quantification and
noise have been evaluated on the basis of 16 circular ROIs within the FDG activity insert (red, left
plot) in each of the 30 PET scans. The geometrical performance was inferred from the analysis of
FWHM and penumbra (middle and right plot) of the 1D profiles along the transaxial coordinates of
the scanner through the centre of the ROIs (green, left plot). In frame 21 (140, 000 trues) noise is
considerably impeding the geometrical accuracy and precision (right plot).
In order to confirm the experimental findings and extend them to an even wider range of
counting statistics, a dedicated simulation study of the experiment has additionally been per-
formed. Within this simulation, sinogram files have been generated by the forward projection
of an artificially generated image of the well-known experimental set-up under consideration of
the detector sensitivity of the mCT scanner and the attenuation correction, as described by the
AC-CT. Additionally, simulated scatter coincidences and random coincidences in a user-defined
amount, as well as Poisson-noise could be added to the simulated sinogram data, thus enabling to
separately investigate the influence of scatter coincidences in the presence and absence of random
noise. The retrieved sinograms have been reconstructed by exactly the same algorithms as the
measured data. The data analysis has, however, been extended by additionally analysing the
amount of activity outside the FDG insert (in this case covered by a circular ROI of 56 mm),
outside the water phantom and in the summed-up image.
5.1.2 Application to clinical cases
Based on the results retrieved from the phantom imaging study and the corresponding simulation,
the applicability of the proposed optimal reconstruction settings to clinical cases has been inves-
tigated for four original post-irradiation patient PET data-sets: two head patients, representing
the most frequent indication for PET-based treatment verification, and two liver patients (L1 and
L2) which will also be discussed in chapter 6. The analysis focused on the activity quantification
and image noise within a user-defined set of ROIs in planes perpendicular to the incident beam,
where a rather constant activity pattern has been expected. Moreover, the optimised reconstruc-
tion strategy has been compared to the previously used standard reconstruction scheme at HIT,
namely PSFTOF with 3 iterations, 21 subsets and a 5 mm post-reconstruction Gaussian filter
(PSFTOF, 3i21s, gf5, inspired by the typical settings in conventional nuclear medicine imaging),
in terms of beam range verification (following the most-likely shift approach described in section
3.4.4 and [Frey et al., 2014]) in order to carefully ensure an equal sensitivity to range deviations
from the planned treatment application, which is of utmost importance in PET-based treatment
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Figure 5.3: Relative deviation of the mean activity within the ROIs with respect to the injected
activity (yellow bar, left plot) and image noise (right) for the OSEM (blue), PSF (red), OSEMTOF
(green) and PSFTOF (cyan) reconstruction algorithms at 2i21s (cf. text). The patient-like counting
regime is indicated by the grey shaded area. OSEM cannot recover the correct activity below about
200, 000 trues. PSF and TOF information can help to overcome this limitation. In terms of noise, slight
advantages have been found for reconstructions including PSF information at small true numbers.
monitoring.
5.2 Results
5.2.1 Phantom data: activity quantification, noise and geomet-
rical fidelity
The relative deviation of the mean activity determined in the 16 circular ROIs with respect to
the injected activity of 2007±22 Bq/ml as a function of the number of detected true coincidences
is shown in figure 5.3 for the different investigated reconstruction algorithms at 2 iterations
with 21 subsets (2i21s) 1. It has been found that below about 200, 000 true counts, the OSEM
reconstruction can no longer recover the correct activity and is thus not suitable for low statistics
patient imaging. Including PSF and TOF information has been observed to help overcoming
this limitation. If applying both information (i.e., PSFTOF), the activity could be determined
correctly down to about 60, 000 true counts at a RF of 98%. In terms of the image noise, here
defined as the standard deviation divided by the mean value of all pixels within the 16 ROIs, a
slight decrease has been identified for reconstructions with PSF-modelling at very few true counts
(below about 100, 000), if not exceeding 3 iterations at 21 subsets (see figure 5.3).
The impact of the number of iterations on the activity quantification and image noise is il-
lustrated in figure 5.4 for the PSFTOF algorithm: a small number (below 50) of MLEM-like
iterations (calculated as the number of subsets times the number of OSEM iterations) has been
found to lead to a slight overestimation of the determined target volume activity by up to 5%,
as the reconstructed activity converges from higher to lower values. On the other hand, a sig-
nificantly reduced noise-level in the reconstructed images has been observed for less iterations,
particularly at small true numbers. Similar findings have been made for the other reconstruction
1If not differently stated, a post-reconstruction Gaussian filter of 5 mm has been applied to all data
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Figure 5.4: Relative deviations in activity quantification (left) and assessment of image noise (right)
for 1 (blue), 2 (red), 3 (green) and 4 (cyan) iterations of the PSFTOF reconstruction. Fewer iterations
tend to overestimate the activity by up to 5%, but were found to result in a significantly reduced
image noise.
Figure 5.5: Geometrical performance for different numbers of iterations. The FWHM of the phantom
can be recovered more accurately for less iterations (left). At the same time, less iterations provide a
reduced lateral penumbra at low true count numbers.
algorithms and different numbers of subsets (14 and 24). Consequently, if accepting a poten-
tial overestimation of the activity by typically less than 5%, the image noise can be reduced by
more than 30% below 100, 000 true counts for 1 OSEM iteration of PSFTOF with respect to the
currently used standard setting with 3 iterations.
In terms of geometrical fidelity, the best results could be obtained with the PSFTOF algo-
rithm. Compared to the other reconstructions, PSFTOF was found to obtain a slightly more
accurate and precise recovery of the FWHM of the imaged FDG insert as well as a smaller lateral
penumbra at a reduced variance. As depicted in figure 5.5, an improved geometrical accuracy and
precision has also been observed for a reduced number of iterations. This can directly be related
to the reduced image noise, which generally makes the definition of thresholds (20, 50 and 80%
fall-off) more prone to uncertainties (cf. figure 5.2, right plot). Similar thresholds are also used in
PET-based range verification [Knopf et al., 2011; Helmbrecht et al., 2012; Frey et al., 2014], which
could consequently gain in robustness by reducing the image noise level, as well. In this context,
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(a) Image noise (b) FWHM fidelity (c) Penumbra
Figure 5.6: Impact of the post-reconstruction filter size. As expected, larger filters result in a reduced
image noise (left). This also leads to an improved recovery of the FWHM of the cylindrical insert for
low true rates (middle), without increasing the lateral penumbra (right).
improvements have also been found by the application of larger Gaussian post-reconstruction
filters, as shown in figure 5.6: larger filters result in a reduced image noise level and consequently
an improved recovery of the FWHM of the cylindrical insert at small true numbers, without sig-
nificantly affecting the activity quantification or the lateral penumbra. Still, enhanced Gaussian
filters should be handled with care, since they reduce the granularity of the reconstructed images.
Therefore, an equivalent sensitivity to detect potential range deviations has been tested for real
clinical cases, as will be discussed in section 5.2.3.
5.2.2 Impact of the LSO random background
Under consideration of the results discussed in the previous section, the analysis of the truncated
phantom LM data at fixed true counts and varying random fractions particularly aimed at sepa-
rating the impact of small true numbers, high random fractions and the scatter coincidences on
the acquired low statistics PET data.
The quantification of the ROI mean activity retrieved by the standard OSEM reconstruction
is shown in figure 5.7 for different fixed numbers of true coincidences (T1 = 1, 200, 000, T2 =
650, 000, T3 = 190, 000 and T4 = 80, 000) as a function of the random/true count rate for the
measured, as well as for the simulated data. The previously observed failure of the OSEM to
recover the correct activity in the acquired late PET frames has been confirmed in the truncated
LM data: for only 80, 000 true coincidences, the determined activity decreases with increasing
random background, as encountered during these late frames. It could, however, be found that
the small number of true coincidences alone does not cause this inaccuracy, as quantification
holds for 80, 000 true counts at RFs below about 60%. However, also a high random fraction
itself has been found to not necessarily lead to a decreasing activity in the additional analysis of
the simulated data: at reasonably high true count numbers, quantification is stable up to more
than 95% RF. Besides, it has been observed that activity quantification will not fail under all
investigated statistical conditions, if no scatter coincidences are simulated. Consequently, the
OSEM failure in the late PET frames has to be attributed to inaccuracies in the scatter estimate
which arise at very small true numbers and a high random background. Indeed, this explanation
was confirmed by a significant increase in the amount of estimated scatter coincidences in the
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(a) Measurement (b) Simulation, with scatter (c) Simulation, no scatter
Figure 5.7: Quantification of the ROI mean activity by the OSEM algorithm at fixed true counts
(T1 = 1.2M (blue), T2 = 650k (green), T3 = 190k (red), T4 = 80k (cyan)) and varying RFs.
Below 100, 000 trues, absolute quantification fails for the measured data at high RFs (left, injected
activity indicated by the yellow bar). The decrease in the determined amount of activity has also been
observed in the simulation with scatter (middle), but was not present if scatter coincidences have not
been simulated (right). For simplicity, the simulated data have not been scaled to absolute activities
and are given in arbitrary units.
late frames, which then directly leads to a decrease in the determined scatter-corrected activity.
Further reconstruction attempts including a scatter correction without scaling of the simulated
scatter estimate to the measured emission data and/or with an increased number of iterations
of the underlying single scatter simulation have been investigated, but could not improve the
quantification. Similar observations have been made for the PSF and OSEMTOF reconstructions,
though at an overall reduced level of inaccuracy in the determined activity.
The PSFTOF reconstruction algorithm, on the other hand, has been found to be considerably
less sensitive to this inaccurate scatter estimate and to enable a correct quantification, even under
very challenging statistical conditions (see figure 5.8). The reproducibility of the mean activity
value, corresponding to the standard error of the ROI mean activity (calculated as the standard
deviation of the 16 determined ROI mean values), has been found to be in the order of 10%,
even at only 80, 000 true coincidences, and to be determined by the number of acquired true
coincidences, while being independent of the actual RF. Similar observations have been made in
terms of the image noise and the geometrical performance (considering accuracy and precision of
the FWHM and penumbra) for the PSFTOF reconstruction algorithm: the main limitation under
clinical-like counting statistics has been identified in the small number of true coincidences, not
the comparably high LSO-related random background (cf. figure 5.8). This result was confirmed
by the corresponding simulations with and without scatter coincidences over an even wider range
of counting statistics than accessible in the measured data, as shown in figure 5.9. For the other
regarded algorithms, i.e., OSEM, OSEMTOF and PSF, the true count rate has been determined
as the crucial point, too, although for these methods a slight degradation of the geometrical
fidelity has been observed due to high RFs, even in the absence of scatter coincidences, in the
corresponding simulations.
Although neither undermining the activity quantification, nor the image noise in the regarded
ROIs or the geometrical performance of the PSFTOF algorithm, it has, however, been noticed
that higher random fractions lead to an increased integral image activity (sum of all image voxel)
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(a) Quantification (b) Reproducibility
(c) Image noise (d) FWHM fidelity
Figure 5.8: Performance of the PSFTOF algorithm at fixed true counts and varying RF (truncated
measured data). Absolute quantification is neither hampered by small true numbers, nor by high
RFs (top left). The reproducibility (standard error of the ROI mean activity, top right), image noise
(bottom left) and geometrical fidelity (here represented by the FWHM, bottom right) are mainly
limited by the small number of true counts, not by high random fractions.
and to spurious, clumped activity within the whole PET FOV (see figure 5.10), even outside
the actual water phantom. By analysing the truncated measured data at fixed true counts,
the spurious activity throughout the FOV could be solely attributed to the high RF, as not
being present at arbitrary true numbers for small RFs. Still, investigation of the simulated data
showed that the increase of the integral activity towards higher RFs is more pronounced for
smaller numbers of true coincidences. The observed effect can be explained by the positive bias
which is being introduced to the underlying OSEM algorithm by the non-negativity bound in
image space under the assumed Poisson-statistics. This bias is enhanced for small numbers of
true coincidences and high RFs. In the acquired original measurement data, an increase in the
total image activity between about 20 and 50% with respect to the first acquired frame has been
observed below 100, 000 true counts, depending on the applied reconstruction algorithm and the
number of iterations: the smallest increase of the integral activity has been identified for the
PSFTOF algorithm and a small number of iterations.
Another effect that has been encountered in the analysis of the activity in the different ROIs
shown in figure 5.10 is the build up of an activity halo, spatially restricted to the water phantom,
outside the actual FDG insert (cf. figure 5.10 (left plot)). This halo has only been observed for
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(a) Reproducibility (b) Image noise (c) FWHM fidelity
Figure 5.9: PSFTOF performance under varying statistical conditions in the simulated data without
scatter contribution. Reproducibility (left), image noise (middle) and geometrical fidelity (right) are
ruled by the number of true coincidences, but independent of the RF. Similar results have been
retrieved for simulated data including scatter coincidences.
very small numbers (in the order of 100, 000) of true coincidences in the truncated measured data
and appears over the whole range of investigated RFs, down to about 20%. Nevertheless, an
enhancement of this halo with increasing RF at a fixed number of true counts has been found,
as shown in figure 5.11. In the corresponding simulations with and without scatter coincidences,
the activity halo at small RFs (≈ 20%) was found to appear only in the presence of scatter.
Consequently, the origin of this halo could be partially attributed to inaccuracies in the scatter
correction, leading to a positive bias that is restricted to the volume of the water phantom
and already appears at comparably small RFs. At high RFs, this bias will increase, such that
also in the simulation without scatter coincidences the halo could be observed, although at a
notably reduced level with respect to the simulation with scatter. Under the statistical conditions
encountered in the original PET data (without truncation) of the late measurement frames, the
observed halo thus has to be mainly attributed to the small number of true coincidences, but will
be enhanced by the high random background. As shown in figure 5.11 a more pronounced halo
has been observed for the OSEM algorithm compared to the PSFTOF reconstruction, while the
activity build-up in the FOV outside the water tank has been found at a similar level. This can
directly be explained by the previously observed higher sensitivity of the OSEM to an inaccurate
scatter estimate, which translates to an increased positive bias within the water phantom, but not
in the background where no scattering appears. For all investigated reconstruction algorithms,
it has also been found that a larger number of iterations will result in an enhanced (larger
mean value and standard deviation) halo within the water tank and in an enhanced background
activity outside the phantom due to an increased bias by repeated iteration. The application of
an absolute scatter correction (without scaling of the scatter simulation to the measured emission
data) and/or more iterations of the underlying single scatter simulation could not reduce the
observed halo within the phantom.
In terms of PET-based treatment verification, the spurious activity building up throughout
the FOV can generally be neglected as the approximate position of the beam is a-priori known
and the quantification in the irradiated area not affected. Also the observed activity halo in direct
proximity to the actual activity distribution did not negatively affect the geometrical performance
within this phantom study. For real patient data, however, the influence of scatter coincidences is
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(a) T4 = 80k (b) T4 = 80k, RF = 0.94 (c) T4 = 80k, RF = 0.2
Figure 5.10: Summed up activity within different ROIs for the PSFTOF algorithm (2i21s). The
integral image activity (blue ROI) increases with increasing RF at fixed true counts (left) and leads
to spurious activity in the whole FOV (middle). This effect is not present at small RFs for the same
number of true coincidences (right). Still, at small true numbers an activity halo builds up around the
FDG insert (red ROI), but is restricted to the area of the water phantom (green ROI).
expected to be enhanced and single activity hot-spots within the halo might impede a thorough
treatment verification if their activity level exceeds a certain threshold, e.g., used for beam range
verification. Consequently, it is highly desirable to keep this halo as small as possible, which can
be realised by applying the PSFTOF algorithm and only a small number of iterations.
5.2.3 Patient data: activity quantification, noise and range ver-
ification
In agreement with the observations made in the phantom imaging study, the mean activity
within the selected ROIs was typically found to converge from higher to lower activity values
when increasing the number of iterations in the reconstructions of the post-irradiation patient
PET data. This is shown for one exemplary patient case (L2) in figure 5.12. It should be noticed
that in the patient data analysis 24 subsets have been used for OSEM and PSF reconstruction,
but 21 for the PSFTOF algorithm, as a consistent number of subsets (21 or 24) cannot be selected
within the Syngo user-interface on the Biograph mCT scanner. In the phantom study, a consistent
analysis was only allowed by direct usage of the underlying basic routines which are, however,
not accessible for the standard user.
Figure 5.12 moreover illustrates that noise within the ROIs can significantly be reduced by
performing less iterations and by including PSF modelling for less than 3 OSEM iterations, as
observed in the previous phantom study. With respect to the currently clinically used setting
with 3 iterations of the PSFTOF algorithm, it has been found that image noise can be reduced by
15− 30% in the investigated cases if performing only 1 iteration. The additional application of a
larger post-reconstruction Gaussian filter could further reduce the noise by 10−25%. Comparing
the originally used PET reconstruction settings (PSFTOF, 3i21s, gf5) with the proposed optimal
settings (PSFTOF, 1i21s, gf8), an overall noise reduction by 25− 50% has been achieved. Figure
5.13 clearly illustrates the reduced image noise level for the exemplary patient case L2. At the
same time, the patient data analysis proved that the overestimation of the irradiation-induced
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(a) Fixed true counts, PSFTOF (b) Original data, PSFTOF (c) Original data, OSEM
Figure 5.11: Analysis of the activity outside the FDG insert. An activity halo within the phantom,
outside the FDG insert (green) is present down to small RFs in the truncated measured data at a fixed
number of 80, 000 true counts. The halo is enhanced by high RFs (left, note the higher scaling factors
in the legend). In the original measured data, the halo is increased for the OSEM (right) with respect
to the PSFTOF (middle), due to the higher sensitivity of the OSEM to inaccurate scatter estimates.
Activity throughout the FOV, even outside the water tank (cyan), builds up additionally at high RFs
at a similar level for different reconstruction algorithms.
activity at 1 iteration is typically smaller than 3−4% with respect to the values retrieved after 10
iterations, similar to the findings of the phantom study. For the PSFTOF algorithm in particular,
a variability of the mean ROI activity within the first 10 iterations between only 0.3 and 2.0%
has been determined for the studied clinical cases, thus being even smaller than observed in the
phantom imaging study. Considering the overall reproducibility of the determined mean activity
(in the order of 2 − 10% according to the phantom data analysis), the deviations between the
different reconstruction algorithms (in the order of 1− 9%) and the inaccuracies encountered by
the washout modelling (estimated in the order of about 10− 40%), the observed variability over
different numbers of iterations is deemed to not be critical in the context of PET-based treatment
verification.
A more important aspect for PET monitoring than absolute quantification is the verification
of the particle beam range within the patient. Consequently, the most-likely-shift beam range
verification algorithm, as described in section 3.4.4 and used for PET-based treatment verification
at HIT, has been utilised to compare the original and the proposed optimal reconstruction scheme
in terms of their geometrical performance in the four investigated patient cases. In particular, the
enhanced Gaussian filter which reduces the image noise, but also the image granularity, has been
verified to not impact the results of the range verification. Indeed, the enhanced filter (from 5 to
8 mm FWHM), as well as the reduced number of iterations (1 instead of 3), were found to lead to
a small positive bias in the determined PET ranges with respect to the original settings. However,
the mean range shifts were found to be in the same order as the corresponding uncertainties, not
exceeding a size of 1.6 mm.
For verifying the correct application of the treatment, the reconstructed images need to be
compared to an expectation, simulated on the basis of the TP-CT. In this context, the enhanced
smoothing due to the proposed new reconstruction scheme had to be considered by an adaptation
of the Gaussian filter applied to the calculated activity distribution according to equation 3.2.
The size of the updated filter for post-processing of the simulation data has been retrieved on
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Figure 5.12: Activity quantification (left) and image noise (right) as a function of MLEM-like
iterations for patient L2 and different reconstruction algorithms (OSEM (blue), PSF (red), PSFTOF
(green)). The ROI mean activity only varies slightly for one algorithm (less than 2.0%), while the
noise is significantly reduced for less iterations and when including PSF modelling.
Figure 5.13: Comparison of original (left) and proposed optimised reconstruction settings (middle)
applied to patient L2. While the structure of the activity pattern and the beam range is preserved,
noise is considerably reduced by the new settings. This is confirmed in the profiles along the depicted
red (original) and blue (optimised) arrows parallel to the beam direction (right).
the basis of high-statistics post-irradiation phantom data: it has been chosen such that it models
the proximal increase of the activity at the edge of the irradiated phantom as retrieved by the
regarded PET reconstruction. For the proposed new reconstruction scheme, the post-simulation
Gaussian filter had to be increased from 7.1 to 8.5 mm FWHM. By this, the observed positive
range bias due to the new reconstruction settings has been found to be partially compensated in
the comparison of simulated and reconstructed measured data. Eventually, as depicted in figure
5.14 for patient L2, the most striking impact of the new reconstruction settings on the patient
range verification has been identified as a considerable smoothing of the 2D range deviation
maps. In all investigated cases, the determined mean range deviations between simulation and
reconstruction agreed well within 1 standard deviation when comparing the old and optimised
reconstruction scheme. All observed deviations with respect to the simulated expectation could
be reliably detected, despite the reduced granularity. In two of the four cases, the reduced
image noise could even lead to an enhanced agreement with the observed proximal CT contour
differences, determined according to [Frey et al., 2014] (cf. figure 5.14).
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(a) TP-CT vs. PET-CT (b) Simu vs. measurement, old (c) Simu vs. measurement, new
Figure 5.14: Comparison of the range verification for the old and the new reconstruction settings, as
proposed in this work. The upper row depicts the proximal CT contour deviations (TP-CT vs. PET-
CT, left) and the distal PET-based range deviations (simulation vs. measurement) in BEV as 2D
colourmap (old settings: middle, new settings: right). The bottom row shows the corresponding range
difference histograms, including their mean values and standard deviations. With respect to the old
settings, the deviation map is considerably smoothed by the optimised settings and shows an overall
enhanced agreement to the proximal CT shifts.
In conclusion, the applicability of the new reconstruction scheme (PSFTOF, 1i21s, gf8) to
post-irradiation patient data could be demonstrated and has been found to enable a significant
reduction of the image noise, representing one of the main challenges in PET-based treatment ver-
ification, while preserving activity quantification and ion beam range verification results. More-
over, the activity halo around the actual irradiation-induced activity pattern, which has been
observed to be even more pronounced in clinical cases due to the more demanding scatter cor-
rection, has been found to be considerably reduced. In particular, activity hotspots outside the
actual activity pattern that could potentially impede the beam range analysis can effectively be
suppressed by the new reconstruction scheme (see figure 5.13).
5.3 Discussion and conclusion
Under the particular statistical conditions encountered in post-irradiation PET imaging, i.e.,
small numbers of true coincidences and high LSO-related RFs, the PSFTOF algorithm has been
found to be the most suitable reconstruction option that is presently available on the Biograph
mCT scanner. The algorithm enables accurate (less than 5% deviation from true value) and
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reasonably precise (mean error below 10%) PET imaging for PET-based treatment monitoring
down to about 80, 000 true coincidences at 96% RF. Similar observations in terms of activity
quantification at low counting scenarios with a Philips TOF PET/CT scanner have been reported
in [Murray et al., 2010]. The standard OSEM approach, on the other hand, was found to fail below
about 200, 000 true coincidences, which could be attributed to an overestimation in the scatter
correction which appears at very small true numbers (in the order of 100, 000) and high random
fractions (above 85%). Comparable conclusions have been drawn in [Cheng et al., 2010], though
at different counting statistics for a different experimental set-up and PET scanner. Inclusion of
TOF and PSF information makes the reconstruction less sensitive to inaccurate scatter estimates,
and thereby results in an improved quantification under high RFs and small true numbers.
In the scope of the phantom study, it has also been shown that less iterations result in a
small overestimation of the activity (< 5%), but a significant reduction of the image noise and
herewith an enhanced geometrical fidelity at small true counts rates. In the investigated clinical
post-irradiation PET data-sets, the inaccuracy in activity quantification by using only 1 iteration
was even found to be below 2%, which is not of concern for clinical applications as absolute quan-
tification in PET-based treatment verification is challenged by larger uncertainties, e.g., in the
modelling of the biological clearance. With respect to the originally used reconstruction settings
at HIT (PSFTOF, 3i21s, gf5), which had been inspired from the typical nuclear medicine imaging
settings, the proposed new reconstruction scheme (PSFTOF, 1i21s, gf8) enabled a reduction of
the image noise by up to 50%. Despite the reduced image granularity due to the enhanced GF,
the results obtained in the patient data range verification, and correspondingly the sensitivity to
unexpected range deviations, were found to be preserved (except from the expected smoothing
in the 2D range difference maps) or to be even improved in terms of an enhanced agreement
to the observed differences in the patient anatomical contour due to the reduced image noise
level and the more robust definition of relative activity thresholds in the range verification al-
gorithm. As a consequence, the proposed new reconstruction settings have entered the clinical
routine of PET-based treatment verification and are presently applied for the reconstruction of
all post-irradiation PET data-sets at HIT, including those discussed in the context of 4D offline
PET-based treatment verification in the following chapter.
In general, the main limitation in PET-based treatment verification has been identified in
the small number of true coincidences, rather than in the high LSO random background. The
phantom study clearly proved that image noise, reproducibility of the activity quantification
and geometrical fidelity are determined by the number of true coincidences and only marginally
affected by the amount of random background, if using the PSFTOF algorithm. Still, the high
random background has been found to lead to the build-up of spurious activity clumped within
the whole PET FOV, and herewith to an increasing integral image activity. This observation can
be explained by the positive constraint in the underlying OP-OSEM algorithm, which does not
allow for negative image values and thus leads to a positive bias in the reconstructed images [van
Velden et al., 2009]. Further improvements in this aspect are foreseen by dedicated reconstruction
algorithms, such as Negative(NEG)-ML [Nuyts et al., 2002; Grezes-Besset et al., 2007] and AB-
OSEM [Byrne, 1998; Verhaeghe and Reader, 2010], which both allow for negative image values.
Besides the build-up of spurious activity throughout the FOV, the encountered high RFs were
found to slightly enhance the activity halo which has been observed within the water phantom
for small true numbers (below about 100, 000). This halo was, however, found to be present even
at small RFs and could thus be mainly attributed to an inaccurate scatter estimate at small true
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numbers, introducing the observed positive bias. While the comparably small background activity
within the FOV can be neglected in PET-based treatment verification, where the approximate
beam position is a-priori known, this halo in direct proximity to the irradiation-induced activity
distribution might impact the patient data analysis if exceeding certain activity thresholds. In
patient cases, inaccuracies in the scatter correction are even enhanced, thus requiring to keep the
observed positive bias due to the inaccurate scatter estimate as small as possible (in terms of mean
value and standard deviation). A reduction of this bias due to intra-reconstruction smoothing by
implementing a scanner resolution model (PSF modelling) has already been reported in [Walker
et al., 2011] and could be confirmed in the presented phantom imaging study. Moreover, it could
be shown that a further decrease of the encountered halo is feasible by additionally including TOF
information, which make the reconstruction more robust against inaccurate scatter estimates
[Conti, 2011]. An unfavourable impact of the positive bias, once due to the inaccurate scatter
correction within the phantom and once due to the high RF throughout the FOV, on the activity
quantification in the analysed phantom geometry, emulating a typical patient-like activity pattern,
has, however, not been observed for the PSFTOF algorithm.
In the scope of the thesis, the results retrieved in this chapter are of particular interest
due to the generally reduced number of true coincidences in the pursued 4D gated PET image
reconstruction with respect to 3D offline PET monitoring, which demands for a cautious charac-
terisation of the PET scanner performance under extremely low numbers of true counts and high
random fractions. Nevertheless, the obtained results are not only limited to the application of
PET-based treatment verification in ion beam therapy, but might be translated to other emerging
PET imaging fields at low counting statistics, such as dynamic PET imaging or PET-based 90Y
radio-embolisation treatment monitoring [Lhommel et al., 2010; Gates et al., 2011].
Chapter 6
First study on the feasibility of 4D
offline PET-based treatment
verification for HCC patients at HIT
After having studied the feasibility and potential of 4D offline PET-based treatment verification in
dedicated moving phantom experiments under simplified conditions (regular motion, no washout,
relatively high counting statistics) in chapter 4, this chapter will present the first application of
4D PET-based treatment monitoring to clinical cases. As a prerequisite, the studies described
in chapter 5 showed that reasonably accurate PET imaging down to very low numbers of true
coincidences at high random fractions is feasible with the used commercial full-ring TOF PET/CT
scanner, and identified the reconstruction algorithm and parameters which are ideally suited to
these statistical scenarios. Aim of this chapter is to infer the feasibility and potential advantages
of considering organ motion in offline PET-based treatment monitoring under clinical conditions.
6.1 Material and methods
6.1.1 Patient cohort and data acquisition
In total, four different HCC patients, L1 to L4, with respiratory-motion affected target volumes in
the liver have been investigated for this purpose. All patients have been included in the clinical
trial PROMETHEUS [Combs et al., 2011] and treated according to the strategy described in
section 2.6.5 (irradiation in four fractions of 8.1 Gy(RBE) on the basis of a 3D TP-CT with
increased ITV margins derived from a contrast-enhanced 4D CT scan). For patients L1 to L3
motion has been mitigated by an abdominal compression system, for patient L4 by a gated beam
delivery. The mean motion amplitudes within the CTVs, as retrieved from a deformable image
registration (DIR) of the end-exhale and the end-inhale 4D CT phases, are given in table 6.1. In
all cases, motion was found to be pronounced in the SI direction, with a mean amplitude between
about 2 and 14 mm. For the gating patient L4, a reduced SI motion amplitude of 5.2 ± 1.4 mm
within the applied 50% gating window around end-exhale has been determined.
Moreover, table 6.1 depicts the irradiation times and time delays between the end of the
irradiation and the start of the subsequent PET scan for the treatment fractions that have been
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investigated in the scope of this chapter. The specific workflow for HCC patient post-irradiation
PET monitoring follows the description in section 3.4.3: patients have first been immobilised
including vacuum mattress, arm holder and abdominal compression at the PET/CT room prior to
the irradiation (see figure 6.1). After a 3D position verification CT, patients have been transferred
to the treatment room by a dedicated shuttle system, irradiated and transported back to the
PET/CT room without re-positioning. During the subsequent 30 min PET LM data acquisition,
as well as during the irradiation, the patient respiratory motion has continuously been monitored
by the ANZAI respiratory gating system, thus enabling a first coherent verification of the applied
treatment under consideration of the target movement. For patients L1 and L2, an additional 4D
CT, in the following referred to as 4D PET-CT, has been acquired after the irradiation at the
PET/CT scanner for clinical comparison to the 4D treatment planning CT (4D TP-CT).
6.1.2 PET image reconstruction
The acquired PET LM data, containing between 400, 000 and 900, 000 true coincidences (see table
5.1), have been reconstructed statically (3D) with the PSFTOF algorithm, using 1 iteration with
21 subsets and an 8 mm post-reconstruction Gaussian filter, following the findings of chapter 5.
In addition, based on the ANZAI gate-tags in the recorded LM files, 4D gated PET images with
8 motion states have been reconstructed using the same parameters. In all cases, the recorded
PET data has been corrected for attenuation on the basis of a free-breathing 3D AC CT and for
scatter coincidences.
In order to obtain one single, motion-compensated PET image in a user-defined reference
phase, a dedicated workflow had to be established, as the Biograph mCT scanner, up to present,
does not allow for such a procedure. First, a phase-correlation between the phase-sorted 4D gated
PET and the relative-amplitude-sorted 4D PET-CT (cf. section 3.4.3) had to be established. For
this, an average breathing cycle of the patient on the basis of the acquired ANZAI signal during the
30 min PET acquisition has been calculated (see figure 6.1), and was used to determine the mean
Table 6.1: Overview of the investigated HCC patient cohort. The motion amplitudes in SI, AP and
LR direction are given as mean value within the patient-specific CTVs. Moreover, the irradiation
times and time delays between the end of the irradiation and the start of the PET scan (tirr and ∆t)
for the analysed treatment fractions (Fx) of each patient are shown.
Patient CTV SI [mm] AP [mm] LR [mm] Fx tirr[min:sec] ∆t[min:sec]
L1
1 1.8± 0.9 0.3± 0.2 0.0± 0.1
2 29:03 12:03
2 9.1± 1.1 2.2± 0.3 0.2± 0.1
L2 1 9.4± 3.7 3.2± 1.2 1.2± 0.6 3 05:48 08:09
L3 1 13.7± 3.3 7.5± 2.8 4.0± 1.4 1 07:17 11:39
3 08:03 10:10
L4 1 7.4± 1.9 3.4± 0.8 0.4± 0.5
1 43:50 13:17
Within GW 5.2± 1.4 3.0± 0.8 0.7± 0.5
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Figure 6.1: Patient set-up (left) and calculation of the average breathing cycle (right). All patients
have been fixated in a vacuum mattress and motion has been mitigated by an abdominal press for
patients L1 to L3. During the irradiation and the subsequent PET acquisition, motion has been
monitored by the ANZAI gating system. The signal acquired during the 30 min PET scan (right, green)
has been used for calculating the patient-specific averaged breathing curve (right, red), required for
generating the motion-compensated 4D PET image. The reference motion states used in the analysis
of the four investigated liver patients are moreover depicted by the red circles. Maximum inhalation
corresponds to 100%, maximum exhalation to 0% relative amplitude.
relative motion amplitudes within each of the 8 reconstructed PET phases. The corresponding 4D
PET-CT has been reconstructed at exactly the same amplitudes, thus yielding two coherent 4D
data-sets. The single phases of the 4D PET-CT have then been registered to a chosen reference
phase by a DIR with the open-source registration code Plastimatch [Shackleford et al., 2010],
which has also been used for determination of the mean CTV motion amplitudes in table 6.1.
The result of the DIR is a motion vector containing the 3D displacement for each individual
image voxel between the two registered images. The retrieved motion vectors could thus be used
to warp the single PET phases to the chosen reference phase, where they have eventually been
summed up and divided by the number of phases in order to form the aimed motion-compensated
4D PET image. Using the corresponding 4D PET-CT and the DIR-based motion-model of the
patient, the retrieved motion-compensated 4D PET image might be warped to any other motion
state, as well.
An indispensable prerequisite for creating the motion-compensated 4D PET image is, however,
the availability of the 4D PET-CT raw data in order to enable the reconstruction of the 4D PET-
CT at exactly the same amplitudes as the phase-based 4D gated PET. Hence, the generation of
a 4D motion compensated PET image has not been feasible for patients L3 and L4.
6.1.3 4D dose and activity calculation
Besides the reconstructed PET images, PET-based treatment monitoring demands a prediction
of the expected irradiation-induced activity within the patient for comparison. Up to present,
the SimInterface environment (cf. , section 3.4.4) only allows for calculating 3D dose and activity
distributions on the basis of a 3D CT (either the 3D TP-CT or the registered 3D PET-CT) and the
patient-specific RTplan file. Consequently, the SimInterface capabilities had to be extended in the
scope of this work in order to enable the handling of 4D CT and 4D RTplan data and to calculate
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Figure 6.2: Illustration of the 4D extension of the SimInterface. Instead of a 3D RTplan and a 3D
CT image, a 4D CT with N motion states and a set of N corresponding state RTplan files have to
be used for dose and activity calculation. The different motion states are connected by a DIR, which
eventually allows for calculating a prediction of 4D dose and β+-emitter distribution in the patient.
the expected physical dose and activity distributions within the patient under consideration of
the organ motion. This is schematically illustrated in figure 6.2: instead of a single 3D CT and
the corresponding RTplan, the 4D activity and dose simulations have to be based on a series
of N phases from a 4D CT, representing the different motion states of the patient, and the
corresponding set of state RTplans covering each of the considered 4D CT phases.
The required set of state RTplan files has been generated in the same way as described in
section 4.1.1.3, namely by the TRiP4D software on the basis of the synchronised beam delivery
sequence and the recorded respiratory motion signal during the patient irradiation. For coherence
with the underlying 4D CT data of the performed calculations, the generation of the state RTplan
files had to be based on relative amplitude-sorting (cf. section 3.4.3), as well.
In analogy to the approach followed by [Richter et al., 2013] for analytical 4D dose calculations,
the physical dose, as well as the β+-emitter distribution, have been simulated for each single
motion state on the basis of the corresponding 4D CT phase and state RTplan, using the FLUKA
MC code. In order to calculate the total 4D physical dose in a user-defined reference motion state,
chosen such that it exhibits approximately the same respiratory amplitude as the 3D TP-CT,
the physical dose of all single phases have been warped to the reference phase and summed
up. The warping is based on a DIR of all regarded 4D CT phases and the chosen 4D CT
reference phase. Quality and accuracy of the required DIR have been investigated in [Richter
et al., 2014] for exactly the same registration settings of the plastimatch software that have
been used in this work. Based on the inverse consistency error, an accuracy of few millimetres
for the applied DIR has been reported. Due to the non-linear dependence of the biological
dose on the physical dose, 4D biological dose distributions could not be obtained by warping
and summing up the single-phase biological dose. Instead, the additionally simulated α and β
values [Mairani et al., 2010], characterising the biological response of the tissue to the incident
irradiation, would have to be used in a future extension of the SimInterface to allow for 4D
biological dose calculations. However, this was deemed beyond the scope of this work, where
calculations of the 4D activity distributions to be expected within the patient are of main interest.
For this, the simulated β+-emitter distributions in each of the considered single motion phases
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have been post-processed according to equation 3.2. In particular, this means that the washout
modelling has been calculated individually for each motion phase on the basis of the corresponding
4D CT phase in order to avoid inaccuracies introduced by a previous warping to the reference
phase. Due to the comparably short respiratory period, typically in the order of about 3−4 s, with
respect to the irradiation and transportation time, all phases have been post-processed by exactly
the same time parameters (cf. table 6.1), introducing an error of below 0.5% in the calculated
amount of activity for all investigated cases. The readily post-processed activity distributions of
the single phases have eventually been warped to the given reference phase, using the 4D CT-
based DIRs, and summed up to form the 4D activity distribution expected to be measured within
the patient. This expectation has then directly been compared to the post irradiation PET image
reconstruction (static, or motion-compensated) of the measured data in order to infer the quality
of the applied treatment under consideration of the target motion.
Within the implemented extension of the SimInterface, the described 4D physical dose and
activity calculations can be carried out on the basis of 4D TP-CT data, as well as of post-
irradiation 4D PET-CT data, which, however, need to be registered rigidly to the reference 3D
TP-CT prior to the simulation. In analogy to the patient alignment by orthogonal X-ray imaging
prior to irradiation in the treatment room, this registration has to aim at matching the bony
patient anatomy in the TP-CT and PET-CT data, rather than the surrounding soft tissues or
patient contours.
For comparison of 3D as well as 4D calculated and measured activities, synchronous 2D
visualisation of CT and PET data, 1D profile comparison along the beam axis and 2D verification
of the beam range in BEV by the most-likely shift approach [Frey et al., 2014], as described in
section 3.4.4, have been utilised.
6.2 Results
6.2.1 Patient L1
The results of the activity calculations for patient L1 in 3D, using the static RTplan and the
3D TP-CT, as well as in 4D, using the generated set of state RTplans and the 4D TP-CT,
are compared to the static (3D) reconstruction of the recorded PET LM data after the second
treatment fraction in figure 6.3. The 4D simulation is given in the reference phase of 0% exhale
(cf. figure 6.1), being closest to the respiratory phase of the 3D TP-CT.
For calculated and measured activity distributions, a characteristic crescent shape close to
the distal edge of the irradiated PTV has been noticed. This observation can be explained by the
subsequent irradiation of iso-energy layers with increasing energies, the typically larger number
of particles applied to the most-distal slices and to the characteristic shape of the dominating 11C
activity depth profile, which exhibits a maximum close to the primary beam range. Altogether,
this leads to an enhancement of the irradiation-induced activity at the distal edge. The sequential
irradiation of iso-energy layers also explains the observed lower activity within the smaller CTV
2 in the measurement with respect to the simulation: due to the more proximal position, the
smaller CTV 2 had been irradiated several minutes before the irradiation of the second, larger
CTV 1 has been completed. Consequently, by assuming the same delay time between irradiation
and PET imaging for both, the activity in CTV 1 is overestimated in the expectation. Future
extensions of the underlying PET simulation workflow might account for this by taking into
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Figure 6.3: 2D activity distributions (colour-wash), corresponding CTs (grey-scale) and PTVs (white
contours) for patient L1. The static simulation (i.e., 3D RTplan on 3D TP-CT) is shown on the left
and compared to the 4D simulation (state RTplans on 4D TP-CT, reference phase 0% exhale) in
the middle and to the static reconstruction of the acquired PET data on the right. An overall good
agreement of simulated and measured data has been found. The relatively small SI motion amplitude
(1.8 mm for the larger CTV 1) was found to result in only a slight distortion of the calculated activity.
consideration the exact irradiation and delay times for each individual energy slice, but have not
been available at the time of this work.
Still, an overall good agreement of 3D calculated expectation and 3D measurement has been
found for patient L1. The observed remaining differences can mainly be attributed to inaccuracies
in the washout modelling of the irradiation-induced activity, to the considerable image noise, even
in the 3D PET reconstruction using the optimised parameters, and to possible inaccuracies in the
PET scatter correction, which might lead to an enhanced activity outside the PTV as has been
observed in the phantom imaging study presented in chapter 5. In terms of the PET-based range
verification, on average only a small, clinically not relevant, deviation between 3D measurement
and 3D simulation of below 2 mm has been found. Still, in some part of the irradiation field, an
over-range of about 5 − 20 mm in the measurement has been observed. This was attributed to
similar deviations in the proximal CT contour due to a slight mis-positioning of the patient (see
figures 6.4 (a) and (b)).
When comparing the 3D and 4D calculated activity distributions, only a slight distortion of
the induced activity has been identified, mainly visible in the coronal plane. With respect to the
measured data, an improved agreement of 3D or 4D simulation has not been observed. Partic-
ularly in terms of the PET-based range assessment, deviations between 3D and 4D simulation
were found to be not significant, exhibiting only an almost constant shift by about 1.4 mm of the
4D simulation towards smaller depths, due to the applied contrast agent, which leads to globally
enhanced HU values in the 4D CT images (cf. figure 6.4 (c)). The overall negligible impact of
the tumour motion for this patient is directly related to the very small motion amplitude of only
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(a) 3D TP-CT vs. 3D PET-CT (b) 3D sim vs. 3D meas. (c) 3D sim vs. 4D sim
Figure 6.4: Results of the range verification for patient L1. The observed distal PET range deviations
between 3D reconstruction of the measured data and 3D simulation (middle) were found in relatively
good agreement with the deviations between TP-CT and PET-CT in the proximal patient contour
(left). Range differences between 3D and 4D activity prediction (right) were found to be minor. The
systematically smaller range in the 4D simulation is attributed to the applied contrast agent, resulting
in overall increased HUs in the 4D CT images with respect to the native 3D CT.
about 2 mm in the SI direction for the larger CTV 1. This was additionally confirmed by the 4D
physical dose calculations on the basis of the 4D TP-CT, as well as by additional 4D physical dose
and activity simulations on the basis of the 4D PET-CT acquired after the discussed treatment
fraction. None of these data showed a considerable influence of the small target motion, such that
it can be concluded that a 3D post-irradiation verification is sufficient for this kind of patient.
A gain of knowledge by including organ motion to the post-irradiation treatment monitoring
workflow could not be found.
Nevertheless, it should be remarked that interplay patterns have been found in the 4D physical
dose calculation within the smaller CTV 2, which is subject to a considerably larger motion
amplitude (cf. table 6.1). In the 4D activity simulation, however, the observed interplay pattern
has been observed to be smeared for the most part by the limited PET resolution, modelled by
a post-simulation Gaussian filter, and thus to be not detectable in the reconstructed image of
the measured data, which is moreover significantly obstructed by the extremely low amount of
activity within CTV 2, as can be seen in figure 6.3.
6.2.2 Patient L2
The investigated activity distributions for the second liver patient, L2, are shown in figure 6.5:
besides the 3D simulation on the 3D TP-CT and the 4D simulation on the 4D TP-CT, the 3D
and 4D simulations of the irradiation-induced activity distributions on the 3D and 4D PET-CT,
respectively, are depicted as well as the 3D (static) and 4D (motion-compensated) reconstructed
PET images. All 4D data-sets are displayed in the 75% inhale phase (cf. figure 6.1), which has
been found to best match the respiratory state of the 3D TP-CT.
As can be seen in the comparison of 3D and 4D simulation data, the considerable SI motion
amplitude of above 9 mm for this patient leads to the formation of a clearly visible interplay
pattern, namely two separate activity hotspots in the distal region of the homogeneously irra-
diated PTV (cf. red arrow in figure 6.5). This pattern could clearly be identified in the corre-
sponding PET measurement after the second treatment fraction, as well. Although the induced
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Figure 6.5: 2D activity distributions and corresponding CTs for patient L2. The 3D and 4D activity
calculations on the basis of the 3D and 4D TP-CT, respectively (top row, left and middle), are
compared to the 3D and 4D simulations on the basis of the 3D and 4D PET-CT data (bottom row,
left and middle) and the measured data after the second treatment fraction reconstructed in 3D (top,
right) and motion-compensated in 4D (bottom, right). Due to deviations in the absolute activity
quantification, a different scaling of the color-wash display has been applied to the measured data. All
4D data-sets are given in the 75% inhale phase. Consideration of organ motion introduces a visible
interplay pattern in the distal PTV region (red arrow) and a slight caudal shift of the calculated
activity distribution (green arrow), which can be identified in the measurement, as well. The PET-
CT-based calculations exhibit a shorter range, particularly in the cranial part of the PTV (light blue
arrow), due to changes in the patient external contour, and match more accurately the measurement.
interplay effects could be recovered with reduced blurring in the SI direction by the 4D motion-
compensated image reconstruction of the measured data, a notably enhanced agreement to the
4D simulations with respect to the static PET reconstruction has not been found. Besides, the
motion-compensated reconstruction is subject to additional uncertainties by the required DIR
and, in particular, by the enhanced level of uncertainty in the underlying single-phase PET im-
ages, which suffer from a reduced (by a factor of 8) number of true coincidences. Unfavourable
effects, such as an increased activity outside the irradiated area due to inaccuracies in the scat-
ter correction (as shown in the previous chapter), are hence expected to be enhanced in the 4D
PET image with respect to the 3D PET image. Consequently, an advantageous performance of
motion-compensated 4D gated PET imaging in the context of post-irradiation treatment verifi-
cation could not be conclusively demonstrated for this patient.
Besides the motion-related interplay effects, the irradiation-induced activity has also been
found to be slightly shifted towards the caudal direction in the 4D simulations with respect to
the static calculations (for the TP-CT and for the PET-CT data), as indicated by the green
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arrow in figure 6.5. This finding can be attributed to the fact that the 3D TP-CT, on which the
actual 3D RTplan has been optimised, represents a motion state close to the maximum inhale.
Consequently, during the irradiation, the liver is located in a more cranial position most of the
time, and the activity is induced further caudal in the depicted 75% inhale reference phase than
actually planned on the 3D TP-CT. In a similar way, this caudal shift with respect to the static
simulations has been observed in the corresponding PET measurement. Overall, the 4D activity
calculations were found to be in a notably better agreement with the acquired post-irradiation
data than the 3D simulations, thus demonstrating the potential advantages of considering organ
motion at least in the calculation of the expected activity distributions for offline PET-based
treatment monitoring.
However, although the shape of the activity distribution in simulated and measured data was
found in reasonably good agreement, a limited accuracy in terms of absolute activity quantifica-
tion has been observed for this patient. While the measured activity is typically about 10− 20%
higher in the fatty tissue close to the patient skin, it is approximately 10 − 40% smaller in the
distal part of the PTV. This level of inaccuracy is clearly above the expected uncertainties in
the simulation of the induced β+-emitter distribution. Also in terms of activity quantification
by the PET/CT scanner, where additional uncertainties with respect to the static imaging study
discussed in chapter 5 might be introduced by the comparably large motion amplitude in the PTV
region, inaccuracies of below 10% are expected (based on the results of the LineMult phantom
irradiation study in section 4.1.2.3 at a comparable number of true coincidences and an even
enhanced motion amplitude and level of inhomogeneity of the induced activity pattern). As a
consequence, the observed deviations are mainly attributed to inaccuracies in the modelling of
the biological washout when post-processing the simulated data. In comparison, considerably
smaller deviations in the absolute activity, concerning particularly the ratio of induced activity
in the subcutaneous fatty tissue and the distal region of the PTV, have been found for patient
L1 (cf. figure 6.3), which suggests a high inter-patient variability of the biological clearance. Up
to present, this is not considered in the applied washout model, which relies on the same set of
tissue washout parameters (fraction of the slow biological decay component and biological decay
constant) for every patient.
When comparing the simulations based on the TP-CT and the PET-CT data, a consider-
ably reduced range in the cranial part of the PTV has been observed for the simulations on the
PET-CT data (cf. light blue arrow in figure 6.5). This shorter range has been found to be in
better agreement with the reconstructed measured data, as can also be seen from the 2D range
deviation maps in figure 6.6: while the measured data shows a considerably reduced range with
respect to the 3D TP-CT simulation in the cranial PTV region (blue areas in figure 6.6 (b)) and
an average distal PET range deviation of almost 6 mm, a considerably improved agreement to
the measurement is provided by the 3D PET-CT simulation, exhibiting an average deviation of
below 1 mm. This finding can directly be explained by the observed differences in the patient
CT contour between the 3D TP-CT and the 3D PET-CT (figure 6.6 (a)), which provoke the
observed differences in the 3D TP-CT simulation with respect to the post-irradiation PET ac-
quisition. Comparing the PET-based ranges deduced from 3D and 4D simulations, very small
differences have been found for the investigated TP-CT data, except from a constant shift of the
4D simulation by about 1 mm to smaller depths due to the already mentioned injected contrast
agent. For the PET-CT data, the mean range difference between 3D and 4D simulations is even
smaller (0.2 mm), as no contrast agent has been applied. However, in the most cranial part of
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(a) 3D TP-CT vs. 3D PET-CT (b) 3D TP-CT sim vs. 3D meas (c) 3D sim vs. 4D sim, TP-CT
(d) 4D PET-CT sim vs. 3D meas (e) 3D PET-CT sim vs. 3D meas (f) 3D sim vs. 4D sim, PET-CT
Figure 6.6: Results of the range verification for patient L2. In comparison to the 3D TP-CT
simulation (top, middle), the 3D PET-CT simulation exhibits notably less deviations with respect
to the measured data (bottom, middle), as these have mainly been attributed to differences in the
proximal patient CT contour (top, left). Differences between 3D and 4D simulations are overall small
for the TP-CT (top, right), as well as for the PET-CT (bottom, right) data-sets. Still, the 4D PET-CT
simulation has been observed to best agree with the measurement (bottom, left) due to an enhanced
PET-based range in the cranial PTV region (indicated by the red arrow).
the PTV (indicated by the red arrow in the bottom row of figure 6.6), a 5− 10 mm higher range
of the 4D simulation has been identified, leading to an further improved agreement with the
measured data (figure 6.6 (d)). Still, due to the relatively central position of the lesion within
the homogeneous liver tissue, respiratory motion generally only results in small changes of the
WEPL and herewith of the particle beam range, in agreement with the findings for patient L1.
Eventually, it should be mentioned that when using the 4D motion-compensated reconstruction
of the measured data, a generally increased level of uncertainty in the determined PET range
deviations, corresponding to a notably increased inhomogeneity of the retrieved 2D range devi-
ation maps, has been encountered. Moreover, a slightly reduced agreement to the 4D PET-CT
simulation (mean range deviation approximately 1.5 mm) has been observed. This finding should,
however, be handled with care due the previously discussed increased level of uncertainty in the
motion-compensated image on the basis of a gated 4D PET image reconstruction of the acquired
data.
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Figure 6.7: 2D activity distributions and corresponding CTs for patient L3. The 3D TP-CT simula-
tion, post-processed according to the timing structures of fractions one (top, left) and three (bottom,
left), is compared to the 4D TP-CT simulations (depicted in the 20% inhale reference phase) on the
basis of the state RTplans of fraction one (top, middle) and fraction three (bottom, middle), as well
as to the corresponding measurements after fraction one (top, right) and three (bottom, right). Due
to differences in the absolute amount of induced activity, a different scaling has been applied to the
measured data. The 4D simulations exhibit a notable interplay pattern, which has, however, been
found to be hardly detectable in the corresponding measured data which suffer from high image noise
due to the low counting statistics. An activation of the vertebral bone that has been observed in both
measurements (red arrow) could not be reproduced by the 4D TP-CT simulations.
6.2.3 Patient L3
The activity distributions considered in the analysis of patient L3 are shown for a central coronal
plane through the irradiated PTV in figure 6.7. The 3D simulation on the basis of the 3D TP-
CT, post-processed according to the timing structure of the first (F1) and the third treatment
fraction (F3), is compared to the 4D TP-CT simulations (depicted in the 20% inhale reference
phase) using the state RTplan sets of fraction one and three as well as to the corresponding 3D
PET images acquired after the respective fractions. A simulation based on the fraction-specific
4D PET-CT data and the generation of a motion-compensated 4D PET image have not been
feasible for this patient, as no post-irradiation 4D CT scan has been acquired.
In the comparison of 3D and 4D activity calculations, the relatively large SI motion amplitude
of approximately 14 mm (see table 6.1) has been found to lead to the formation of motion-related
interplay patterns in the distal region of the PTV, in agreement with the findings for patient
L2, who was subject to a comparably large SI motion. Comparing the 4D calculations on the
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basis of the two considered state RTplan sets of fractions one and three, clear differences due to
inter-fractional variations in the irregular respiratory motion of the patient have been noted. In
general, a higher fraction of the irradiation-induced activity has been found in a further caudal
location in the 4D simulation of treatment fraction three.
This slight caudal redistribution has also been observed in the corresponding 3D PET images
acquired after the two regarded treatment fractions. In general, however, a very limited agreement
of measurement and simulation has been found for patient L3. Due to the (by about 30%)
reduced number of true coincidences for patient L3 with respect to patient L2, a considerably
enhanced image noise level has been encountered, which particularly limits the detectability of
motion-related interplay effects within the irradiated PTV. Although differences in the interplay
patterns after fractions one and three are visible in the simulated data, an identification of the
calculated interplay patterns and a clear distinction between the two fractions on the basis of the
two reconstructed 3D PET images was found to not be feasible. Further challenges are posed
by the strongly limited accuracy of the isotope washout modelling: while an agreement within
about 10% between measurement and calculated expectation in the subcutaneous fatty tissue
has been determined, the calculated activity in the PTV was found to be about twice as high as
in the measured data, hinting on a significant underestimation of the biological clearance, even
if considering an increased level of uncertainty in the activity quantification by the PET/CT
scanner in the presence of organ motion. Particularly in the caudal region of the PTV, a strong
isotope washout has been observed in both PET measurements, resulting in a further degradation
of the ability to detect the expected interplay patterns.
Nevertheless, another motion-related implication could clearly be recovered in the measured
post-irradiation PET data, namely a substantial overshoot in the region of the diaphragm, leading
to the activation of the vertebral bone distal to the liver (see red arrow in figure 6.7). With
respect to the previously discussed patients, suffering from central lesions within the liver, the
more cranial location of the PTV close to the diaphragm makes the irradiation substantially more
prone to range deviations by respiratory motion: during inspiration, the liver shifts further caudal
and is replaced by low-density lung tissue, in which the beam has a significantly larger range. In
the performed 4D simulations on the available 4D TP-CT, this overshoot has also been observed,
but at a significantly reduced activity level. The reason could be found in the fact that the
simulated activation is not directly located in the vertebral bone, but in the muscle tissue slightly
cranial to the spot of activation in the measurement, such that it is subject to a remarkably
larger biological clearance. The cranial shift of the activation itself can be explained by the
fact that the patient 4D TP-CT, on which all 4D calculations have been based, does not fully
cover the respiratory motion amplitude during the two regraded fractions due to inter-fractional
variations in the patient breathing cycle. A deeper inhalation than actually represented by the
4D TP-CT phases directly results in a more caudal activation (within the low-perfused vertebral
bone) than observed in the presented simulations. After treatment fractions two and four (not
shown here), no activation of the vertebral column has been detected. These findings further
indicate the variability of the respiratory motion for this patient, as well as the sensitivity of the
applied treatment to such alterations and, consequently, the importance of using consistent 4D
CT data of the treatment day for the prediction of motion-induced interplay patterns and range
deviations.
In the determined distal PET range deviations between simulation and measurement, the
observed overshoot has been identified as well (cf. deep red area indicated by the red arrow on
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(a) 3D sim vs. 3D meas, F1 (b) 3D sim vs. 3D meas, F1 (c) 3D sim vs. 4D sim, F1
Figure 6.8: Results of the range verification for patient L3. Although the vertebral activation has
been identified as over-range in the comparison of 3D simulation and measurement after fraction 1
(left, deep red region indicated by the red arrow), the range analysis is undermined by the inaccurate
washout modelling, leading to considerably distorted 1D profiles along the beam axis (x-axis, middle)
and herewith an incorrect determination of range deviations (left, dark blue regions). Differences
between 3D and 4D simulations (right) have been observed to be generally small, with some exception
in the cranial PTV region (cf. yellow arrow in the right plot), which is more sensitive to anatomical
changes. The measured data, however, exhibits significantly larger range deviations in the same
region (cf. yellow arrow in the left plot) due to the above-mentioned deeper inhalation than actually
represented by the 4D TP-CT. For the same reason, the vertebral bone activation is not modelled
correctly in the 4D calculation.
the top right of the 2D range deviation map depicted in figure 6.8 (a)). The inaccurate washout
modelling has, however, been found to unacceptably spoil the retrieved range verification results
for this patient and to introduce artificial range deviations, reaching values of up to 25 mm
(cf. deep blue areas in figure 6.8 (a)), due to the substantially different shapes of the analysed 1D
profiles along the beam axis, as depicted for an exemplary case in figure 6.8 (b). Range differences
between 3D and 4D simulations are generally small, with an average deviation of below 0.5 mm
due to the applied contrast agent, except from a small region in the most cranial part of the PTV
(indicated by the yellow arrow in figure 6.8 (c)). Here, deviations amount to 5 − 10 mm due to
the higher sensitivity of the primary beam range to anatomical changes, introduced by the large
density gradients in this region (similar to the findings for patient L2). Although the identified
range deviations lead to a slightly enhanced agreement with the measured data, the latter still
exhibits significantly larger over-ranges in this cranial PTV region (yellow arrow in figure 6.8
(a)) because of the above-mentioned deeper inhalation during the irradiation than represented
by the 4D TP-CT. Finally, it should be remarked that the observed overshoot did not represent
a clinically relevant hazard for the patient, as the beam was stopped in the outer vertebral bone,
but did not hit the radiation sensitive spinal cord.
6.2.4 Patient L4
The investigated activity patterns for the first gating patient irradiated at HIT, L4, are depicted
in figure 6.9. Besides the 3D simulations based on the 3D TP-CT and the 3D PET-CT acquired
after the first treatment fraction, the 4D simulation on the basis of the 4D TP-CT, inherently
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Figure 6.9: 2D activity distributions for patient L4. The 3D (left) and 4D (second from left) TP-CT
simulations are shown next to the 3D PET-CT simulation (second from right) and the corresponding
3D PET image (right) after the first treatment fraction. The 4D simulation is depicted in the 100%
exhale reference phase. A different scaling is applied to the measured data in order to account for
inaccuracies in the washout modelling. Due to the extreme inhale position of the PTV region in the 3D
TP-CT, while the irradiation has been gated on the end-exhale phase, considerable deviations between
the 3D TP-CT simulation and the 3D PET measurement, representing a time-averaged distribution
close to the end-exhale position as well, have been found. Consequently, the 3D simulation on the free-
breathing 3D PET-CT, representing a respiratory state of about 20% exhale, and also the 4D TP-CT
simulation, providing the correct anatomy in each of the considered motion states, have been found
in a better agreement with the measurement. For a more coherent comparison to the measurement,
the 4D TP-CT simulation should be warped to the 20% exhale phase, as shown in appendix B.
accounting for the gated beam delivery by the used state RTplans of fraction one, and the
corresponding 3D PET measurement are shown. The 4D simulation study is depicted in the
reference phase of 100% exhale, i.e., close to maximum inhalation (see figure 6.1). Although the
3D TP-CT had been intended as end-exhale (i.e., 0% relative motion amplitude) breath-hold CT
(cf. section 2.6.5), only the upper part of the liver, close to the diaphragm, has been found close
to this motion state, while the caudal region of the liver, where the irradiated PTV has actually
been located, was found to match best the 100% exhale state of the 4D TP-CT. Probably, this
artefact has to be attributed to an unwanted inspiration by the patient during the 3D TP-CT
acquisition. Also for this patient, no coherent 4D CT data from the day of the treatment has
been available.
Due to the considerably prolonged irradiation time by the gated beam delivery in combina-
tion with the extremely irregular respiratory motion of the regarded patient, the activity induced
within the liver tissue and also within the right kidney has been found to be washed out for
the most part in the acquired post-irradiation PET scan. Only in the abdominal fatty tissue
surrounding liver and kidney, a considerable amount of irradiation-induced activity could be
detected. Qualitatively, the same observation has been made in the corresponding activity simu-
lations. However, while the amount of induced activity could be reproduced with an accuracy of
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Figure 6.10: Comparison of different 3D CT images of patient L4. The 3D TP-CT is shown as grey-
scale and overlayed by the rigidly registered 3D PET-CT (red) in the transaxial (left) and coronal
(middle) plane, as well as by the calculated 4D TP-CT-based mid-ventilation CT (red, right). In the
region of the PTV (white contour) and the right kidney (green contour), the TP-CT represents a phase
of significantly deeper inspiration, close to 100% exhale. PTV and kidney are thus shifted caudally
with respect to the 3D PET-CT and the mid-ventilation CT, which both show a comparable motion
state near 20% exhale in the PTV region.
about 10% in the liver, the simulation significantly overestimated the activity in the kidney, while
it underestimated the activity in the abdominal fatty tissue by about 50% (see figure 6.9). Due
to the high gradients in biological clearance in the caudal PTV region, the calculated activity
distribution is highly sensitive to the position of the kidney, the liver and the fatty tissue in the
underlying CT scan. As a consequence, rather large differences between the 3D simulations based
on the TP-CT and on the PET-CT have been observed (cf. figure 6.9) due to the clearly devi-
ating anatomies represented by these two scans, as shown in figure 6.10. While the 3D TP-CT
represents a motion state close to the maximum inspiration in the caudal PTV region, where
most of the activity has been detected, the 3D PET-CT corresponds to a motion state of about
20% exhale, i.e., liver and kidney are shifted in the cranial direction with respect to the TP-CT.
Compared to the measured data, a notably higher agreement has been found for the 3D
simulation based on the 3D PET-CT with respect to the 3D TP-CT simulation. The reason for
this has been identified in the more representative position of the kidney and the caudal edge
of the liver in the 3D PET-CT, as confirmed by a comparison to the calculated mid-ventilation
CT [Wolthaus et al., 2008] (see figure 6.10). The latter CT represents a time-averaged motion
state of the patient and was found close to the respiratory state of PET-CT scan in the PTV
region. As irradiation has also been performed with gating around end-exhale (i.e., 0% relative
amplitude), and herewith in a motion state considerably closer to the mid-ventilation CT and the
PET-CT, and since the 3D PET image also represents a time-averaged distribution of the induced
activity, a high agreement of measurement and PET-CT simulation could be found. Similarly, an
enhanced agreement of the 4D TP-CT simulation to the measurement has been observed, as the
calculation is inherently based on the presumably correct, phase-specific CT image and patient
geometry.
In the 4D TP-CT simulations of the physical dose, only slight interplay effects have been
noticed, thus demonstrating an effective motion mitigation by the gated beam delivery and con-
firming the finding that differences between 3D TP-CT and 4D TP-CT simulations are predom-
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(a) 3D TP-CT sim vs. 3D meas (b) 3D PET-CT sim vs. 3D meas (c) 3D sim vs. 4D sim, TP-CT
Figure 6.11: Results of the range verification for patient L4. The underestimated biological clearance
in the kidney leads to an apparent under-range in the measurement with respect to the 3D TP-CT
(left) and the 3D PET-CT (middle) simulations (cf. deep blue regions). Except from these range
differences, an enhanced agreement can be achieved by using the PET-CT, as differences between
TP-CT simulation and measurement are partially attributed to deviations in the CT contour. The
mean distal PET range deviation decreases from −1.7 mm for the TP-CT to −4.6 mm for the PET-CT
simulation, as range deviations in the kidney region are no longer compensated by over-ranges in the
upper part of the depicted range map on the left. Due to the discrepancy of the motion phases used for
gating (50% around 0% exhale) and represented by the TP-CT (100% exhale) remarkable deviations
between 3D and 4D TP-CT simulations have been found (right).
inantly caused by the previously described discrepancy of the 3D TP-CT motion state and the
average patient motion state, being close to the anticipated patient anatomy within the applied
gating window. Still, an enhanced agreement of the 4D TP-CT simulation to the measurement
with respect to the 3D PET-CT simulation has not been observed, even when being warped to a
coherent phase close to the mid-ventilation phase of the PET image (see appendix B). Probably,
this is due to remaining inter-fractional differences in the patient anatomy, as have been observed
in the comparison of the proximal CT contours in the performed range verification (cf. figure B.2
in appendix B).
These deviations in the patient contour have been found to enhance the overall agreement of
PET-based range estimations in the measurement and the 3D PET-CT simulation with respect
to the 3D TP-CT simulation, as illustrated in figure 6.11. Still, although the position of the
kidney is more representative in the 3D PET-CT, the significant underestimation of the biological
clearance in the kidney has been identified to provoke a severe over-range in the simulated data,
leading to an apparent under-range in the measurement (cf. , dark blue areas in figures 6.11 (a)
and (b)). In contrast to the other patients, it has also been noted that the determined PET-
based range of the 4D simulation remarkably depends on the actually regarded motion state. For
a coherent comparison to the time-averaged 3D PET measurement, the 4D calculated activity
distribution has thus been warped to the 20% exhale phase, close to the mid-ventilation position
(see appendix B), and a similar agreement as observed for the 3D TP-CT simulation (see figure
6.11 (a)) has been determined. However, this does not allow for the conclusion that 3D and 4D
TP-CT simulations exhibit similar ranges, as the 3D TP-CT does not represent the considered
20% exhale motion state in the PTV region. For a coherent comparison of these two data-sets,
the 4D TP-CT simulation in the 100% exhale phase, as described by the 3D TP-CT, has to
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be considered (cf. figure 6.11 (c)). Here, substantial differences in the distal PET ranges have
been found, which can be mainly attributed to the fact that the irradiation has been gated on
end-exhale, as considered in the 4D simulation, while the 3D TP-CT was found to represent a
motion state close to maximum inhale in the PTV region. As a consequence, the induced activity
is shifted to the caudal direction in the 4D TP-CT simulation, which introduces the observed
range differences with respect to the (3D) planned treatment. Although these range deviations
with respect to the 3D planning are clinically not critical, they might have been avoided, if the 3D
TP-CT had represented a motion state close to the end-exhale position, as originally intended.
This would have lead to coherent phases of 3D TP-CT, the applied GW and the post-irradiation
3D PET measurement, herewith diminishing range-differences due to the phase-mismatch of GW
and 3D TP-CT, and enabling an easier, more straightforward analysis of the data. In conclusion,
these investigations show that even if gating efficiently mitigates motion-related interplay effects,
the comparably large motion amplitude has to be carefully considered at the (3D) planning stage
and for data evaluation.
6.3 Discussion and conclusion
To the best knowledge of the author, this chapter presented the first application of PET-based
treatment verification to clinical cases under consideration of the patient respiratory motion.
While 3D (static) PET-based treatment monitoring has already been investigated in clinical
scenarios for in-beam, in-room, as well as offline PET acquisition systems (cf. section 3.3), inves-
tigations on the potential of extending this method to moving targets have, up to present, been
restricted to simplified moving phantom experiments (see section 4.1). In this chapter, four of the
first HCC patients treated with scanned 12C ion beams at HIT have been studied in detail to in-
fer feasibility and performance of 4D offline PET-based treatment verification under considerably
more challenging clinical conditions.
For patients L1 and L4 with comparably small (residual) SI motion amplitudes of 2 and
5 mm, respectively, hardly any motion-related interplay effects were noticed in the 4D physical
dose and activity simulations, in agreement with the findings reported in [Richter et al., 2014] for
analytical 4D dose reconstructions of HCC patient irradiation at HIT. In the case of patient L1,
tumour motion could effectively be diminished due to the location of the target volume close to
the abdominal press and the inclusion of the organ motion into the offline PET-based treatment
monitoring workflow did not result in a gain of knowledge. Hence, a 3D analysis of irradiation
and post-therapeutic PET measurement is deemed sufficient for patients with comparably small
motion amplitudes. In the case of patient L4, a somewhat different situation has been encoun-
tered, as the tumour motion has been mitigated by beam gating during the irradiation, while
the CTV mean motion amplitude itself still amounted to more than 7 mm. As a consequence,
the underlying 3D TP-CT is affected by imaging artefacts and does not represent one coherent
motion state. In particular, the PTV region was found in a state of extreme inhale, so that
beam gating around the end-exhale plateau lead to a phase-mismatch between planning and ir-
radiation and herewith to an overall limited agreement (without clinically relevant implications)
of 3D calculated PET expectation and measurement. Improved agreement with the measured
irradiation-induced activity could be achieved by using the 4D TP-CT data and the correspond-
ing set of state RTplan files for simulating the expected activity. Due to the overall small motion
amplitude within the GW, it has, however, been found that results similar to the 4D calculation
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can be achieved by a 3D simulation on a 3D CT image close to the average respiratory state of
the patient, and herewith to the respiratory phase within the GW (applied around the stable
end-exhale position) and the time-averaged 3D PET image. Still, even though a 3D approach
might be sufficient for these kind of gating patients, it is mandatory to account for the target
motion in the selection of the used 3D data-sets, which have to exhibit a coherent respiratory
state for conclusive comparison of treatment planning data, simulation and post-irradiation PET
measurement.
In contrast to patients L1 and L4, patients L2 and L3 are both subject to a significantly
larger respiratory motion amplitude of about 10 mm in SI direction. In both cases, the inclusion
of organ motion in the performed simulations lead to the formation of interplay patterns in the
distal PTV region. Particularly for patient L2, the calculated interplay pattern could be detected
in the corresponding post-irradiation measurements as well, thus indicating the advantages of
incorporating target motion into the PET-based treatment verification workflow. The potential
benefits of 4D motion-compensated PET image reconstruction were studied for this patient, too,
but could not be finally concluded due to the enhanced level of uncertainty in the 4D PET
image, introduced by the reduced number of true coincidences in the underlying 4D gated PET
image reconstruction, as well as by the required DIR. Moreover, the predicted interplay pattern
could be detected in the 3D PET image without significant loss of information due to motion-
induced blurring, as well. For patient L3, an identification of the expected interplay effects in the
reconstructed measured data was considerably more challenging, due to the by about 30% reduced
number of true coincidences with respect to patient L2. The comparison of 4D simulations and
measurements especially showed that a distinction of the expected different interplay patterns
after the two regarded treatment fractions is hindered by the high noise level in the reconstructed
images, even though the optimised reconstruction scheme deduced in chapter 5 has been applied.
In general, the small number of true counts and the resulting high noise level are seen as one
of the main challenges in 4D offline PET-based treatment verification, since the image noise
might exceed the inhomogeneity level of motion-related interplay patterns and thus prevent their
detection. A further reduction of the image noise would be feasible by enhancing the post-
reconstruction Gaussian filter, which would, however, directly lead to the blurring of small-scale
interplay effects. Hence, a compromise between image granularity and image noise has to be
carefully made.
Additional uncertainties in 4D offline PET monitoring, particularly affecting the MC calcu-
lation of the expected activity pattern, are introduced by uncertainties in the time alignment of
the beam delivery sequence and the respiratory motion signal (lately eliminated by the use of a
dedicated EtherCAT system for synchronous data recording [Richter et al., 2014]), by possible
irregular breathing motion, by inter-fractional variations of the respiratory motion, by changes
in the correlation of the external motion surrogate and the internal motion with respect to the
4D TP-CT acquisition and by the limited accuracy of the used DIR. While the DIR uncertainties
are considered less crucial with respect to the limited spatial resolution and the high noise level
in the acquired PET images, variations in the breathing motion have been found to lead to sub-
stantial deviations between 4D activity prediction and measurement. In particular, the vertebral
bone activation observed for patient L3 due to a significant over-shoot in the cranial PTV region,
could not be reproduced in the 4D calculations on the basis of the 4D TP-CT data, which does
not cover motion states of comparably deep inhalation as presumably encountered during the
beam application. Probably, these uncertainties could be limited by acquiring 4D CT data on
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the actual treatment day, though at the drawback of an additional radiation exposure to the pa-
tient. A future alternative to handle potential breathing irregularities and variations during the
actual beam application might be provided by the construction of an extended 4D CT data-set
on the basis of 4D MRI imaging [Boye et al., 2013]. MRI imaging is dose-free and thus allows for
repeated, prolonged imaging and studying of breathing irregularities and variations. DIR maps
retrieved from the time-resolved MRI data can then be used for warping of a 3D (breath-hold)
CT to form a 4D CT data-set which covers a considerably wider range of respiratory states than a
conventional 4D CT scan. Direct tracking of internal structures in absolute coordinates during 4D
imaging and beam application, as potentially provided by the US tracking device investigated in
section 4.2 [Schwaab et al., 2014], might additionally be employed for an improved identification
of the actual respiratory motion state.
The observed overshoot for patient L3 is, however, also directly related to the location of
the PTV close to the diaphragm, which is prone to range uncertainties due to the large density
gradients between lung and liver tissue. For more central lesions within the liver (cases L1 and
L2) a substantially smaller impact of the target motion on the beam range could be identified. In
the case of patient L4, changes in the WEPL due to respiratory motion are expected to be small
as well, but due to the activity localisation in the fatty tissue caudal to the liver, a dependence of
the 4D calculated range on the respiratory reference state in the 4D simulation has been found.
Thus, for similar cases a coherent phase of simulation and PET measurement has to be ensured
for proper range validation and comparison.
In two (L3 and L4) of the four studied patients, considerable deviations in the determined
distal PET ranges were found to be introduced by inaccuracies in the modelling of the biological
clearance, leading to severe differences in the shape of the analysed 1D activity profiles along the
beam axis and hindering a thorough range comparison. In general, the modelling of the isotope
washout was identified as a second major challenge in 4D offline PET-based treatment verification,
besides the inaccuracies in the PET image reconstruction due to the low amount of detected true
coincidences. In particular, a large inter-patient variability in the liver has been found. Also in the
abdominal fatty tissue, large discrepancies (> 50%) in the absolute amount of activity between
measurement and prediction could be detected. Moreover, in the study of patient L3, a space-
dependency of the isotope washout within the irradiated PTV has been observed, which further
undermines a proper identification and quantification of irradiation-induced interplay patterns.
Summarising the results of this chapter, the feasibility of 4D offline PET-based treatment
verification under clinical conditions has been shown and the major challenges have been iden-
tified. For the particular cases of patients exhibiting small motion amplitudes, not exceeding a
size of about 5 mm, a static (3D) analysis of the post-irradiation data and comparison to a static
FLUKA calculation is deemed to be sufficient. In the case of SI motion amplitudes in the order
of 10 mm and above, however, interplay patterns due to respiratory motion have been detected
in the calculated 4D activity distributions, thus indicating a potential gain of knowledge for of-
fline PET-based treatment verification by taking organ motion into account. In one case, with
comparably high counting statistics (about 700, 000 true counts), the expected interplay pattern
could be detected with high agreement in the measured data, as well. If going to lower num-
bers of true coincidences (around 400, 000) the considerable image noise, however, substantially
challenges the detection of the expected interplay patterns in the measured data and herewith
limits the sensitivity of PET monitoring to motion-related deviations from the planned treat-
ment application. Dedicated image reconstructions algorithms with improved noise robustness
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are presently under investigation, with a special focus on 4D motion-compensated PET imaging.
Here, potential benefits with respect to the currently applied 4D gated image reconstruction are
anticipated by 4D MLEM algorithms [Stützer et al., 2013], as well as by the so-called sinogram
warping technique [Gianoli et al., 2014]. Both methods make used of the full amount of detected
true coincidences in each of the reconstructed motion states, and thus reduce uncertainties in the
reconstructed single-phase 4D PET images. Besides the low amount of induced activity, a main
restriction in the potential of 4D offline PET-based treatment verification is imposed by uncer-
tainties in the modelling of the biological clearance. As a consequence, PET-based treatment
verification, up to present, has to be considered as a qualitative tool for in-vivo dose monitor-
ing. In particular, a reliable quantification, i.e., with uncertainties of few percent, of over- and
under-dosage due to motion-related interplay effects cannot be ensured. Further improvements in
this context can be achieved by implementing patient-specific washout models for post-processing
of the simulated data, which should thus be addressed in future investigations, or by dedicated
instrumentation allowing for in-room or in-beam PET imaging, being considerably less sensitive
to washout processes [Helmbrecht et al., 2013].
The presented results are still based on a small number of exemplary patient cases. In order
to draw conclusions on the potential of 4D offline PET-based treatment verification with high
confidence, a careful analysis of further patient data-sets is of need. In particular, these cases
should exhibit motion amplitudes of above 10 mm, a high enough (> 600, 000) number of true
coincidences and provide 4D CT data of the treatment day. Up to present, beyond the presented
case of patient L2, such data-sets are not available.
Chapter 7
Conclusion and outlook
Over the last decades, tumour therapy with proton and heavy ion beams has become an emerging
alternative to conventional radiation therapy with photons. The accessible steep dose gradients in
ion beam therapy enable a highly conformal dose delivery to arbitrarily shaped tumour volumes, a
low exposure of close-by organs at risk and a reduced integral dose to normal tissue with respect
to photon therapy. On the other hand, they are accompanied by an enhanced sensitivity to
uncertainties, e.g., in patient positioning or due to changes in the patient anatomy. Hence, it is
highly desirable to thoroughly monitor the actually applied treatment in order to fully exploit
the anticipated advantages of ion beam therapy. Up to present, the only clinically implemented
approach of monitoring the delivery of single treatment fractions close in time to the actual
irradiation is based on PET imaging of the irradiation-induced β+-emitter within the patient.
This method is also being pursued at HIT, using a commercial full-ring TOF PET/CT scanner
installed next to the treatment rooms for post-irradiation patient imaging.
Additional uncertainties in ion beam therapy are introduced by inter- and intra-fractional
motion. Particularly intra-fractional motion, mostly related to the respiration of the patient,
might introduce severe changes in the particle beam range on a time-scale of seconds and here-
with during the actual beam application. In the case of scanned ions beams, as used at HIT,
interference effects between the dynamic beam delivery and the respiratory motion can addition-
ally lead to distortions of the applied dose distribution and the formation of regions of over- and
under-dosage. However, despite the increased level of uncertainty, the application of heavy ion
beams to moving tumours is of high interest, since e.g., HCC patients, which have been investi-
gated in the scope of this work, have been shown to significantly benefit from irradiation with 12C
ions in clinical trials at NIRS, Japan. Although motion can be mitigated by techniques like beam
gating or by abdominal compression, the residual tumour motion, the questionable correlation
between the required external motion surrogate and the internal tumour movement, as well as
variations in the breathing trajectory evoke a strong need for verification of the actually applied
treatment under consideration of the actual organ motion.
In this work, the feasibility and potential of 4D offline PET-based treatment verification with
a commercial full-ring TOF PET/CT device, taking into consideration the target motion during
the beam application, as well as during the subsequent PET acquisition, have been investigated
for the first time. A dedicated moving phantom irradiation study at a comparably high number
of true coincidences not only demonstrated the feasibility of the pursued 4D offline PET-based
treatment monitoring approach, but also highlighted the potential of this technique under labora-
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tory conditions: the different investigated set-ups coherently showed that sub-millimetre accuracy
and precision can be achieved in the determination of the ion beam range as well as in the de-
tection of distortions introduced by interplay effects between the dynamic beam delivery and the
phantom motion. The sensitivity of the pursued 4D PET monitoring approach was underlined
by 4D simulation studies on potential time shifts between the recorded surrogate motion signal
and the beam delivery sequence, which could be determined with an accuracy of about 50 ms
on the basis of the post-irradiation PET measurement. One major limitation for the achievable
precision, accuracy and sensitivity to motion-related interplay patterns was identified in the low
amount of irradiation-induced activity and the resulting high image noise level. Particularly in
the pursued 4D gated PET image reconstruction, which is presently the only implemented time-
resolved reconstruction technique on the used Biograph mCT scanner, the reconstructed images
of the single motion states suffer from considerably reduced statistics due to the subdivision of
the acquired LM data into the single phases. Improvements are foreseen by 4D MLEM and
sinogram warping image reconstruction algorithms, which inherently consider the full amount of
events for image reconstruction within each motion state, and are currently under investigation.
In the case of irregular breathing patterns, as typically encountered in post-irradiation patient
PET imaging, an improved performance might moreover be achieved by enhancing the reliability
of sorting the acquired data into the reconstructed motion states. In this context, one promis-
ing approach is the direct tracking of internal structures in absolute coordinates by ultrasound
imaging. First steps for an integration of this tracking technique in time-resolved PET imaging
have been presented in this work, as well: in a simplified set-up with moving point sources, an
equivalent performance to the certified ANZAI gating system could be demonstrated in terms
of motion mitigation. Investigations with a static point-source arrangement also proved that
the degradation of the acquired PET images due to the presence of the US probe within the
FOV is negligible, as long as a minimum distance between measured activity and US probe of
few centimetres is kept. Further studies with decoupled motion trajectories in more than one
dimension and under conditions closer to clinical scenarios, however, still have to demonstrate
the anticipated superiority of US-based motion tracking.
Besides possible future improvements in 4D PET imaging by new reconstruction algorithms
and tracking devices, this work also showed that optimisation of the applied image reconstruc-
tion scheme, considering only reconstruction options already provided by the used commercial
PET/CT device, can enhance the imaging performance in low count scenarios, as particularly
encountered in time-resolved gated PET imaging. In a dedicated phantom imaging study, an
improved geometrical fidelity, as well as an up to 50% reduced image noise could be achieved by
reducing the number of iterations and increasing the size of the post reconstruction Gaussian filter
with respect to the originally used settings at HIT, which had been inspired by typical settings
in nuclear medicine imaging at significantly higher counting statistics. Under poor statistical
conditions, the inclusion of a scanner resolution model (PSF) and TOF information in the recon-
struction algorithm were found to enhance the imaging performance and to allow for an accurate
activity quantification down to less than 80, 000 true coincidences at random fractions of above
95%. The performed measurements and corresponding simulations also helped to identify the
low number of true coincidences as the limiting factor in terms of geometrical fidelity and image
noise in low-statistics PET-based treatment verification, as long as PSF and TOF information
are considered during reconstruction. The high LSO-related random background, on the other
hand, was found to mainly lead to an increased background activity which can be neglected in
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the context of treatment monitoring, where the approximate position of the beam is known. A
more critical issue was found in the build up of spurious activity within the imaged object due
to an inaccurate scatter correction at very low true numbers (below 100, 000). This effect can,
however, be limited by the application of PSF and TOF information and a reduced number of it-
erations. The analysis of exemplary 3D post-irradiation patient PET scans confirmed a reduction
of the image noise by about 50% when using the optimised reconstruction scheme derived in the
phantom imaging study at an equivalent or even improved geometrical performance in terms of
beam range verification. Consequently, the retrieved optimal reconstruction scheme is presently
in clinical use for all post-irradiation PET imaging studies at HIT.
Following the results of the characterisation of the PET/CT scanner performance under ex-
tremely low counting statistics, the feasibility of 4D offline PET-based treatment verification
has eventually been studied on the basis of four exemplary HCC patients irradiated at HIT,
representing the first attempt to extend the technique of PET-based treatment monitoring to
moving targets under clinical conditions. In comparison to the above-mentioned phantom irra-
diation study, patient cases typically exhibit further challenges due to a reduced number of true
counts emerging from a less confined region of activation, irregular respiratory motion and ac-
tivity washout due to biological processes. Nevertheless, the feasibility of 4D offline PET-based
treatment verification under clinical conditions could be shown. Based on the investigated small
patient cohort, a benefit by taking into account the target motion is anticipated particularly
for patient cases with comparably high numbers of true counts (above 600, 000) and SI motion
amplitudes in the order of 10 mm. Still, improvements have mainly been noticed on the side
of the calculated prediction of the induced activity, while a gain of knowledge by 4D motion-
compensated PET imaging could not be finally concluded due to the underlying uncertainties in
the 4D gated PET image reconstruction, despite using the optimised reconstruction scheme. At
reduced numbers of true counts (about 400, 000), image noise increases and a reliable detection
of motion-induced interplay patterns is deemed not feasible at present. Additional challenges are
imposed by inaccuracies in the modelling of activity washout. Variations from patient to patient
or even within a single target volume are presently not considered in the applied washout model,
but might further impede an accurate quantification of motion-induced interplay effects. As a
consequence, 4D offline PET-based treatment verification can, up to now, only be considered
as a qualitative tool for monitoring the treatment of moving targets. For a reliable statement
on the potential of 4D offline PET-based treatment monitoring under clinical conditions, more
patient data-sets with large enough motion amplitudes and counting statistics, as well as coher-
ent 4D CT data of the treatment day, are still of need. Additionally, irradiation studies with
anthropomorphic moving phantoms are considered of high interest for closing the gap between
the presented simplified homogeneous phantom cases and the substantially more complex patient
irradiation. Future studies should particularly aim at the development of dedicated noise-robust
image reconstruction algorithms and an improved patient-specific washout model.
The two main limiting factors, namely the low number of acquired true coincidences and
the inaccurately modelled biological clearance, might, however, also be tackled by dedicated
in-beam PET implementations, which inherently offer the ability to detect a higher number of
counts [Shakirin et al., 2011; Parodi et al., 2008b] and are less prone to washout processes due
to the significantly shorter delay between formation and detection of the β+-emitter [Helmbrecht
et al., 2013]. Over the last years, various studies on the optimal geometrical design of dedicated
in-beam PET cameras, including Open-PET [Yamaya et al., 2008; Tashima et al., 2012], partial-
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ring detectors [Surti et al., 2011; Robert et al., 2013] and C-shaped [An et al., 2013] arrangements,
have been conducted and demonstrated a high potential for improvement with respect to presently
operating in-beam cameras. Moreover, the development of detector systems with new crystals
like LaBr3 (Lanthanum(III) bromide) and read-out by (digital) silicon photomultiplier (SiPM)
promises advances in the accessible TOF resolution [Moses, 2007; Schaart et al., 2010] in the
near future, which will strongly enhance the imaging performance of partial ring PET detector
systems that suffer from truncated projections and the related limited angle artefacts [Crespo
et al., 2007; Surti et al., 2011]. Beyond that, improvements are foreseen by the implementation
of depth-of-interaction (DOI) PET detectors [Shao et al., 2013], by dedicated reconstruction
algorithms [Cabello et al., 2013], as well as the feasibility of increasing the number of detected
coincidences by acquiring PET data also during the beam application, and not only within the
spill pauses [Sportelli et al., 2014]. Taking into consideration these on-going developments, a
clear benefit for PET-based treatment verification can be expected from dedicated TOF in-
beam PET cameras within the next years and might further push the potential of 4D in-vivo
treatment monitoring. For commercial full-ring PET/CT scanner, advances by an increased TOF
resolution, implementation of DOI detectors and noise-robust image reconstruction algorithms are
anticipated as well, but in the case of offline imaging, the number of detectable true coincidences
still remains limited and the sensitivity to biological clearance increased with respect to in-beam
solutions. In this context, in-room PET imaging with commercial full-ring PET devices might
be considered as further option to foster 4D PET-based treatment monitoring. The reduced
time-delay between irradiation and PET acquisition allows for imaging at higher true coincidence
rates and provides a reduced sensitivity to biological washout with respect to offline imaging.
Compared to in-beam implementations, however, washout still plays an increasingly important
role and has been observed to degrade the results of in-room PET-based treatment verification
if not being modelled correctly [Zhu et al., 2011].
Alternative approaches for in-vivo range and treatment verification beyond PET imaging,
such as prompt-γ [Testa et al., 2009; Smeets et al., 2012] or interaction vertex imaging [Henriquet
et al., 2012; Gwosch et al., 2013], both relying on the detection of prompt irradiation products
(γ-rays, protons, ions) emitted on a time-scale of 10−21−10−16 s in nuclear reactions, are presently
under investigation, too. In contrast to PET-based treatment monitoring, these techniques are
insensitive to washout processes, but they are still at an experimental stage and a careful eval-
uation of their potential under clinical conditions, particularly in the presence of organ motion,
is of need. Many of the computational methods developed in the scope of this work, concerning
in particular the inclusion of organ motion in the underlying MC simulations, could, however, be
applied to these techniques, as well.
Appendix A
Additional results of the moving
phantom studies
A.1 Line Mono irradiation study
The results retrieved in the range-analysis of the Line Mono irradiation study are given in table
A.1. The PET-based range differences DRi presented in section 4.1.2.2 have been calculated on
the basis of these range data with respect to RPET,4. The determined absolute ranges in table
A.1 should not be compared to the ranges determined in the Square study evaluation, because of
the different shapes of the integrated ADP and herewith the inconsistent position of A5 in both
studies.
Table A.1: Results of the range analysis of the Line Mono irradiation study for all investigated
data-sets. The used PMMA fence leads to the formation of four different range values, which have
been analysed separately in terms of mean value and standard deviation.
Study RPET,1[mm] RPET,2 [mm] RPET,3[mm] RPET,4[mm]
Line Mono, static 58.2± 0.1 62.9± 0.3 68.6± 0.7 75.4± 0.5
Line Mono G50, 3D 57.8± 0.2 63.3± 0.3 69.1± 0.6 75.0± 1.1
Line Mono G50, 4D 57.3± 0.1 62.8± 0.3 68.1± 0.5 74.9± 0.5
FLUKA, static 58.5± 0.1 63.5± 0.1 68.9± 0.6 75.8± 0.4
FLUKA G50, 4D 58.2± 0.1 63.3± 0.2 68.7± 0.8 75.5± 0.6
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A.2 Line Mult irradiation study
All results obtained in the profile analysis of the Line Mult irradiation study data-sets are given
in table A.2. The determined PET-based ranges are not suited for a direct comparison to the
ranges of the two other studies (Square and Lino Mono) because the PMMA fence has not been
taken into account in the data analysis and the position of A5 slightly varies with the particular
shape of the ADP for each investigated geometry.
Table A.2: Results of the Line Mult irradiation study. A high agreement (within 1 mm) of all consid-
ered data-sets in terms of RPET, FWHMy and Py has been found. For the direction of motion, results
are notably less accurate and precise, which can mainly be attributed to the significant distortion
of the shape of the analysed lateral profiles by the target motion and the resulting interplay effects,
particularly in the case of the G50 study.
Study RPET[mm] FWHMy[mm] FWHMz[mm] Py[mm] Pz[mm]
Line Mult, static 52.6± 0.6 19.7± 0.7 142.6± 0.9 8.7± 0.4 11.3± 0.9
Line Mult G50, 3D 52.8± 0.4 20.2± 0.7 141.8± 1.9 8.5± 0.6 24.3± 4.2
Line Mult G50, 4D 52.2± 0.5 19.8± 1.2 138.6± 2.3 7.9± 1.1 20.5± 10.2
Line Mult G20, 3D 52.9± 0.6 20.1± 0.9 146.8± 1.6 8.6± 0.4 16.7± 2.0
Line Mult G20, 4D 52.2± 0.6 19.9± 1.0 143.1± 0.6 8.1± 0.5 10.1± 2.7
FLUKA, static 52.7± 0.3 20.4± 0.3 145.1± 0.1 8.8± 0.2 9.4± 0.2
FLUKA G50, 4D 52.7± 0.3 20.1± 0.3 140.1± 0.9 8.8± 0.6 26.8± 15.0
FLUKA G20, 4D 52.5± 0.3 20.4± 0.2 144.9± 0.1 8.8± 0.1 9.6± 0.1
Besides, single motion phases as retrieved within the 4D gated PET reconstruction have been
analysed in a similar way as the motion-compensated 4D PET images to infer the accuracy and
precision under a reduced number of true coincidences. Each single phase contains only 1/8 of
the total number of coincidences, leading to a significantly decreased SNR. The results of the
single phases are presented in table A.3 and compared to the results of the registered, and hereby
smoothed, 4D motion-compensated images.
Table A.3: Results of the Line Mult irradiation study for a single phase (number 5) of the gated 4D
PET images. In comparison to the motion compensated images, a considerably reduced precision can
be noticed. In the G20 study, the penumbra in the direction of motion cannot be recovered correctly.
Study RPET[mm] FWHMy[mm] FWHMz[mm] Py[mm] Pz[mm]
L. Mult G50, 4D 52.2± 0.5 19.8± 1.2 138.6± 2.3 7.9± 1.1 20.5± 10.2
L. Mult G50, 4D, ph 5 52.4± 1.1 19.1± 2.3 133.9± 4.4 8.5± 1.4 19.9± 7.7
L. Mult G20, 4D 52.2± 0.6 19.9± 1.0 143.1± 0.6 8.1± 0.5 10.1± 2.7
L. Mult G20, 4D, ph 5 53.0± 1.7 18.9± 1.8 137.0± 4.2 8.4± 1.1 24.6± 11.0
Appendix B
Additional results of the 4D patient
data analysis
B.1 Patient L4
In addition to the 2D activity distributions for patient L4 shown in section 6.2.4, the 4D TP-CT
simulation data, warped to the 20% exhale phase, is shown in figure B.1. This phase was found
close to the mid-ventilation phase and is thus best suited for comparison to the acquired time-
averaged 3D PET data. Indeed, the 4D TP-CT simulation warped to the 20% exhale phase shows
an enhanced agreement to the measured 3D PET data with respect to the 4D TP-CT simulation
in the reference phase of 100% exhale, particularly in terms of the beam range (indicated by
the red arrow in figure B.1). For comparison to the 3D TP-CT simulation, however, the 4D
TP-CT simulation in the reference phase of 100% exhale, as represented by the 3D TP-CT in the
PTV region, should be considered. Here, an over-ranges in the 4D TP-CT simulation due to the
phase-mismatch between 3D TP-CT and gating window could be noticed (cf. section 6.2.4).
In addition to the distal PET range deviations between the statically reconstructed measure-
ment after the first treatment fraction and the 3D TP-CT and the 3D PET-CT simulation, as
shown in section 6.2.4, figure B.2 additionally shows the determined proximal CT profile de-
viations for patient L4. As can be seen, the determined PET-based range differences between
measurement and 3D TP-CT simulation are partially attributed to deviations in the proximal
CT contour on the treatment day. Consequently, an enhanced agreement of 3D PET-CT simula-
tion and 3D measurement has been found outside the region which is affected by the incorrectly
modelled washout in the kidney (deep blue region in the 2D range deviation maps).
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Figure B.1: 2D activity distributions for patient L4. The 3D (left) and 4D TP-CT simulations, once
in the 100% exhale reference phase (second from left) and once in the 20% exhale phase (second from
right) are shown next to the corresponding 3D PET image (right) after the first treatment fraction.
While the 100% exhale phase corresponds to the phase of the 3D TP-CT in the PTV region, the 20%
exhale phase is close to the mid-ventilation phase, and herewith the phase of the time-averaged PET
image. Consequently, the 20% exhale 4D TP-CT simulation is best suited for the comparison to the
3D PET acquired after the first treatment fraction. Compared to the 3D TP-CT simulation and also
to the 4D TP-CT simulation in the 100% exhale phase, the 4D TP-CT simulation in the coherent 20%
exhale phase exhibits an improved agreement with the measured data. Particularly the beam range
matches better with the measurement in the 20% exhale than in 100% exhale representation (cf. red
arrows).
(a) 3D PET-CT sim vs. 3D meas (b) 3D TP-CT sim vs. 3D meas (c) 3D TP-CT vs. 3D PET-CT
Figure B.2: Additional results of the range verification for patient L4. Except from the range
differences due to the inaccurately modelled isotope washout in the kidney (deep blue region), an
enhanced agreement to the measurement is achieved by the 3D PET-CT simulation (left), as differences
between TP-CT simulation and measurement (middle) are partially attributed to deviations in the
CT contour (right). The dark red regions in the CT contour deviation map are attributed to a mis-
identification of the vacuum mattress as outer patient contour in the CT profile analysis and are thus
not of concern.
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Haberer, T., Härtig, M., Jäkel, O., Parodi, K., Welzel, T., and Combs, S. E. (2013). Hypofrac-
tionated carbon ion therapy delivered with scanned ion beams for patients with hepatocellular
carcinoma feasibility and clinical response. Radiat. Ocol., 8(59).
Harpen, M. D. (2004). Positronium: Review of symmetry, conserved quantities and decay for the
radiological physicist. Med. Phys., 31(1):57–61.
Hashimoto, T., Tokuuye, K., Fukumitsu, N., Igaki, H., Hata, M., Kagei, K., Sugahara, S., Ohara,
K., Matsuzaki, Y., and Akine, Y. (2006). Repeated proton beam therapy for hepatocellular
carcinoma. Int. J. Radiat. Oncol.Biol.Phys., 65(1):196–202.
Helmbrecht, S., Enghardt, W., Parodi, K., Didinger, B., Debus, J., Kunath, D., Priegnitz, M.,
and Fiedler, F. (2013). Analysis of metabolic washout of positron emitters produced during
carbon ion head and neck radiotherapy. Med. Phys., 40(9).
Helmbrecht, S., Santiago, A., Enghardt, W., Kuess, P., and Fiedler, F. (2012). On the feasibility of
automatic detection of range deviations from in-beam PET data. Phys. Med. Biol., 57(5):1387–
1397.
118 BIBLIOGRAPHY
Henriquet, P., Testa, E., Chevallier, M., Dauvergne, D., Dedes, G., Freud, N., Krimmer, J.,
Létang, J. M., Ray, C., Richard, M.-H., and Sauli, F. (2012). Interaction vertex imaging (IVI)
for carbon ion therapy monitoring: a feasibility study. Phys. Med. Biol., 57(14):4655–4669.
Highland, V. (1975). Some practical remarks on multiple scattering. Nucl. Instrum. Methods,
129(2):497–499.
Hof, H., Herfarth, K. K., Mnter, M., Hoess, A., Motsch, J., Wannenmacher, M., and Debus, J.
(2003). Stereotactic single-dose radiotherapy of stage I nonsmall-cell lung cancer (NSCLC).
Int. J. of Radiat. Oncol. Biol. Phys., 56(2):335–341.
Hoisak, J. D., Sixel, K. E., Tirona, R., Cheung, P. C., and Pignol, J.-P. (2004). Correlation of
lung tumor motion with external surrogate indicators of respiration. Int. J. Radiat. Oncol.,
60(4):1298–1306.
Hudson, H. and Larkin, R. (1994). Accelerated image reconstruction using ordered subsets of
projection data. IEEE T. Med. Imaging, 13(4):601–609.
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